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ABSTRACT 
ADAPTATIONS OF THE SUPRASPINATUS TENDON AND MUSCLE IN A RAT 
MODEL OF EXERCISE 
 
Sarah Ilkhanipour Rooney 
Dr. Louis J. Soslowsky 
 
Rotator cuff tendon and muscle can beneficially adapt to exercise, but it is 
unknown how acute responses following a single bout of exercise lead to chronic, 
beneficial adaptations. To develop new prevention and treatment strategies for overuse 
injuries, we must first characterize how tissues adapt to non-injurious loading. One 
feature that may distinguish beneficial and detrimental responses are pathways associated 
with inflammation and tissue healing, including activation of the arachidonic acid 
cascade and matrix turnover facilitated by matrix metalloproteinases (MMPs). The 
objective of this dissertation was to characterize temporal, acute and chronic responses of 
the rat supraspinatus to non-injurious exercise and examine the roles of cyclooxygenases-
1 and -2 (arachidonic acid cascade components) and MMPs in governing these responses 
by using pharmacologic inhibition. Using a rat model of non-injurious exercise, we 
showed that tendon adapted chronically by enhancing its mechanical properties. 
Following a single bout of exercise, tendon showed mild trends toward reduced 
mechanical properties, which may initiate the beneficial adaptations detected chronically. 
Exercised tendon also had decreased MMP activity. We administered ibuprofen, an 
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inhibitor of cyclooxygenases-1 and -2, to understand how this commonly used over-the-
counter drug affects muscle and tendon responses to exercise. Ibuprofen did not 
detrimentally affect tendon mechanical properties but did result in decreased muscle fiber 
cross-sectional area. Taken together, these findings imply that the arachidonic acid 
cascade is not a primary modulator of tendon adaptations to non-injurious exercise but is 
important for muscle growth. Finally, we studied the effects of doxycycline, a broad-
spectrum MMP inhibitor, on supraspinatus muscle and tendon adaptations to exercise. 
Doxycycline enhanced tendon mechanical properties and collagen organization from 
sedentary animals but not in exercised animals, which supports the increased MMP 
activity detected in sedentary tendons. Doxycycline reduced muscle fiber cross-sectional 
area specific to exercised animals. We conclude that the pathways responsible for muscle 
and tendon adaptations to exercise may be tissue-dependent, and drugs such as ibuprofen 
and doxycycline also have activity-dependent effects. These studies provide a foundation 
for future work to develop more efficient physical training regimens and new prevention, 
treatment, and rehabilitation modalities for overuse injuries.      
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Chapter 1: Introduction 
A. Introduction 
Rotator cuff tendinopathy, which primarily affects the supraspinatus tendon, is 
estimated to affect 6.1% of women and 4.5% of men ages 25-64 years in the general 
population.
113
 If left untreated, the tendon degeneration can progress to a rotator cuff tear, 
which affects up to 50% of asymptomatic people over the age of 50 years.
72,102,117
 These 
injuries are especially common in laborers and athletes that repeatedly use overhead 
activity. The proposed etiology is accumulated microtrauma in which the tendon is 
unable to properly adapt to the loading, resulting in a chronic overuse injury. These 
injurious changes are in contrast to those found following non-injurious exercise, in 
which the tissue is able to beneficially adapt to the loading. The fine line between 
beneficial and detrimental loading conditions has not been elucidated.  
One feature that may distinguish beneficial and detrimental adaptations to loading 
is the role of pathways associated with inflammation. Acute inflammation is a series of 
biologic events following injury. Two important processes related to inflammation are 
activation of the arachidonic acid cascade and matrix turnover facilitated by a class of 
enzymes called matrix metalloproteinases (MMPs). Previous studies suggest that 
activation of these inflammatory pathways is important for enabling tendon and muscle 
regeneration following acute injury; however, the mechanisms governing the role of these 
inflammatory pathways in the adaptation of tendon and muscle to physiologically 
relevant loading conditions is unknown.  
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The use of pharmacologic inhibitors of these two inflammation-related pathways 
(arachidonic acid cascade and MMPs) may help identify their roles in tissue adaptations 
to load. Ibuprofen, one of the top three consumed drugs in the United States, is an 
inhibitor of cyclooxygenases-1 and -2, components of the arachidonic acid cascade. 
Current literature exploring the effects of ibuprofen on tissue adaptations to loading is 
unclear, despite its prevalent use. Doxycycline, in addition to being an antibiotic, is an 
MMP inhibitor that has been suggested as a treatment to improve tissue healing following 
acute injury. The effect of doxycycline on muscle and tendon adaptions to load has not 
been explored. Administration of ibuprofen and doxycycline, inhibitors of two pathways 
associated with inflammation, may highlight the mechanisms that manage tissue 
responses to loading.  
The original objective of this dissertation was to investigate and compare an 
overuse and non-injurious exercise model to distinguish pathologic from physiologic 
adaptations to load; however, only the non-injurious exercise model was used here.  
Therefore, the goal of this dissertation is to use an animal model to characterize how 
supraspinatus tendon and muscle adapt to non-injurious exercise over time and the roles 
of two inflammation-related pathways (arachidonic acid cascade and MMPs). Aim 1 
characterizes the natural, temporal response of tendon to non-injurious loading. Aim 2 
helps to answer the question “Will ibuprofen adversely affect muscle and tendon 
adaptations to exercise?” Finally, Aim 3 explores the role of MMPs in sedentary and 
exercised supraspinatus tendon and muscle by using doxycycline as a pharmacologic 
agent to inhibit MMP activity.  
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Before addressing the role of inflammation in overuse injuries, we must first 
understand its role in tissue adaptations to non-injurious exercise. This research is 
innovative in that it directly investigates the supraspinatus tendon and muscle response to 
non-injurious loading acutely and chronically using clinically relevant drugs. These 
studies will identify the key processes associated with beneficial tissue responses to 
exercise to inform physical training regimens. Importantly, results will reinforce or 
challenge the regular use of anti-inflammatory drugs. Finally, these studies will also 
provide a foundation to support development of new prevention, treatment, and 
rehabilitation modalities for tendinopathy.  
B. Background 
1. Rotator Cuff Anatomy 
The rotator cuff refers to the four muscles and associated tendons that stabilize the 
shoulder: supraspinatus, infraspinatus, subscapularis, and teres minor. These muscles 
originate on the scapula and insert (through their tendons) on the humerus. Of these four 
tendons, the supraspinatus is most commonly injured with tendinopathy (tendon 
degeneration) or tear. The supraspinatus passes underneath the coracoacromial arch, a 
bony-ligamentous arch formed by the acromion and coracoid processes of the scapula 
and the coracoacromial ligament that spans the two processes (Figure 1.1).  
2. Supraspinatus Tendinopathy 
a. Prevalence 
Rotator cuff tendinopathy, which primarily affects the supraspinatus tendon, is a 
common clinical condition. In the general population, the prevalence of this injury is 
estimated at 6.1% for women and 4.5% for men ages 25-64 years.
113
 Of reported shoulder 
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complaints, 29% were due to rotator cuff tendinopathy.
112
 This injury is frequent in 
overhead laborers and athletes. For example, 18% of industrial welders suffered from 
rotator cuff tendinopathy.
39
 Degeneration precedes spontaneous tendon rupture in 97% of 
patients,
44
 and if left untreated, chronic tendinopathy may progress to a full tendon tear. 
Up to 50% of asymptomatic people over the age of 50 years suffer from a rotator cuff 
tear.
72,102,117
 These tears can be difficult to treat, and tendinopathy can be painful and 
debilitating; therefore, strategies to prevent the onset of supraspinatus tendinopathy are 
needed. 
b. Presentation 
Tendinopathy is a clinical diagnosis characterized by focal tenderness, activity-
related pain, weakness, and increased size. Ultrasound shows hypoechoic regions, and 
MRI shows increased signal due to fluid retention. “Tendinosis” is confirmed upon 
Figure 1.1. Shoulder Anatomy 
The supraspinatus passes underneath a bony-ligamentous arch 
formed by the acromion, coracoid, and coracoacromial ligament. 
(Image from http://www.edinburghosteopathy.co.uk) 
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histological evaluation of a tendon biopsy showing increased cellularity, rounding of 
nuclei, increased mucoid ground substance (proteoglycans), loss of collagen organization, 
and increased vascularity.
43,46,61
 These changes are generally heterogeneous and may be 
present without clinical symptoms. Inflammation is not seen in the late stages of 
degeneration when biopsies are taken, and early stages have not been studied since 
patients typically present to the clinic only once tendon degeneration has progressed to a 
chronic stage. Animal models would allow investigation of these early stages, but few 
studies have yet been performed. Chronic tendinopathy is often described as a “failed 
healing” response,35 with increases in both matrix synthesis and degradation that result in 
net matrix catabolism. A summary of changes associated with chronic tendinopathy is 
presented in Table 1.1.  
Table 1.1. Chronic Tendinopathy Characteristics 
↑  
Synthesis 
Vascularity 
Nerve fibers 
Cellularity 
Total proteoglycan/glycosaminoglycans 
Collagen type III : I ratio 
↑ 
Degradation 
Collagen disorganization 
Apoptotic cells 
Alterations in MMPs and their inhibitors (TIMPs) 
↑  
Cartilage 
phenotype 
Rounded cell shape 
Aggrecan  
Collagen type II  
Sox9 
↓ 
Mechanical 
properties 
Max stress 
Modulus  
Stiffness 
6 
 
 
c. Proposed Etiology 
The proposed etiology of supraspinatus tendinopathy is gradual accumulation of 
microtrauma, resulting in an overuse injury. Overuse injuries account for approximately 
29% of all injuries in college athletes.
119
 Over one-third of these overuse injuries could be 
attributed to inflammation or tendinopathy.
119
 Highlighting the role of overuse in the 
initiation and progression of tendon degeneration, supraspinatus tendinopathy in elite 
swimmers correlated with the hours and kilometers swum per week.
92
 Overuse injuries 
occur due to maladaptations to loading: while beneficial exercise results in matrix 
turnover and net anabolism, overuse injuries result in unbalanced degeneration-repair 
processes creating net catabolism. In order to understand the initiation and progression of 
these injuries, we must first identify the physiologic adaptations to beneficial, non-
injurious exercise.  
d. Conservative Treatments 
When a patient presents with tendinopathy, the first treatments prescribed are 
conservative: e.g., administration of nonsteroidal anti-inflammatory drugs (NSAIDs) 
such as ibuprofen, physical therapy, corticosteroid injections, extracorporeal shock wave 
therapy, and/or sclerotherapy.
6
 NSAIDs and corticosteroid injections appear to provide 
short-term pain relief but no long-term benefits.
4,6
 Other potential treatment mechanisms 
targeting biologic pathways include modulating substance P,
5,16,31
 administration of 
glyceryl trinitrate or L-NAME to alter nitric oxide,
22,77,105
 anti-TNF-α,85,1 NMDA 
antagonist to target glutamate signaling pathways,
85
 and anakinra (IL-1 antagonist).
1
 The 
efficacy of these treatments is debated and should be explored further. One promising 
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treatment strategy is use of MMP inhibitors. Several studies have shown alterations in 
MMP expression with tendinopathy. It is believed that an imbalance in these enzymes 
and their inhibitors leads to the advanced degeneration of the tendon. Aprotinin (MMP 
inhibitor) injections to the Achilles tendon are promising in treatment of chronic 
tendinopathy in humans,
76
 though another study has found no benefit over placebo.
15
 
While changes in MMP expression are characteristic of chronic tendinopathy, non-
damaging exercise may also produce changes in MMP expression indicative of matrix 
turnover and beneficial adaptation. Exploring effects of potential “treatments” such as 
NSAIDs and MMP inhibitors in sedentary and non-injurious exercise models would help 
elucidate the differences between beneficial adaptations and maladaptations to loading.  
3. Exercise 
 Exercise has both local and systemic effects on the body. Locally, exercise affects 
the muscle, tendon, and bone of the region (among other tissues not discussed here). 
Systemically, exercise affects the cardiac and metabolic systems (among other systems 
not discussed here). The effects of exercise are both acute, wherein the 
tissue/organ/system shows an immediate response to the altered loading or stress, and 
chronic, wherein the tissue/organ/system shows adaptations with repeated exercise 
sessions. These acute responses and chronic adaptations to exercise are tissue- and time-
dependent in addition to exercise protocol-dependent. Defining whether a tissue has been 
“exercised” requires the analysis of a combination of features. Importantly, no single 
metric can define exercise; therefore, a number of measurements must be made to 
understand the entirety of the response. In the following sections, tendon- and muscle-
specific adaptations commonly found in response to exercise are discussed.      
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4. Tendon Properties 
a. Biology 
Tendons are tissues that connect muscle to bone, allowing transfer of loads. The 
primary constituents are tenocytes (tendon fibroblasts), extracellular matrix, and water. 
The extracellular matrix is composed of collagens (types I, II, III, V, IX, X), which are 
the main structural proteins, with smaller amounts of proteoglycans, elastin, and 
fibronectin.
33
 Type I collagen is the primary component, comprising approximately 60% 
of the tendon dry weight and 95% of the total collagen.
114
 The collagen in healthy 
tendons is arranged longitudinally along the axis of loading to facilitate efficient load 
transfer. With injury, this collagen becomes more disorganized. The extracellular matrix 
varies regionally along the tendon and is believed to be defined by the loading profile 
experienced in that location. Healthy tendon is specifically adapted to its required 
function. The biology and composition of tendon is influenced by age, loading 
(unloading, exercise, overloading), gender, disease, and injury. These changes in 
composition can lead to changes in tissue function, and alternately, changes in function 
can lead to changes in composition. For example, eliminating compressive loading in a 
rabbit flexor tendon led to changes in tendon thickness, nuclear density, 
glycosaminoglycan content, collagen organization, and type II collagen.
63
 These biologic 
and structural changes can lead to alterations in tendon mechanical properties.     
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b. Mechanics 
 Tendons are characterized by having non-linear, strain-dependent viscoelastic 
behavior. The unique crimping pattern of the tendon results in a toe region during which 
the fibers straighten before entering the linear region of the stress-strain curve (Figure 
1.2).
114
 Furthermore, tendons exhibit stress-relaxation, creep, and unique recovery 
properties.
28,27
 The viscoelasticity of tendon has been attributed to accumulation of highly 
polarized glycosaminoglycans that attract water.  
c. Adaptations to Beneficial Exercise 
As previously described, tendons alter their composition and structure to meet the 
demands of their function, such as adaptations to non-injurious exercise. These changes 
occur over time with chronic, non-injurious exercise. Compared to more metabolically 
active tissues (such as muscle or bone), tendon adaptations to exercise may be mild and 
difficult to detect, which results in unclear descriptions of exercise effects in the 
literature. For example, tendon cross-sectional area is often unchanged
32,51,57 
with chronic 
Figure 1.2. Tendon Stress-Strain Curve 
(Figure from Wang 2006
27
) 
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exercise but some studies find increases.
21,93
 Similarly, tendon stiffness and modulus may 
increase
21,32,51,93
 or remain unchanged
49,57,62
 with chronic exercise. Importantly, the 
mechanical properties do not decrease, as this would be indicative of injury. Increased 
collagen content is likely the compositional change that supports these functional 
adaptations.
10,99
 The temporal, chronic adaptations to exercise have not been well-
defined, making it difficult to draw conclusions from studies that investigate a single time 
point. In addition to chronic adaptations, tendons respond acutely to a change in loading, 
as in response to a single bout of exercise.
101
 These changes include increased collagen 
turnover,
37,50,53,55,98
 blood flow,
14,89
 and evidence of inflammation-related 
components.
52,54
 Again, these changes are time-dependent, and it is unknown how acute 
responses to exercise translate to chronic adaptations.  
5. Skeletal Muscle Properties 
a. Biology 
Skeletal muscle is a voluntarily controlled, striated tissue. It has a hierarchical 
structure composed of numerous muscle fibers. Muscle fibers (also called muscle cells or 
myocytes) are cylindrical structures that have multiple nuclei. In mature, healthy tissue, 
these nuclei are located on the periphery of the muscle fibers. During myogenesis or fiber 
regeneration, myoblasts differentiate into myotubes, which contain centrally located 
nuclei before maturing. Muscle fibers are composed of myofibrils which primarily 
contain actin and myosin filaments in a repeating pattern, forming the contractile unit 
(sarcomere). Muscle fibers come in a variety of “types” that result in different functional 
capacities, summarized in Table 1.2. Myosin heavy chain (MHC) fiber type can be 
determined through immunohistochemical staining for the different MHC isoforms. 
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Depending on the function of the muscle, different muscles have different compositions 
of fiber type. 
Table 1.2. Properties of Skeletal Muscles 
 Type I Type IIa Type IIb 
Also known as 
Slow oxidative  
(slow twitch) 
Fast oxidative 
(fast twitch A) 
Fast glycolytic 
(fast twitch B) 
Color Red fibers Red fibers White fibers 
Fatigue 
Fatigue 
resistant 
Fatigue resistant Fatigable 
Myoglobin ↑ ↑ ↓ 
Mitochondria ↑ ↑↑ ↓ 
Oxidative capacity ↑ ↑ ↓ 
Glycolytic capacity 
and Glycogen levels 
↓ ↑ ↑↑ 
Storage fuel Triglycerides 
Creatine 
phosphate 
Glycogen 
ATP 
Creatine 
phosphate 
Functional Examples 
Aerobic 
activities  
(long run) 
Middle-distance  
aerobic activities 
Sprinting 
  
b. Adaptations to Beneficial Exercise 
Skeletal muscle adapts to both resistance and endurance exercise. In response to 
resistance training, the most notable adaptation is skeletal muscle hypertrophy which 
leads to increased maximal force production. In response to endurance training, muscle 
enhances its capacity to efficiently create energy by increasing the number of 
mitochondria and their oxidative phosphorylation proteins. This response leads to 
decreased fatigability of the trained muscle. These hypertrophic and aerobic metabolism 
changes can be independent of each other. Furthermore, these adaptations may be fiber 
type-specific.29 Whether fibers change type as a result of exercise training (e.g., type I 
transitioning to type II fibers) is controversial, though if changes do occur they normally 
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result in transition towards increased proportion of oxidative fiber types with endurance 
training. Glycogen is the main energy storage form in muscle. With endurance training, 
glycogen content within the resting muscle is increased compared to untrained 
muscle.
120,56
 Additionally, the trained muscle is depleted of glycogen more slowly than 
untrained.
29
 Gene expression and protein transcription is altered with exercise training. 
PPARβ/δ transcription factor and PGC-1α and -1β transcriptional co-activators play a 
major role in controlling the oxidative metabolism of skeletal muscle fibers.
90
 PGC-1α 
overexpression in skeletal muscle is associated with resistance to fatigue and a shift to 
oxidative phenotype.
64
 AMP-activated protein kinase (AMPK) activation can lead to 
increased levels of mitochondrial oxidative enzymes.
90
 Exercise training induces a higher 
basal AMPK activity level.
34
 It has been shown that AICAR, an AMPK agonist, 
improves running endurance.
73
 AMPK and PPARδ regulate type I muscle fiber 
specification and endurance adaptations during exercise.
73
 Finally, Myo1c is an actin-
based motor protein that acts in GLUT4 translocation. GLUT4, the major glucose 
transporter protein expressed in skeletal muscle, is increased in highly oxidative 
muscle.
106
 Endurance training has been shown to significantly increase the GLUT4 
expression and Myo1c abundance.
106
   
Muscle also exhibits acute responses to a single bout of exercise, suggesting 
matrix turnover and influences of growth factors.
36-38,57
 After an acute bout of exercise, 
glycogen content is diminished. Although muscle responses to exercise are much better 
defined than tendon, it is still debated what role inflammatory processes play in initiating 
these adaptations.   
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6. Rat Rotator Cuff Model 
The rat has previously been identified as a model of the human rotator cuff.
96
 
Apart from non-human primates, the rat was the only species to satisfy a checklist of 
criteria important to model the human shoulder. Importantly, the rat supraspinatus passes 
through a bony tunnel similar to that in humans. Furthermore, during normal walking, the 
rat supraspinatus passes repeatedly underneath the coracoacromial arch, mimicking the 
movements of the human supraspinatus during lateral arm raise and overhead activity.  
The rat has also been used to develop a model of supraspinatus tendinopathy.
97
 In 
this model, rats run on a 10º decline treadmill at a speed of 17 m/min, 5 days per week. 
After as early as 4 weeks, the tendon shows degenerative changes consistent with injury, 
including inferior mechanical properties, disorganized collagen matrix, hypercellularity, 
and rounding of cell nuclei. The rat overuse model has since been used in several studies. 
Similar to human tendinopathy, changes to the tendon matrix are evident in specific 
alterations of MMPs,
8
 their inhibitors TIMPs,
8,7
 ADAM-10,
7
 proteoglycans (decorin, 
biglycan, versican, aggrecan),
7,9
 and collagens (I, II, III, VI).
9,7
 Rounded cell shape and 
increased aggrecan, type II collagen, and Sox9 are indicative of a shift toward a 
fibrocartilaginous phenotype. Apoptosis may be present,
69,91
 and increased expression of 
nitric oxide synthases
100
 and heat shock proteins
69
 are indicative of cellular stress.  
Inflammatory regulators have also been identified in this model. Gene expression 
quantified using PCR shows temporal changes in five-lipoxygenase activating protein 
(FLAP), cyclooxygenase-2 (COX-2), vascular endothelial growth factor (VEGF), and 
von Willebrand factor (VWF) over the span of 3 days to 16 weeks, indicating that 
inflammatory and angiogenic markers are altered by overuse.
81
 From a microarray study, 
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Molloy and co-authors
70
 showed that inflammatory and apoptotic genes are altered after 4 
weeks of overuse. In a model of human rotator cuff tendinopathy, genes IL-15, -18, -6, 
MIF, TNF-α, caspase 3, and caspase 8 were upregulated compared to control, similar to 
the findings in the rat model.
68
 More recently, a slight progressive increase in TNF-α 
protein expression from 2 to 4 weeks of overuse with no increase in ED1 (pro-
inflammatory) or ED2 (anti-inflammatory) macrophages in that time frame was shown in 
the rat overuse model.
8
 Inflammatory cytokines including MCP-1, IL-1, IL-6, and IL-13 
were decreased at 2 but not 4 weeks of overuse.
8
 TGF-β3 has also been shown to 
decrease at 2 and 4 weeks of overuse.
7
 These studies suggest a role of inflammation in 
the early stages of supraspinatus tendinopathy in the rat overuse model, but whether this 
response is pathologic or physiologic is unknown. Until recently, a model of non-
injurious exercise to the rat supraspinatus did not exist. 
7. Rat Model of Supraspinatus Non-Injurious Exercise 
To address the need for a model to allow distinctions between detrimental and 
beneficial adaptations to exercise, we developed a non-injurious exercise model to which 
the rat supraspinatus overuse model could be compared, as described in the published 
study by Rooney et al., 2015.
88
 In this initial study, adult, male Sprague-Dawley rats were 
divided into exercise (EX; n=8) and control cage activity (CA; n=8) groups (IACUC 
approved). EX rats ran on a flat treadmill at 10 m/min, 1 h/day, 5 days/wk, for 12 
weeks
104
 while CA rats maintained normal cage activity. Upon completion, rats were 
euthanized, weighed, and stored at -20°C.   
Tissue Harvest: Rats were thawed, and the right supraspinatus (supra) muscle and 
tendon were dissected and weighed, and muscle cross-sectional area (CSA) was 
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measured with a custom laser device.
79
 Tendon at the insertion site was isolated from the 
muscle for o-Hydroxy-proline (OHP) assay. The superficial and deep regions of the supra 
muscle
11
 were collected separately for protein analysis. The heart and retroperitoneal and 
epididymal fat pads were dissected and weighed. Tendon Mechanics: Rats were thawed, 
and the left supra tendon was dissected and prepared for tensile mechanical testing with 
preconditioning and ramp to failure.
80
 Tendon Collagen: OHP, a measure of collagen 
content, was determined
26,74
 and normalized to tendon wet weight. Muscle Protein: A 
Western blot was performed to quantify mitochondrial proteins. Total protein from the 
supra muscle superficial region was probed for oxidative phosphorylation complexes I-V 
using Total OXPHOS antibody cocktail (MitoSciences). Bands were visualized by 
chemiluminescence, imaged, and analyzed with commercial software. Mitochondrial 
proteins were normalized to α-tubulin, and the relative quantity of target protein in the 
EX group compared to CA was calculated. Humerus Bone μCT: μCT (Scanco 
VivaCT40) was used to determine trabecular and cortical bone structure. For trabecular 
bone, a 2mm region just distal to the growth plate was scanned (15μm isotropic voxels); 
for cortical bone, a 1.5 mm region at 60% of the humerus length was scanned (35μm 
isotropic voxels). Bone was segmented from marrow using a global thresholding 
technique and then subjected to standard microstructural analysis. Humerus Bone 3-Point 
Bending: A custom fixture attached to an Instron created a 3-point bend in the humeral 
shaft until fracture.
84
 Statistics: Comparisons between EX and CA were made with t-tests 
for significance (p ≤0.05) and trends (p ≤0.1). 
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EX rats had reduced body (-7%) and fat pad (retroperitoneal: -45%, epididymal: -
39%) mass. An 8% increase in supra muscle mass was measured with no change in heart 
mass (Figure 1.3). Supra muscle CSA significantly increased 10% with exercise (Table 
1.3). Tendon Mechanics: Supra tendon CSA and elastic modulus were not different 
between groups (Table 1.3). Tendon Collagen: Collagen content of the supra tendon 
normalized to wet weight trended toward increased in the EX group (Table 1.3). Muscle 
Protein: Supra muscle had increased oxidative phosphorylation proteins (Figure 1.4). 
Bone μCT: Trabecular bone in the EX group demonstrated trends toward increased 
trabecular number (Tb.N) and connectivity (Conn.D) and decreased spacing (Tb.Sp) as 
well as significantly greater degree of anisotropy (DA, Table 1.3). No differences were 
found in trabecular bone volume, structure model index, thickness, bone mineral density 
Figure 1.3. Weight Changes with Exercise. Consistent with exercise, 
treadmill-trained rats trended toward decreased body weight over time 
and had significantly decreased fat pad weight, increased supraspinatus 
muscle weight, and no change in heart weight. Mean + StDev 
Figure from Rooney , et al. 2015
88
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(BMD), or tissue mineral density (TMD, not shown). Cortical bone in the EX group had 
significantly increased BMD and TMD (Table 1.3) with no changes in volume or cortical 
thickness (not shown). Bone 3-Point Bending: No differences were found for second 
moment of area, max load, max displacement, modulus, flexural rigidity, or max stress 
(not shown).  
Table 1.3. Shoulder Adaptations to Exercise Protocol. Treadmill-trained 
rats showed adaptations consistent with exercise in supraspinatus tendon and 
muscle, and trabecular (Tb) and cortical (Ct) humerus bone. Mean ± StDev 
Tissue Measurement CA EX p-value 
Muscle CSA (mm
2
) 34.3 ± 3.9 37.7 ± 2.6 *0.04 
Tendon 
CSA (mm
2
) 1.97 ± 0.42 1.97 ± 0.28 0.5 
Failure Load (N) 22.3 ± 5.8 26.8 ± 3.0 *0.04 
Failure Stress (MPa) 11.6 ± 3.4 14.0 ± 3.2 
+
0.09 
Modulus (MPa) 100 ± 42 101 ± 24 0.5 
Collagen/Wet Weight (%) 25 ± 5 28 ± 1 
+
0.07 
Bone 
Tb Connective Density (1/mm
3
) 60 ± 12 70 ± 12 
+
0.07 
Tb Number (1/mm) 3.1 ± 0.7 3.5 ± 0.4 
+
0.10 
Tb Spacing (mm) 0.34 ± 0.09 0.28 ± 0.04 
+
0.08 
Tb Degree of Anisotropy 1.79 ± 0.07 1.86 ± 0.07 *0.03 
Ct Thickness (mm) 0.77 ± 0.02 0.80 ± 0.03 *0.05 
Ct BMD (mgHA/cm
3
) 1116 ± 12 1126 ± 10 *0.05 
Ct TMD (mgHA/cm
3
) 1212 ± 18 1227 ± 7 *0.02 
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After 12 weeks of treadmill training, rats showed systemic (decreased body and 
fat pad mass) and local shoulder (tendon, muscle, bone) changes consistent with exercise. 
Heart mass did not change, indicating that this protocol does not tax the cardiovascular 
system. No changes were seen in tendon elastic properties, but stress-relaxation 
significantly increased. Other studies on tendon mechanics after training show mixed 
results but often find no differences in modulus or CSA.
e.g.,57
 Unlike the established supra 
overuse model, tendons did not have decreased mechanics, indicating that this protocol is 
non-injurious to the tendon.
97
 Supra muscle showed hypertrophy (increased weight and 
CSA), indicative of a response to loading, and increased oxidative phosphorylation 
proteins, indicative of endurance training. Humerus trabecular bone had increased 
Figure 1.4. Oxidative Phosphorylation Proteins. Consistent with 
adaptations to aerobic exercise, treadmill-trained rats had increased 
expression of oxidative phosphorylation proteins. Relative quantity of 
exercise to cage activity after normalizing by tubulin. Mean + StDev 
Figure from Rooney , et al. 2015
88
 
 
19 
 
anisotropic orientation, consistent with load-induced bone remodeling. Cortical bone 
showed increased BMD and TMD with no volume change, suggesting that bone mass 
changes are due to tissue mineralization. Other studies have also shown no changes in 
humerus mechanics following moderate treadmill training.
e.g.,116
 Although these 
adaptations to exercise are mild, they are consistent and present across multiple tissues 
using multiple assays. This study
88
 is limited by the quality of tissue available, sample 
size, and single time point investigated. In conclusion, this is the first non-injurious rat 
shoulder exercise model, which can be compared to the previously established overuse 
model
97
 to differentiate beneficial adaptations and maladaptations to loading.  
8. Inflammation 
Wound healing is a structured, temporal response that consists of four phases: 
hemostasis, inflammation, proliferation, and remodeling. Inflammation is a complex 
biologic event that aims to protect and repair tissue. Acute inflammation is an immediate 
(minutes to days) response to tissue insult. Two pathways associated with inflammation 
are activation of the arachidonic acid (AA) cascade and matrix turnover facilitated by 
matrix metalloproteinases (MMPs).   
a. Arachidonic Acid Cascade and MMPs 
An important pathway in the acute inflammatory response is the acrachidonic acid 
cascade (Figure 1.5).
40
 In this system, arachidonic acid is converted by cyclooxygenase 
(COX) to prostaglandins, prostacyclins, or thromboxane or by 5-lipoxygenase (LOX) to 
leukotrienes. COX-1 is constitutively expressed, and COX-2 is induced.
60
 Prostaglandins, 
synthesized through a COX-2 specific mechanism, can mediate blood flow to the tissue
48
 
and upregulate MMP expression.
103
 MMPs are responsible for matrix turnover and if not 
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Figure 1.5. Arachidonic Acid Cascade 
(Figure from Hertel 1997) 
 
carefully balanced with their inhibitors can result in excess fibrosis or degeneration.
78
 
b. Roles of Inflammation in Tendon Adaptations 
Tendon is a dynamic tissue that responds biologically to mechanical loads. In 
vitro experiments show that cultured human tendon fibroblasts, known as “tenocytes,” 
respond to strain by modulating production of prostaglandin E2 (PGE2), COX-1, COX-
2,
115
 and leukotriene B(4),
58
 components of the arachidonic acid pathway. Direct 
administration of PGE2 to these cells reduced proliferation and increased MMP-1 and 
MMP-3 protein levels with no effect on collagen type I gene expression.
103
 Similarly, 
PGE2, collagenase, and cell death increased in in vitro loaded tendon explants with no 
change in collagen or sulfated GAG.
25
 Increases in PGE2, collagenase, and cellular 
turnover were dependent on both duration and magnitude of loading.
24
 In vivo, patellar 
and Achilles tendons of mice run to exhaustion also showed increased PGE2, which 
decreased tendon stem cell proliferation and increased differentiation into non-
tenocytes.
122
 Repeated, direct injections of PGE2 in patellar tendons resulted in 
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histological changes mimicking tendon degeneration in rabbits.
47
  
Despite the implications that PGE2 may be a contributor to early tendinopathy, 
repeated, direct injections improved mechanical properties in another study.
30
 The 
presence of PGE2 may indicate tendon remodeling, which is supported by increased 
levels in humans following a bout of exercise.
54,55
 Also immediately following exercise, a 
marker of collagen synthesis and an indicator of collagen breakdown were decreased, 
with a rise in collagen synthesis seen 72 hours later.
55
 PGE2 and inflammatory cytokines 
may be involved in converting mechanical load to type I collagen synthesis, the primary 
component of tendon.
48
 Similar to in vitro experiments,
118
 tendons from mice undergoing 
moderate and intense loading protocols demonstrate distinct biologic responses, 
suggesting that appropriate loads could be beneficial while intense loads could lead to 
tendon degeneration.
121
 Whether inflammation is a physiologic response to load or 
pathologic in early tendon degeneration is unknown.  
In an initial study, we examined the response at a molecular level of the rat 
supraspinatus tendon following acute and chronic exercise.
87
 Twenty male, Sprague-
Dawley rats were divided into cage activity (CA) or acute or chronic exercise (EX) 
groups. Rats in the acute group ran a single bout of non-injurious exercise on a flat 
treadmill and were euthanized 12 or 24 hours after. Rats in the chronic group ran 5 
days/week for 1 or 8 weeks and were euthanized 72 hours after their final bout.
88
 CA 
animals maintained normal cage activity for 5 weeks to be within 10% body weight of 
the other groups. Supraspinatus muscle and tendon were harvested for RNA extractions 
(n=4 per group), and a custom Panomics QuantiGene 2.0 plex array was used to 
simultaneously detect and quantify 48 target genes for inflammation, extracellular matrix 
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components, matrix turnover enzymes, and factors associated with tendinopathy. Results 
were log2 transformed and normalized by the geometric mean of the 3 housekeeping 
genes for each sample. Principal components analysis (PCA) confirmed distinctions 
between tissues and time points, supporting the study design. Results of this assay 
support the hypothesis that a physiologic, mild, acute inflammatory response occurs in 
tendon following a single bout of exercise. Specifically, changes in arachidonic acid 
cascade components were detected (Table 1.4), supporting investigation of this pathway 
and effects of nonsteroidal anti-inflammatory drugs that inhibit this pathway. 
Additionally, results support the hypothesized adaptive matrix changes following chronic 
loading. Increased collagen expression was detected, consistent with beneficial 
adaptation to exercise. Mmp14 and TIMP expression were altered acutely and 
chronically, indicative of matrix turnover (Table 1.4). This finding supports investigation 
of the role of MMPs in acute and chronic responses of tendon to exercise, as well as 
investigation of drugs that inhibit these enzymes. Finally, results suggest that tendon 
response to chronic, beneficial exercise is distinct from overuse. Unlike overuse, we did 
not find increased expression of cartilage markers (Sox9, Acan, Col2a1), heat shock 
proteins (Hspa2, Hspb1), or nitric oxide synthases (Nos2, Nos3) in tendon. This study 
provides direct evidence for inflammation (arachidonic acid cascade) and matrix turnover 
(MMPs/TIMPs) responses of supraspinatus tendon and muscle to acute and chronic 
exercise. 
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Table 1.4. Genes altered acutely and chronically in supraspinatus tendon 
following non-injurious exercise 
 Acute 
Tendon 
Chronic  
Tendon 
Inflammation 
Ptges 
Ptger4 
Tnf 
Alox5ap 
Matrix  
Mmp14 
Timp3 
Col1a1 
Col3a1 
Dcn 
Mmp14 
Timp1 
Timp3 
Growth Factors 
Igf1 
Ctgf 
Igf1 
Tgfb3 
Vegfa 
Tissue-Specific 
Bmp7 
Sox9 
 
Tendon Degeneration: Heat Shock Proteins   
Tendon Degeneration: Apoptosis  Casp3 
Remodeling and Adhesion Tnc Fn1 
 
c. Roles of Inflammation in Muscle Adaptations 
This initial, mild inflammatory response is also believed to be important for 
skeletal muscle adaptation to load. At rest, healthy people almost exclusively express 
COX-1, but COX-2 appears to play a role in response to muscle injury. PGE2 is the 
dominant prostaglandin in human skeletal muscle, and PGF2α is thought to be a regulator 
of muscle protein synthesis, contributing to hypertrophy.
107
 This response to exercise is 
intensity-dependent.  
In the same gene screening study described previously, we also investigated 
changes in rat supraspinatus muscle following non-injurious exercise.
87
 Similar to the 
changes found in tendon, our results supported a mild, acute inflammatory response as 
indicated by changes in arachidonic acid cascade genes and a robust chronic adaptive 
24 
 
response, as indicated by matrix protein changes (Table 1.5).    
Table 1.5. Genes altered acute and chronically in supraspinatus muscle 
following non-injurious exercise 
 Acute  
Muscle 
Chronic  
Muscle 
Inflammation 
Ptges 
Ptger4 
Ptgfr 
Ptgfr 
Matrix  
Col1a1 
Timp3 
Timp4 
Col1a1 
Col3a1 
Fmod 
Mmp14 
Growth Factors 
Ctgf 
Tgfb1 
Tgfb3 
Ctgf 
Tgfb3 
Tissue-Specific 
Bmp7 
Ppargc1a 
 
Tendon Degeneration: Heat Shock Proteins 
Hspb1 
Hspa2 
 
Tendon Degeneration: Apoptosis   
Remodeling and Adhesion  Tnc 
 
9. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) 
Nonsteroidal anti-inflammatory drugs (NSAIDs) are a class of drugs that are 
either nonspecific COX-1 and COX-2 inhibitors or COX-2 specific inhibitors. 
Administration of these drugs inhibits production of prostaglandins and thromboxanes. 
Examples include naproxen, aspirin, ibuprofen, indomethacin, meloxicam, and celecoxib. 
Ibuprofen, an over-the-counter, nonspecific COX inhibitor, is one of the mostly 
commonly used NSAIDs.     
a. Prevalence of Use 
In the United States, acetaminophen, ibuprofen, and aspirin are the top 3 
consumed drugs by adults.
45 
95.7% of college football players had or were using 
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NSAIDs.
41
 75% of high school football players had used NSAIDs in the previous 3 
months and 15% used them daily, while NSAID use among Olympic athletes was second 
only to vitamins.
19
 Clearly, many people frequently use these over-the-counter drugs 
following injury or prophylactically, so the drug’s effects on musculoskeletal tissues 
should be examined.  
b. Effect of NSAIDs on Tendon 
In vitro studies on tenocytes have shown that administration of NSAIDs reduces 
PGE2
115,58,2
 and DNA
2
 but increases protein synthesis
2
 and leukotriene B(4),
58
 suggesting 
that drug administration may have negative effects during the proliferative phase of 
healing but beneficial effects during remodeling.
2
 In accordance with these findings, our 
lab has shown that administration of ibuprofen following an acute supraspinatus 
detachment and repair produced inferior mechanical properties and fiber organization at 
an early time point compared to control.
20
 Other studies have shown that tenocytes 
cultured with ibuprofen had decreased proliferation
111
 and migration
110,111
 and increased 
MMP expression with no effect on collagen I or III.
109
 These studies begin to identify 
ibuprofen’s effects on tendon; however, they were not designed to replicate an adaptive 
response of the tendon to load. 
The literature on the effects of NSAIDs on in vivo tendon is equivocal. In 
response to an acute bout of exercise in humans, a non-specific COX inhibitor decreased 
PGE2
18,52
 abolished the adaptive increase in collagen synthesis,
18
 and decreased blood 
flow
52
 in tendons. In contrast, NSAID administration in Achilles tendinopathic patients 
that underwent an acute bout of running decreased IL-10, an anti-inflammatory cytokine, 
but had no other effects.
83
 In response to chronic resistance training in older adults, 
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ibuprofen administration did not affect tendon cross-sectional area, strain, or ultrasound 
readings.
17
 Few other studies have investigated the effects of chronic ibuprofen 
administration on tendon. Overall, little is known about the interaction between ibuprofen 
and the response of tendons to mechanical loading.  
c. Effect of NSAIDs on Muscle 
NSAID effects on skeletal muscle have been more widely studied than tendon but 
again reveal contradicting results. Following acute loading in humans, NSAID 
administration has been shown to reduce the number of muscle satellite cells,
66
 increase 
COX-2 mRNA,
67
 have no effect on myofibrillar and collagen protein synthesis,
67,82
 have 
no effect on COX-1, HGF, bFGF, VEGF, ColI, Col3, tenascin c, TGF-β, PPARγ, 
myostatin, or PGC-1α mRNA,67 and decrease circulating PGF2α.
82
 In studies on older 
adult adaptation to chronic training, ibuprofen surprisingly increased muscle volume and 
strength, had no effect on muscle protein content, water content, myosin heavy chain 
distribution, COX-1, or COX-2,
17
 increased PGF2α receptor, and prevented the 
characteristic increase of IL-6 and IL-10 that was seen with the placebo group.
108
 A 
review is provided by Trappe and colleagues.
107
 Overall, muscle protein synthesis 
appears to be acutely inhibited by ibuprofen, but this effect is not detected chronically. To 
gain insight into the mechanisms behind these findings, animal studies have been 
undertaken. 
Acute muscle strain injuries in rats administered a non-selective COX inhibitor 
demonstrated a delayed inflammatory reaction and muscle regeneration.
3,75
 Also 
worrisome, ibuprofen administration in mice undergoing 4 weeks of wheel running 
abolished the correlation between run distance and skeletal muscle adaptations.
59
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Frequently, rat muscle overload is used to model hypertrophy. In these studies, the 
gastrocnemius and/or soleus muscles are transected, significantly increasing the load seen 
by the remaining plantaris or soleus, causing these muscles to hypertrophy. 
Administration of NSAIDs inhibited plantaris hypertrophy by 50% in one study,
95
 but 
had no effect in another study.
65
 A non-specific COX inhibitor administered to rat soleus 
muscles decreased the number of MyoD-positive and satellite cells.
71
 Although the 
plantaris overload model is frequently used, it may not mimic the human hypertrophy 
scenario: hypertrophy takes place at rates of 25-40% per week in the overloaded rat 
plantaris, in contrast to the human hypertrophy rate of 0.75-1%/week.
17
 The use of an 
appropriate animal exercise model that better mimics the human scenario could promote 
advancements in the field.
107
 The inconsistent findings in human and animal studies 
could be due to age, timing of NSAID administration, dose, specific NSAID used, and 
animal model-human differences. Overall it is unknown how changes in inflammatory 
activity are important for mediating the exercise-induced changes in circulation, 
metabolism, and matrix of the tendon and muscle.
48
  
10. Doxycycline 
a. Background 
Doxycycline is a broad-spectrum antibiotic in the tetracycline class. Apart from 
its antimicrobial properties, it is also a broad inhibitor of matrix metalloproteinases.
94
 
MMP inhibition through drugs like doxycycline has been suggested as a treatment for a 
variety of diseases ranging from periodontal disease to cancer.
42
      
b. Effects on Tendon and Muscle Healing 
MMP inhibition has also been suggested as a treatment for skeletal muscle and 
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tendon healing.
23
 Aprotinin, an MMP inhibitor, injected into the Achilles tendon has been 
shown to improve chronic tendinopathy in human patients in one study,
76
 but had no 
benefit over placebo in another study.
15
 For healing rat supraspinatus tendons following 
an acute transection and repair, both doxycycline and α-2-macroglobulin (another MMP 
inhibitor) showed some beneficial effects, though effects depended on the timing of the 
drug administration post-repair.
13,12
 Doxycycline also reduced the severity of skeletal 
muscle reperfusion injury
86
. Exploring effects of doxycycline in sedentary and exercised 
muscle and tendon, which has not been done previously, would help elucidate the role of 
MMPs in tissue adaptations to load. 
C. Specific Aims 
During exercise, muscle and tendon must adapt in order to benefit from the 
training. This adaptation may present in the form of protein or organizational changes 
that improve the mechanics of the tissue in the desired loading condition. Acute 
inflammation is a complex biologic event that aims to protect and repair tissue. Two 
important processes related to inflammation are activation of the arachidonic acid 
cascade and degradation of matrix proteins by matrix metalloproteinases (MMPs). 
Previous studies suggest that inflammation plays an important role in the regeneration of 
muscle and tendon following injury; however, the mechanisms governing the role of 
inflammation in the adaptation of muscle and tendon to beneficial loading conditions 
have not been identified. If the appropriate balance in acute inflammation is not achieved, 
the tissue may not be able to adapt, resulting in injury.  
The overall objective of this study is to elucidate the role of inflammation in the 
adaptation of supraspinatus tendon and muscle to a physiologically-relevant loading 
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condition. My global hypothesis is that a mild inflammatory response is a physiologic 
requirement for muscle and tendon to adapt to load and perturbation of this inflammatory 
response will prevent the tissue from beneficially adapting.   
SPECIFIC AIM 1: Define the temporal, acute responses and chronic adaptations 
of supraspinatus tendon following non-injurious loading to understand how the tissue 
responds to a single physical training session and adapts to exercise over time. 
Hypothesis 1a- Acutely, beneficial exercise induces an increase in MMP activity 
that quickly resolves by 24 hours in supraspinatus tendon. Tendon mechanical properties 
are unaffected 24 hours after a single bout of exercise. Tendon cells will respond to this 
exercise by increasing in number. 
Hypothesis 1b- Chronically, MMP activity will be increased with greater changes 
at earlier time points. Non-injurious exercise produces adaptive matrix changes in the 
tendon over time, leading to increased mechanical properties.  
SPECIFIC AIM 2: Determine effects of ibuprofen, a nonspecific COX inhibitor, 
on tendon and muscle response to non-injurious loading to understand how it affects 
tissue adaptations.  
Hypothesis 2- Chronic ibuprofen administration will detrimentally affect the 
tendon and muscle, impairing its ability to adapt to exercise. Ibuprofen will have no 
effect on tissue from sedentary animals. 
SPECIFIC AIM 3: Determine effects of doxycycline, an MMP inhibitor, on 
tendon and muscle response to non-injurious loading to understand how it affects tissue 
adaptations.  
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Hypothesis 3- Chronic doxycycline administration will detrimentally affect the 
tendon and muscle, impairing its ability to adapt to exercise. Doxycycline will have no 
effect on tissue from sedentary animals.  
These studies help to define how muscle and tendon beneficially adapt to exercise 
and the potential roles for MMPs and the arachidonic acid cascade in these beneficial 
adaptations. These studies investigate both acute responses and chronic adaptations, 
providing a comprehensive investigation of exercise effects on tendon and muscle. 
Furthermore, administration of ibuprofen and doxycycline create clinically relevant 
scenarios. These studies will help define the beneficial adaptations to exercise so that 
future studies may be better informed when investigating maladaptations to exercise. The 
results from these studies provide a foundation for designing more efficient exercise 
training protocols, distinguishing beneficial and detrimental effects of exercise, and 
developing strategies for prevention of overuse injuries.   
D. Study Design 
308 male, Sprague-Dawley rats (400-450g at arrival) were included in these 
studies, approved by the University of Pennsylvania Institutional Animal Care and Use 
Committee (IACUC). In these studies, animals were divided into exercise and cage 
activity groups for acute and chronic time points and received ibuprofen (Aim 2), 
doxycycline (Aim 3), or no drug (Aim 1 and comparison groups for Aims 2 and 3). 
Animals in the acute exercise groups underwent 2 weeks of progressive, downhill 
treadmill training followed by 72 hours of rest and then a single bout of the exercise 
protocol.
87,88
 These animals were then euthanized 3, 12, 24, 48, or 72 hours after 
completion of their single bout of exercise. Animals in the chronic exercise groups 
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underwent 2 weeks of flat treadmill training and then walked on a flat treadmill following 
the exercise protocol for 3 days, 1, 2, or 8 weeks and were euthanized 72 hours after 
completion of their last bout of exercise to avoid potentially confounding acute effects of 
exercise. Animals were compared to control, cage activity groups. At the acute time 
points, animals were used for tendon histology (n=6) and MMP activity (n=8). At the 24 
hour acute time point and 2 and 8 week chronic time points, animals were used for 
tendon mechanical analysis (n=12), tendon histology, and MMP activity. At the 3 day 
and 1 week time points, animals were used for tendon histology and MMP activity. The 
acute and chronic study designs of Aim 1 are shown in Figure 1.6 and Figure 1.7. In 
Aims 2 and 3, animals received ibuprofen (Aim 2) or doxycycline (Aim 3) for one acute 
time point (24 hours) and 2 chronic time points (for 2 and 8 weeks) and were compared 
to the non-drug treated animals of Aim 1 (Figure 1.8). Animals were used for muscle 
histology (n=8), tendon histology, and tendon mechanics.   
 
 
Figure 1.6. Aim 1: Acute Effects of Exercise Study Design. All animals underwent 2 weeks of 
progressive treadmill training. Experimental animals ran a single bout of exercise early Monday morning 
(EX, gray circle). At the time points shown, 8 EX animals were euthanized (white circles) for protein 
(n=8) and histological (n=8) analysis. At the 24 hour time point, 13 EX animals were euthanized (n=8 
protein, n=6 histology, n=12 mechanics). Thirteen animals that were treadmill trained but did not 
undergo an acute bout of EX were euthanized 72 hours after their last bout of training (depicted as X) as 
a control group (n=8 protein, n=6 histology, n=12 mechanics). 
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E. Chapter Overview 
Chapter two describes the characterization of acute responses and chronic 
adaptations to the supraspinatus tendon in the rat model of non-injurious exercise. A 
recap of the important background information, as well as the methods, results, and 
discussions are provided for the assays performed to describe the mechanical, 
histological, organizational, and MMP activity changes to the supraspinatus tendon at 
acute and chronic time points. Chapter three provides an introduction to the effects of 
NSAIDs on connective tissues and describes the methods, results, and discussion for the 
assays performed to determine the effect of ibuprofen on the rat supraspinatus in 
sedentary and exercised animals. Tendon mechanics and muscle and tendon histology are 
discussed. Chapter four provides background on the effects of MMP inhibition on tissue 
healing and describes the methods, results, and discussion for the assays performed to 
determine the effects of doxycycline to the rat supraspinatus in sedentary and exercised 
Figure 1.7. Aim 1: Chronic Effects of Exercise Study Design. Exercise animals underwent 2 
weeks of treadmill training and were euthanized after 3 days, 1 week, 2 weeks, or 8 weeks of 
running their exercise treadmill protocol (gray circles). Euthanasia occurred 72 hours after their 
last bout of running. At the two earliest time points, 8 EX animals were euthanized for protein 
(n=8) and histological (n=8) analysis. At the two later time points, 13 EX animals were euthanized 
(n=8 protein, n=6 histology, n=12 mechanics). Cage activity (CA) animals that were not treadmill 
trained were euthanized as controls at 2 time points corresponding to ~3 weeks total (2 weeks 
“training” + 1 week “exercise”) and 10 weeks total (2 weeks “training” + 8 weeks “exercise”). 
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animals. Again, tendon mechanics and muscle and tendon histology are discussed. 
Chapter five summarizes the findings of these studies and provides potential future 
directions using these studies as a foundation.   
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Figure 1.8. Aims 2 and 3 Study Designs. Chronic: Exercise animals underwent 2 weeks of treadmill 
training, after which they began their full exercise protocol with either ibuprofen or doxycycline 
administration for 2 or 8 weeks. Cage activity (CA) animals that were not treadmill trained were 
euthanized with drug administration for 2 or 8 weeks. Chronic animals from Aims 2 and 3 were compared 
to the 2 and 8 week exercise animals (no drug) of Aim 1. Acute: Animals underwent 2 weeks of 
progressive treadmill training and then a single bout of exercise. Drug administration began the day 
before the acute bout and continued until euthanasia. Comparisons were made to the 24 hour acute 
exercise time point (no drug) of Aim 1. A separate group of cage activity animals maintained normal cage 
activity for 2 weeks and were euthanized at the same time point as the acute exercise group but did not 
undergo a single bout of exercise; these animals received ibuprofen, doxycycline, or no drug for 3 days.   
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Chapter 2: Rat Supraspinatus Tendon Responds Acutely and 
Chronically to Exercise 
 
A. Introduction 
Following exercise training routines, tendons can beneficially adapt to the 
loading. Protein or organizational changes to the tissue may lead to enhanced mechanical 
properties. Prior studies have found either increased
e.g.,4,6,15
 or unchanged
e.g.,7,9
 tendon 
stiffness with chronic, non-injurious exercise; however, these changes have not been 
characterized over time, and it is unknown how acute tissue responses following a single 
bout of exercise lead to beneficial adaptations with repeated bouts of exercise.
21
 In order 
to understand how training can develop into overuse injuries, it is first important to 
characterize the process of natural, beneficial adaptations to non-injurious exercise.   
Tendons respond to exercise by adapting their extracellular matrix. The primary 
extracellular matrix and structural protein of tendons is collagen. Matrix 
metalloproteinases (MMPs) are a class of enzymes responsible for facilitating matrix 
turnover by degrading proteins such as collagens. If not carefully balanced with their 
inhibitors, MMP activity can result in excess fibrosis or degeneration
11
. MMP expression 
is increased in degenerated tendons and also increased with acute injury as a step in the 
healing response. Some studies have also found changes in tendon MMP expression 
following exercise.
e.g.,3,8
 Whether MMP activity is a physiologic response to load or 
pathologic in early tendon degeneration is unknown. 
We have previously established a rat model of beneficial supraspinatus exercise.
14
 
In contrast to the established rat model of supraspinatus overuse
17
, the non-injurious 
exercise protocol does not decrease tendon mechanical properties and shows trends 
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toward increased collagen content, supporting beneficial adaptations after 12 weeks of 
exercise.
14
 This study, however, characterized a single time point, and earlier adaptations 
of the supraspinatus tendon to this exercise protocol are unknown. Using this model, we 
have also identified alterations in inflammatory-related gene expression acutely and 
chronically.
13
 Supporting the findings of previous studies, MMPs were altered with 
exercise acutely (following a single bout of exercise) and chronically (following repeated 
bouts of exercise), and collagen gene expression increased. Importantly, acute and 
chronic exercise produced distinct gene expression profiles, indicating that these 
temporal changes need to be examined to understand how acute processes following a 
single bout of exercise translate to chronic tissue adaptations.  
The objective of this study was to identify acute responses and chronic 
adaptations of supraspinatus tendon to physiologically relevant, non-injurious exercise. 
We hypothesized that chronic, beneficial exercise increases tendon mechanical properties 
and MMP activity and is increased acutely. 
B. Methods 
1. Study Design and Treadmill Protocols 
This study was approved by the University of Pennsylvania’s Institutional Animal 
Care and Use Committee. The rats were housed in an AALAC accredited facility that 
maintained a 12/12 hour light/dark cycle, temperatures between 20-26°C, and humidity 
between 30-70%, as described in the Guide for Care and Use of Laboratory Animals.
2
 All 
animals were euthanized with controlled flow-rate carbon dioxide.  
156 rats (400-450g at start of study) were divided into acute or chronic exercise 
(EX) or cage activity (CA) groups. The rat shoulder has previously been shown to mimic 
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many of the key features of the human shoulder,
16
 making it a suitable animal model for 
this study.  
To investigate the acute effects of a single bout of exercise, animals in the acute 
EX groups underwent 2 weeks of progressive, downhill treadmill training to acclimate to 
the treadmill (Figure 2.1). Following 72 hours of rest, EX animals underwent a single 
treadmill exercise session at a constant speed of 10 meters/minute for 1 hour on a flat 
treadmill.
13
 These animals were then euthanized 3, 12, 24, 48, or 72 hours upon 
completion of their single bout of exercise (EX3h, EX12, EX24, EX48, EX72). A 
control, treadmill-trained CA group (CA-T) was euthanized 72 hours after their last bout 
of treadmill training and did not undergo the single treadmill exercise session. A second 
control group used to measure MMP activity maintained normal cage activity for the 
duration of treadmill training and did not undergo a single bout of exercise (CA24). For 
all other time points, tendon histology and MMP activity were measured. In addition, 
tendon mechanics were determined in the EX24 and CA-T groups.   
To investigate the chronic adaptations of tendon to exercise, animals in the 
chronic EX group underwent 2 weeks of flat treadmill acclimation and then walked on a 
flat treadmill at a constant speed of 10 meters/minute, 1 hour per day, 5 days per week
14
, 
for 3 days, 1 week, 2 weeks, or 8 weeks (EX3d, EX1, EX2, EX8, Figure 2.1). These time 
points were chosen to investigate the temporal response of the tendon soon after starting a 
new exercise routine (3 days, 1 week, 2 weeks) and after having sustained the exercise 
routine for an extended duration (8 weeks). Rats were euthanized 72 hours after their 
final treadmill session to avoid potentially confounding acute effects of exercise.
13
 Two 
control, CA groups maintained normal cage activity for either an early or a late chronic 
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time point. For the early chronic time point, CA animals were kept for a total of 3-4 
weeks (CA2), corresponding to the EX1 and EX2 time points. For the late chronic time 
point, CA animals were kept for a total of 10 weeks (CA8), corresponding to the EX8 
time point. These 2 control CA groups were selected to account for the significant growth 
that occurs between the early chronic time points (3 days, 1 week, 2 weeks), and the late 
chronic time point (8 weeks). For all time points, tendon histology and MMP activity 
were measured. In addition, tendon mechanics were determined in the EX2, CA2, EX8, 
and CA8 groups.   
For both acute and chronic exercise groups, inclusion was set to >75% completion 
of the total treadmill protocol. Animals that completed <10% of the treadmill protocol 
(they did not complete the 2 weeks of treadmill training and were removed before 
beginning the exercise protocol) were included in the CA groups.    
From every animal, each shoulder was designated to histology, MMP activity, or 
mechanics. At euthanasia, shoulders allotted to histology and MMP activity were 
harvested. For tendon histology, humeral head-supraspinatus tendon-supraspinatus 
muscle units were dissected and immediately placed in formalin for fixing. For MMP 
activity, tendons were dissected free from bone and muscle and immediately flash-frozen 
in liquid nitrogen and stored at -80ºC until homogenization. For mechanics, the animals 
were stored at -20ºC, and the shoulders were dissected and prepared at the time of testing.  
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2. Tendon Mechanical Testing 
For mechanical testing, animals were thawed, and the left shoulder of each animal 
was dissected, keeping the supraspinatus tendon attached to its bony insertion on the 
humerus. Verhoeff’s stain lines for optical strain measurements were placed at the bony 
insertion site and 2, 4, and 8 mm proximally. Tendon cross-sectional area was measured 
with a custom laser device.
12
 Cyanoacrylate was used to fix the tendon between two 
Figure 2.1. Acute (A) and Chronic (B) Study Designs. A) Rats in acute exercise groups underwent 2 
weeks of treadmill training followed by 72 hours of rest. These rats were euthanized 3-72 hours after 
completion of a single bout of exercise (EX3h, EX12, EX24, EX48, EX72) and were compared to a 
control, treadmill-trained group (CA-T). A single non-treadmill trained group maintained normal cage 
activity for the duration (CA24). B) Rats in chronic exercise groups underwent 2 weeks of treadmill 
training followed by repeated exercise sessions for 3 days, 1 week, 2 weeks, or 8 weeks (EX3d, EX1, EX2, 
EX8) and were compared to either an early time point cage activity group (CA2) or a later time point cage 
activity group (CA8). Assays were performed on supraspinatus tendon: M- mechanics, H- histology, MMP- 
MMP activity assay 
A B 
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pieces of sandpaper at the 8 mm stain line and gripped with a custom screw clamp. 
Humeri were potted in PMMA, and a custom fixture secured the potted humerus for 
testing with an Instron ElectroPuls E3000 affixed with a 250 N load cell and a LVDT for 
increased displacement resolution. Tendons were submerged in a 37°C PBS bath and 
underwent the following testing protocol: 1) preconditioning (10 triangle cycles from 1-
1.5% strain at 0.25 Hz then held at gauge length for 300s), 2) stress-relaxation to 4% 
strain held for 300s, 3) frequency sweep (0.1, 1, 2, 10 Hz) of 10 sine cycles with 
amplitude of 0.125% strain, 4) return to gauge length and held for 60s, 5) stress-
relaxation to 8% strain held for 300s, 6) recovery to 4% strain held for 300s, 7) return to 
8% strain and held for 300s, 8) frequency sweep (0.1, 1, 2, 10 Hz) of 10 sine cycles with 
amplitude of 0.125% strain, 9) return to gauge length and held for 180s, 10) ramp to 
failure at 0.3%/s. Due to slip in the fixture that occurred near 4% strain, only the 8% data 
were analyzed (steps 5, 8, 10).  
Local 2D Lagrangian strain of the tendon relative to the bone during the ramp to 
failure was measured by tracking the stain lines with a custom MATLAB program. 
Stiffness was calculated as the slope of the linear region of the load-displacement curve, 
and elastic modulus was calculated as the slope of the linear region of the stress-strain 
curve. Percent relaxation was calculated as the percent change in the load after 300 
seconds of relaxation. The dynamic modulus (|E*|, ratio of the stress-to-strain amplitude) 
and tangent of the phase angle between the stress and strain (tan(δ), ratio of the loss-to-
storage modulus, a measure of viscoelasticity) were calculated using the middle 5 sine 
cycles at each frequency.     
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3. Tendon Histology 
After fixing in 10% buffered formalin, bone-tendon-muscle units were decalcified 
in formic acid decalcifier (Immunocal, American MasterTech, Lodi, CA, USA) and then 
processed, embedded in paraffin, and sectioned at 7µm. Sections were stained with 
hematoxylin and eosin and the tendon midsubstance was imaged at 200x magnification 
and used for traditional (acute and chronic groups) and polarized light microscopy 
(chronic groups only). Cell density (cells/mm
2
) and cell shape (aspect ratio 0-1 with 1 
being a circle) were quantified using commercial software (Bioquant Osteo II, Nashville, 
TN, USA). Custom MATLAB software was used to analyze the polarized light images 
and calculate the circular standard deviation, a measure of the spread of collagen fiber 
alignment.
5
  
4. MMP Activity Assay 
A SensoLyte 520 generic MMP assay kit (as-71158, Anaspec Inc., Fremont, CA, 
USA) was used to determine MMP activity in the tendon samples. This kit can detect 
activity of several MMPs, including MMP-1, -2, -3, -7, -8, 9, -12, -13, and -14. 
Specimens allotted to the MMP activity assay were manually pulverized with mortar and 
pestle. 150µl of assay buffer (provided in MMP activity kit) with 0.1% Triton X-100 was 
added to each sample. Samples were centrifuged for 15 minutes 10,000xg at 4ºC, and the 
supernatant was transferred to a new tube and stored at -80ºC. Pierce BCA Protein Assay 
kit (Thermo Scientific, Waltham, MA, USA) was used to quantify protein yield. Samples 
were plated in duplicate on 96-well plates using equal protein quantities for each sample 
(36µg protein for acute groups and 39µg for chronic groups due to differences in total 
yield), and the MMP activity kit protocol was followed with a 2 hour activation 
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incubation time at 37ºC and an endpoint reading 45 minutes after initiating the enzymatic 
reaction. Dilutions of purified human MMP-13 were included on each plate to create a 
standard curve. Duplicates were averaged for each specimen, and background was 
subtracted. The human MMP-13 standard curve was used to normalize the generic MMP 
activity of the tendon samples.        
5. Statistics 
Statistical analysis was performed based on our hypotheses. A pre-study power 
analysis estimated a required sample size of at least 10 specimens per group for 
mechanical testing to detect a modulus effect size of 1.4 (effect size previously detected 
following 4 weeks of overuse
17
) with 80% power and significance level set to 0.05. In 
this study, we sought to obtain at least 12 tendon samples per group for mechanical 
testing to account for potentially smaller effects of exercise (versus injury with overuse).  
To determine the acute effects of exercise on tendon mechanical properties, a t-
test was used to compare EX24 and CA-T groups. To determine the chronic effects of 
exercise on tendon mechanical properties, t-tests were performed to compare CA2-EX2 
and CA8-EX8 groups separately. Significance was set at p≤0.05 and trends p≤0.1.   
To determine acute effects of exercise on tendon histological properties (cell 
density, cell shape), a 1-way ANOVA was performed for the EX3h, EX12, EX24, EX48, 
EX72, and CA-T groups using the commercial software SYSTAT (SYSTAT 13, San 
Jose, CA, USA). If the ANOVA was significant (p≤0.05) or a trend (p≤0.1), then 
pairwise comparisons were performed with Fisher’s LSD tests. To determine the acute 
effects of exercise on MMP activity, CA-T and CA24 control groups were pooled to form 
a single control group (CA-P) after confirming no differences in MMP activity between 
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them (p=0.3 with t-test). Then, a 1-way ANOVA was performed for the EX3h, EX12, 
EX24, EX48, EX72, and CA-P groups with Fisher’s LSD tests for pairwise comparisons. 
P-values are reported.   
To determine chronic effects of exercise on tendon histological properties (cell 
density, cell shape, collagen fiber organization) and MMP activity, a 1-way ANOVA was 
performed for the early time points (EX3d, EX1, EX2, CA2) using the commercial 
software SYSTAT. If the ANOVA was significant (p≤0.05) or a trend (p≤0.1), then 
pairwise comparisons were performed with Fisher’s LSD tests. A t-test was used to 
compare EX8-CA8 groups with significance at p≤0.05 and trends at p≤0.1. Comparisons 
between the early (3 day, 1 week, 2 week) and late (8 week) groups are inappropriate due 
to the significant animal growth that occurs during this period. All figures are shown with 
mean and standard deviation. 
C. Results 
1. Tendon Mechanics 
24 hours after a single bout of exercise, tendon cross-sectional area was 
significantly increased and tendon modulus, maximum load, and maximum stress trended 
toward decreased, consistent with mildly inferior mechanical properties (Figure 2.2).  
In contrast, chronic exercise resulted in beneficial adaptations of tendon 
mechanical properties: increased tendon stiffness, modulus, maximum load, and 
maximum stress after 2 weeks of exercise and increased stiffness, maximum load (Figure 
2.2), and dynamic modulus (Figure 2.3C) after 8 weeks of exercise. Tendon cross-
sectional area trended toward increased after 2 weeks of exercise and decreased after 8 
weeks of exercise (Figure 2.2A). Additionally, 2 weeks of exercise altered the 
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viscoelastic properties of the tendons by significantly decreasing percent relaxation 
(Figure 2.2D) and tan(δ) (Figure 2.3E). By 8 weeks, viscoelastic adaptations were nearly 
absent with only a trend toward increased percent relaxation (Figure 2.2D) and no 
changes in tan(δ) with exercise (Figure 2.3F).       
 
  
A B C 
D E F 
Figure 2.2. Tendon Mechanics. A single bout of exercise followed by 24 hours of rest led to 
significantly increased tendon cross-sectional area (A) and trends toward decreased modulus (B), 
maximum stress (C), and maximum load (F), suggesting mildly inferior properties.  Chronic exercise 
resulted in beneficial mechanical adaptations of the tendon after 2 weeks and 8 weeks. n= 9-12 acute, 
12-17 at 2 weeks, 11-13 at 8 weeks 
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2. Tendon Histology 
Exercise did not acutely or chronically affect cell density (Figure 2.4A,B). 48 
hours after exercise, cells were rounder than the trained control group (Figure 2.4C). 
Cells were also rounder after 3 days, 1 week, and 2 weeks (trend) of exercise compared to 
the CA2 group and trended toward rounder after 8 weeks of exercise compared to the 
CA8 group (Figure 2.4D). All specimens were highly organized, and chronic exercise did 
not affect collagen organization (Figure 2.5). Representative tendon histology images are 
shown in Figure 2.6. The mild rounding of cells, no change in cellularity, and highly 
organized collagen are in contrast to that seen with injury (Figure 2.7). 
A B C 
D E F 
Figure 2.3. Tendon Dynamic Mechanics. A single bout of exercise had minimal effect on dynamic 
tendon mechanical properties (A, D).  2 weeks of exercise decreased tan(δ) (E).  8 weeks of exercise 
increased dynamic modulus (C). n= 11-12 acute, 12-17 at 2 weeks, 11-12 at 8 weeks 
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Figure 2.4. Tendon Histology. Exercise did not affect cell density.  Cells became rounder 
48 hours after a single bout of exercise and after 3 days, 1 week, 2 weeks, and 8 weeks of 
chronic exercise. n=6-8 acute, 6-9 chronic 
A B 
C D 
Figure 2.5. Tendon Organization.  Chronic 
exercise did not affect tendon collagen 
organization. n=6-9 
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CA-T EX48 
CA2 EX1 
Figure 2.6. Representative Tendon Histology Images. 48 hours after a 
single bout of exercise and after 1 week of chronic exercise, cells were 
rounder than controls. Exercise had no effect on cellularity or collagen 
organization. These changes are mild compared to injured tendon 
(Figure 2.7).  
Figure 2.7. Injured Tendon Histology Images. A) After 8 weeks of overuse, 
supraspinatus tendons from rats have increased cellularity, collagen disorganization, and 
rounding of cells. (Figure from Soslowsky, et al. 2000
17
) B) 2 weeks after a supraspinatus 
tendon transection and repair in rats, the tendon shows hypercellularity, cell rounding, and 
collagen disorganization. (Figure from Manning, et al. 2011
10
) These histology images 
from injured tissues are in contrast to the healthy tendon histology images obtained in this 
study (Figure 2.6).  
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3. MMP Activity Assay 
MMP activity decreased by ~10% at 12 (trend), 24, and 48 hours after exercise 
and returned to baseline by 72 hours (Figure 2.8A). 8 weeks of exercise significantly 
reduced MMP activity compared to cage activity (Figure 2.8B). 
 
D. Discussion 
Rat supraspinatus tendons demonstrated both acute responses and chronic 
adaptations to a non-injurious exercise protocol. 24 hours after a single bout of exercise, 
tendons showed mild trends toward reduced mechanical properties. The tendon 
mechanical properties increased after 2 and 8 weeks of chronic exercise, signifying 
beneficial adaptations to the protocol and supporting our hypothesis. Although cell 
density and collagen organization were unaffected by exercise, cells were rounder at 
some time points, which could indicate increased metabolic activity or altered cell type. 
A B 
Figure 2.8. MMP Activity. A single bout of exercise reduced MMP activity acutely with a return to 
baseline by 72 hours (A).  8 weeks of chronic exercise reduced MMP activity (B). n=6-8 acute EX, 
n=14 CA-P, n=8-12 chronic 
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Future studies could use electron microscopy to investigate potentially altered cellular 
components. MMP activity decreased acutely and after 8 weeks of chronic exercise. 
The mild trends toward decreased mechanical properties (modulus, maximum 
stress, maximum load and significantly increased cross-sectional area), following a single 
bout of exercise may initiate chronic adaptations. Although these differences were minor 
acutely, they were enough to produce significant beneficial adaptations chronically. 
Perhaps one distinguishing feature between beneficial and detrimental exercise protocols 
is in the amount of damage and subsequent ability to repair initiated by a single bout of 
loading. By 24 hours, the supraspinatus tendons from rats undergoing this exercise 
protocol had nearly recovered to baseline properties; a more intense protocol may require 
longer recovery time before returning to baseline properties. Previous studies have shown 
differences in the acute response of tendons following mild compared to intense loading 
bouts.
20,22
 A single bout of exercise may initiate a mild healing response that leads to 
beneficial tissue adaptations over time. The connection between tendon microdamage 
from a single bout of loading and the resulting chronic adaptations or chronic injury 
(maladaptations) should be investigated further.  
In contrast to our hypothesis, we found decreased generic MMP activity with 
acute and chronic exercise. Although some studies have found increases in MMPs 
following exercise,
e.g.,3 
others have found decreases in MMP-2 mRNA expression
19
 and 
activity.
8
 MMP-2 is a gelatinase that binds and degrades collagen fragments. Rather than 
investigating specific MMPs, we chose to measure generic MMP activity to understand 
the net degradative response to exercise. The decreased MMP activity acutely and 
chronically may indicate an anabolic instead of a catabolic response to exercise. This 
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response is in contrast to injury, which results in increased MMP expression.
1,18
 MMP 
activity returned to baseline by 72 hours of rest following a single bout of exercise, which 
suggests that the chronic time points, in which the animals were euthanized 72 hours after 
their final bout of loading, were appropriate to avoid the potentially confounding acute 
effects of exercise.  
In this study, we found more significant mechanical changes after 2 weeks of 
exercise than after 8 weeks of exercise, indicating that this adaptive process begins 
shortly after initiating a new exercise protocol. As the tissue adapts over time, it may 
require a greater loading stimulus to achieve the same matrix adaptations. Previously, 
using this same exercise protocol, we found more matrix turnover-related genes altered at 
a 1 week time point than an 8 week time point,
13
 consistent with the increased mechanical 
adaptations found earlier compared to later. Future studies that investigate the acute 
responses of exercise-trained tendons (i.e., how the tendon responds to a single bout of 
exercise following early and later chronic exercise training) may help elucidate the 
effects of training on the acute, temporal responses of tendon.    
This study has several limitations. Although the rat rotator cuff model has been 
used extensively, the use of a quadruped animal does not exactly replicate the human; 
however, during forward locomotion, the rat supraspinatus repetitively passes underneath 
the acromion,
16
 mimicking the function of the human shoulder during lateral raise and 
overhead activity. Furthermore, although the changes found in this study are mild, they 
are consistent with the often mild adaptations seen in human tendons following exercise. 
This study investigated a single exercise protocol, and it is unknown how results would 
differ if the protocol changed in intensity; however, this protocol has previously been 
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shown to be non-injurious to the supraspinatus tendon and produce beneficial adaptations 
to the rat shoulder.
14
 The time points used in this study were chosen to represent early 
and later adaptations of tendon to exercise. Although the exact timing of responses may 
not be identical in humans due to differences in metabolism, the main concepts can be 
translated across species. In this study we performed tendon mechanical analysis on a 
single acute time point, 24 hours after completion of a single bout of exercise. It is 
unknown how the tendon mechanical properties are altered immediately following an 
exercise session or when the properties completely return to baseline. Future studies 
should explore the temporal, acute mechanical changes accompanying a single exercise 
session. Finally, animals in the acute exercise groups underwent two weeks of 
progressive downhill treadmill training followed by 72 hours of rest prior to their single 
bout of exercise. Although we do not know how these two weeks of training may impact 
the acute tendon responses to exercise versus an untrained group, our comparisons are 
valid because we used a trained cage activity group as a control instead of a naïve cage 
activity group. In our experience, two weeks of treadmill training is required to minimize 
animals stress and reduce the number of excluded animals. Despite these limitations, 
results clearly demonstrate that the rat supraspinatus tendon responds acutely and 
chronically to exercise. 
Taken together, results suggest that mild, acute decreases in MMP activity and 
tendon mechanical properties following a single bout of exercise lead to enhanced tendon 
mechanical adaptations with repeated bouts of exercise. This study helps to define the 
acute and chronic temporal response of supraspinatus tendon to load in an in vivo model. 
The results provide a framework for future studies to develop efficient exercise protocols 
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that minimize risk of overuse injury. Future studies will examine the biologic mediators 
of these adaptations, including the roles of inflammatory and vascular processes. 
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Chapter 3: Ibuprofen Differentially Affects Supraspinatus Muscle and 
Tendon Adaptations to Exercise in a Rat Model 
 
A. Introduction 
 In the United States, acetaminophen, ibuprofen, and aspirin are the top 3 
consumed drugs by adults.
12
 Specifically, many athletes self-diagnose and “treat” 
themselves with these over-the-counter medications or use them prophylactically: 75% of 
high school football players had used nonsteroidal anti-inflammatory drugs (NSAIDs) in 
the previous 3 months, while NSAID use among Olympic athletes was second only to 
vitamins.
7
 In addition, 95.7% of college football players have used NSAIDs such as 
ibuprofen.
11
 Previous studies have shown that following acute tendon injury, 
administration of ibuprofen, which blocks cyclooxygenases-1 and -2 (COX-1 and COX-
2) of the arachidonic acid inflammatory cascade, is detrimental,
e.g.,8
 suggesting that early 
inflammation is a required component of successful tissue healing.  
 A mild inflammatory response may also be important in the adaptation of 
musculoskeletal tissues to chronic, non-injurious exercise; however current literature on 
the effects of ibuprofen on tissue adaptations is equivocal. For example, in a plantaris 
overload model in rats, one study found 50% decreased muscle hypertrophy with 
administration of ibuprofen.
28
 Although the plantaris overload model is frequently used, 
its rapid rate of muscle hypertrophy does not mimic the normal rate of human 
hypertrophy with exercise,
4
 which supports the use of a more clinically relevant model. 
In another study, ibuprofen administered to mice undergoing 4 weeks of wheel running 
eliminated the correlation between run distance and skeletal muscle adaptations.
14
 In 
contrast, following chronic resistance training in older adults, ibuprofen administration 
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led to increased muscle hypertrophy and strength but did not affect tendon cross-sectional 
area or strain.
5
 Overall, little is known about the interaction between ibuprofen, a 
commonly consumed drug, and the response of muscles and tendons to exercise. 
Therefore, the objective of this study was to determine the effects of ibuprofen on the 
adaptations of supraspinatus tendon and muscle in a rat model of exercise. We 
hypothesized that administration of ibuprofen would abolish the beneficial adaptations 
found with exercise but have no effect on sedentary muscle and tendon properties.  
B. Methods 
1. Study Design and Treadmill Protocols 
Following approval by the University’s Institutional Animal Care and Use 
Committee, 167 male, Sprague-Dawley rats (400-450g at start of study) were divided into 
cage activity (CA) or exercise (EX) groups. These groups were further divided into an 
acute time point or two chronic time points with half of these animals receiving ibuprofen 
(IBU). The non-drug comparison groups are a subset of another study performed in the 
same time frame by the same personnel (described in Chapter 2). Animals in the IBU 
groups were trained to drink from a needleless syringe
2
 and were administered children’s, 
berry-flavored, liquid ibuprofen (Major Pharmaceuticals, Livonia, MI, USA) at 20mg/kg 
orally every 12 hours as previously described.
8
  
 To investigate the acute effects of ibuprofen on muscle and tendon, animals in the 
acute EX group underwent 2 weeks of progressive, downhill treadmill training to 
acclimate to the treadmill, as previously described.
22
 Following 72 hours of rest, EX 
animals underwent a single treadmill exercise session at a constant speed of 10 
meters/minute for 1 hour on a flat treadmill. These animals were then euthanized by 
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controlled flow-rate carbon dioxide 24 hours after completion of their single bout of 
exercise (EX24). Animals in the IBU groups began receiving ibuprofen 24 hours prior to 
the start of their single bout of exercise and continued receiving ibuprofen every 12 hours 
until euthanasia (5 doses total, EX24IBU). A separate group of animals maintained 
normal cage activity for the 2 week duration and received 5 doses of ibuprofen (every 12 
hours) until euthanasia 1.5 hours after their last dose of ibuprofen (CA24IBU). These 
animals were compared to a cage activity group that did not receive ibuprofen (CA24, 
Figure 3.1A).  
 To investigate the chronic effects of ibuprofen on muscle and tendon adaptations 
to exercise, animals in the chronic EX groups underwent 2 weeks of flat treadmill 
acclimation and then walked on a flat treadmill at a constant speed of 10 meters/minute, 1 
hour per day, 5 days per week
23
 for 2 or 8 weeks (EX2, EX8). Control animals 
maintained normal cage activity for this duration (CA2, CA8, described in Chapter 2). 
Animals in the IBU groups received ibuprofen every 12 hours, 7 days per week for the 2 
or 8 week duration (EX2IBU, EX8IBU, CA2IBU, CA8IBU, Figure 3.1B).  
For both acute and chronic exercise groups, inclusion was set to >75% completion 
of the total treadmill protocol. Animals that completed <10% of the treadmill protocol 
(they did not complete the 2 weeks of treadmill training and were removed before 
beginning the exercise protocol) were included in the CA groups.  
From every animal, each shoulder was designated to muscle/tendon histology or 
tendon mechanics. Tendon mechanical testing was not performed on the CA24 or 
CA24IBU groups. At time of euthanasia, animals were weighed, shoulders allotted to 
histology were dissected, and the supraspinatus muscle was cut transversely through the 
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mid-belly. This muscle piece was pinned to Styrofoam to maintain muscle architecture, 
covered in OCT, and immediately flash-frozen in liquid nitrogen-cooled isopentane. The 
specimens were stored at -80ºC until frozen sectioning. The remaining humeral head-
supraspinatus tendon-muscle half was immediately placed in formalin for fixing. For 
Figure 3.1. Acute (A) and Chronic (B) Study Designs. A) An acute cage activity group maintained 
normal cage activity, received 5 doses of ibuprofen, was euthanized 1.5 hours after their last dose of 
the drug (CA24IBU) and was compared to a group that did not receive ibuprofen (CA24). Rats in 
acute exercise groups underwent 2 weeks of treadmill training followed by 72 hours of rest. These 
rats were euthanized 24 hours after completion of a single bout of exercise (EX24). These animals 
were compared to a group that received ibuprofen beginning 1 day before their exercise session and 
continuing until euthanasia (EX24IBU). B) For analysis of chronic effects, control cage activity 
groups maintained normal cage activity for an early time point (CA2, CA2IBU) or a later time point 
(CA8, CA8IBU). Rats in chronic exercise groups underwent 2 weeks of treadmill training followed 
by 2 or 8 weeks of the exercise protocol (EX2, EX2IBU, EX8, EX8IBU). IBU groups received 
ibuprofen during this 2 or 8 week period. Assays were performed on supraspinatus: M- tendon 
mechanics, TH- tendon histology, MH- muscle histology 
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mechanics, the animals were stored at -20ºC, and the shoulders were dissected and 
prepared at the time of testing.  
2. Tendon Mechanical Testing 
For tendon mechanical testing, animals were thawed, and the left shoulder was 
dissected, keeping the supraspinatus tendon attached to its bony insertion on the humerus. 
Verhoeff’s stain lines for optical strain measurements were placed at the bony insertion 
site and 2, 4, and 8 mm proximally. Tendon cross-sectional area was measured with a 
custom laser device.
19
 Cyanoacrylate was used to fix the tendon between two pieces of 
sandpaper at the 8 mm stain line and gripped with a custom screw clamp. Humeri were 
potted in PMMA, and a custom fixture secured the potted humerus for testing with an 
Instron ElectroPuls E3000 affixed with a 250 N load cell and a LVDT for increased 
displacement resolution. Tendons were submerged in a 37°C PBS bath and underwent the 
following testing protocol: 1) preconditioning (10 triangle cycles from 1-1.5% strain at 
0.25 Hz then held at gauge length for 300s), 2) stress-relaxation to 4% strain held for 
300s, 3) frequency sweep (0.1, 1, 2, 10 Hz) of 10 sine cycles with amplitude of 0.125% 
strain, 4) return to gauge length and held for 60s, 5) stress-relaxation to 8% strain held for 
300s, 6) recovery to 4% strain held for 300s, 7) return to 8% strain and held for 300s, 8) 
frequency sweep (0.1, 1, 2, 10 Hz) of 10 sine cycles with amplitude of 0.125% strain, 9) 
return to gauge length and held for 180s, 10) ramp to failure at 0.3%/s. Due to slip in the 
fixture that occurred near 4% strain, only the 8% data were analyzed (steps 5, 8, 10).  
Local 2D Lagrangian strain of the tendon relative to the bone during the ramp to 
failure was measured by tracking the stain lines with a custom MATLAB program. 
Stiffness was calculated as the slope of the linear region of the load-displacement curve, 
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and elastic modulus was calculated as the slope of the linear region of the stress-strain 
curve. Percent relaxation was calculated as the percent change in the load after 300 
seconds of relaxation. The dynamic modulus (|E*|, ratio of the stress-to-strain amplitude) 
and tangent of the phase angle between the stress and strain (tan(δ), ratio of the loss-to-
storage modulus, a measure of viscoelasticity) were calculated using the middle 5 sine 
cycles at each frequency.  
3. Tendon Histology 
After fixing in 10% buffered formalin, bone-tendon-muscle units were decalcified 
in formic acid decalcifier (Immunocal, American MasterTech, Lodi, CA, USA) and then 
processed, embedded in paraffin, and sectioned at 7µm. Sections were stained with 
hematoxylin and eosin and the tendon midsubstance was imaged at 200x magnification 
and used for traditional (acute and chronic groups) and polarized light microscopy 
(chronic groups only). Cell density (cells/mm
2
) and cell shape (aspect ratio 0-1 with 1 
being a circle) were quantified using commercial software (Bioquant Osteo II, Nashville, 
TN, USA). Custom MATLAB software was used to analyze the polarized light images 
and calculate the circular standard deviation, a measure of the spread of collagen fiber 
alignment.
9
  
4. Muscle Histology 
 Muscle specimens were cryosectioned at 10µm, transverse to the muscle fibers. 
For morphological analysis, sections were stained with an anti-laminin polyclonal 
antibody produced in rabbit (Sigma-Aldrich, Saint Louis, MO, USA), incubated with 
Alexa Fluor 488 goat anti-rabbit secondary antibody (Life Technologies, Grand Island, 
NY, USA), mounted and cover-slipped with ProLong Gold antifade reagent with DAPI 
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(Life Technologies, Grand Island, NY, USA), and visualized with epifluorescence on an 
Eclipse 90i microscope. Six images were acquired at 100x magnification per specimen 
(resulting in analysis of ≥450 fibers per specimen). The number of centrally nucleated 
fibers (CNF) were counted and divided by the total number of fibers to determine 
percent. The total average fiber cross-sectional area was analyzed with a MATLAB 
application.
27
 For fiber type analysis on chronic groups, sections were simultaneously 
stained with anti-myosin heavy chain-1 (MyHC-I) BA-DF, MyHC-IIa SC-71, and 
MyHC-IIb BF-F3 antibodies
25
 (Developmental Studies Hybridoma Bank, University of 
Iowa, Iowa City, IA, USA), and anti-laminin antibody (Sigma-Aldrich). MyHC-IIx fibers 
were left unstained and were not analyzed for cross-sectional area. Sections were 
incubated with secondary antibodies: Alexa Fluor 546 goat anti-mouse IgM (Life 
Technologies), DyLight 405 goat anti-mouse IgG 2b (Jackson Immuno, West Grove, PA, 
USA), Alexa Fluor 488 goat anti-mouse IgG 1 (Jackson), and Alexa Fluor 647 goat anti-
rabbit IgG (Jackson). Stained sections were mounted and cover-slipped with ProLong 
Gold antifade reagent without DAPI (Life Technologies). As previously described, the rat 
supraspinatus muscle fiber type distribution differs in the superficial and deep layers of 
the muscle;
3
 therefore, fiber types of these two regions were analyzed separately, and 3 
images at 100x magnification were captured for each region. These images were 
analyzed with a MATLAB application for muscle fiber type distribution and cross-
sectional area.
27
  
5. Statistics 
Statistical analysis was performed based on our hypotheses. To determine the 
effects of ibuprofen on muscle and tendon adaptations, t-tests were used to compare IBU-
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treated and non-drug treated groups separately for CA and EX at each time point. 
Comparisons between time points are inappropriate due to the significant animal growth 
that occurs. Since our hypotheses were specific to the effects of ibuprofen, we did not 
make comparisons between exercise and cage activity groups. Significance was set to 
p≤0.05. Figures are shown with mean and standard deviation. 
C. Results 
1. Tendon Mechanics 
24 hours after a single bout of exercise, ibuprofen decreased the tendon cross-
sectional area and increased the modulus (Figure 3.2A,B), bringing the properties to 
within 1.7% and 9.4% of previously measured baseline levels, respectively (baseline 
determined in Chapter 2). At 2 Hz, administration of ibuprofen increased tan(δ) (Figure 
3.4C). No other mechanical properties were changed acutely.  
Chronic administration of ibuprofen in the cage activity groups increased 
stiffness, modulus, maximum stress (Figure 3.2), and dynamic modulus (Figure 3.3) at 2 
weeks and decreased tendon cross-sectional area and increased modulus (Figure 3.2) and 
dynamic modulus at 8 weeks (Figure 3.3). Ibuprofen had minimal effect on the 
viscoelastic properties of the cage activity groups, increasing tan(δ) at only 0.1 and 1 Hz 
after 2 weeks, increasing tan(δ) at 0.1 Hz after 8 weeks, and decreasing tan(δ) at 10 Hz 
after 8 weeks (Figure 3.4) with no effect on percent relaxation. 
Chronic administration of ibuprofen in the exercise groups decreased tendon 
cross-sectional area (Figure3.2A) and increased dynamic modulus (Figure 3.3) after 2 
weeks and increased modulus after 8 weeks (Figure 3.2B). Ibuprofen increased tan(δ) at 
0.1 Hz after 2 weeks and at 0.1 and 1 Hz after 8 weeks (Figure 3.4) with no effect on 
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percent relaxation. 
 
2. Tendon Histology 
Acute administration of ibuprofen increased cell density in a cage activity group 
(Figure 3.5A) but had no effect on cell shape and no effect when combined with a single 
bout of exercise. Administration of ibuprofen for 2 weeks combined with exercise 
decreased cell density (Figure 3.5A). 8 weeks of ibuprofen combined with exercise 
increased cell density and rounder cells (Figure 3.5). Ibuprofen did not affect tendon 
collagen organization (Figure 3.6). Representative tendon histology images are shown in 
Figure 3.7. The mild changes in cellularity and cell shape and highly organized collagen 
are in contrast to that seen with injury (Figure 2.7, Chapter 2). 
A B C 
D E F 
Figure 3.2. Tendon Mechanical Properties. Following a single bout of exercise, ibuprofen 
decreased tendon cross-sectional area and increased modulus, returning the properties to baseline 
(dashed gray line). Chronic administration of ibuprofen did not negatively impact tendon mechanical 
adaptations to exercise or cage activity tendon mechanical properties. Open bars- no drug, Solid bars- 
administered ibuprofen (n=10-16 acute, n=8-17 at 2 weeks, n=9-13 at 8 weeks) 
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A B 
C D 
Figure 3.3. Dynamic Modulus. Administration of ibuprofen for 2 weeks increased 
dynamic modulus at all frequencies. Dynamic modulus also increased at 8 weeks in the 
cage activity group. Open bars- no drug, Solid bars- administered ibuprofen (n=10-11 
acute, n=12-17 at 2 weeks, n=11-13 at 8 weeks) 
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A B 
C D 
Figure 3.4. tan(δ). Ibuprofen mildly increased tan(δ) at 2 Hz (C) 24 hours after a single 
bout of exercise. At 0.1 Hz (A), administration of ibuprofen for 2 and 8 weeks increased 
tan(δ) in the exercise and cage activity groups. Tan(δ) also increased with ibuprofen at 1 
Hz (B) for the 2 week cage activity and 8 week exercise groups. Tan(δ) at 10 Hz (D) 
decreased in the 8 week cage activity group with administration of ibuprofen. Open bars- 
no drug, Solid bars- administered ibuprofen (n=11-16 acute, n=11-17 at 2 weeks, n=11-13 
at 8 weeks) 
 
A B 
Figure 3.5. Tendon Histology. Ibuprofen had minimal effect on tendon cell density (A) and cell 
shape (B). Open bars- no drug, Solid bars- administered ibuprofen (n=7-9 acute, n=6-9 at 2 weeks, 
n=6-8 at 8 weeks) 
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3. Muscle Histology  
For all groups, the average percent of centrally nucleated fibers was below 1%, 
and ibuprofen had no effect (Table 3.1). The average total fiber cross-sectional area 
across decreased with administration of ibuprofen at 2 weeks in the exercise group and at 
8 weeks in both the cage activity and exercise groups (Figure 3.8). 
Figure 3.6. Tendon Organization. Ibuprofen had no effect on tendon collagen organization at 
2 and 8 weeks. Open bars- no drug, Solid bars- administered ibuprofen (n=6-8) 
 
CA24 CA24IBU 
EX2IBU EX2 
Figure 3.7. Representative Tendon Histology Images. Ibuprofen mildly 
increased cellularity acutely in the cage activity group and decreased cellularity 
with 2 weeks of exercise.   
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Table 3.1. Centrally Nucleated Fibers, %  
 No drug Ibuprofen 
Group 
% CNF 
(mean ± stdev) 
Sample size (n) 
% CNF 
(mean ± stdev) 
Sample size (n) 
CA24 0.31 ± 0.06 7 0.32 ± 0.21 8 
EX24 0.49 ± 0.40 7 0.30 ± 0.22 9 
CA2 0.32 ± 0.22 8 0.20 ± 0.06 6 
EX2 0.34 ± 0.08 7 0.26 ± 0.14 6 
CA8 0.40 ± 0.40 6 0.35 ± 0.26 6 
EX8 0.61 ± 0.25 7 0.42 ± 0.29 6 
 
 
Muscle fiber-specific changes were also evident with administration of ibuprofen. 
Similar to what has been shown previously,
3
 we found distinctions between the 
superficial and deep regions of the supraspinatus muscle, with the superficial region 
showing no MyHC-I staining, smaller MyHC-IIa fibers, and a greater proportion of 
MyHC-IIb fibers (Figure 3.9).  
 
 
Figure 3.8. Average Muscle Fiber Cross-Sectional Area. 
Administration of ibuprofen decreased average muscle fiber cross-
sectional area in the 2 week exercise group and both of the 8 week 
groups. Open bars- no drug, Solid bars- administered ibuprofen 
(n=7-9 acute, n=6-9 at 2 weeks, n=6-8 at 8 weeks) 
 
86 
 
 
Specifically, in the superficial region of the muscle, ibuprofen decreased the 
percent of MyHC-IIb positive fibers and increased the percent of MyHC-IIx positive 
fibers in the 2 week cage activity group and decreased the percent of MyHC-IIa positive 
fibers in the 2 week exercise group (Table 3.2). In the deep region of the muscle, 
ibuprofen increased the percent of MyHC-IIx positive fibers in the 8 week exercise group 
(Table 3.2). Ibuprofen significantly decreased the cross-sectional area of MyHC-IIb 
positive fibers in the superficial region of the 2 week exercise group and the MyHC-IIa 
positive fibers in the superficial region of the 8 week cage activity group (Table 3.3). No 
ibuprofen-induced, fiber type-specific cross-sectional area measurements were found in 
the deep region of the supraspinatus muscle. 
 
 
 
Superficial Deep 
Figure 3.9. Deep and Superficial Region Supraspinatus Muscle Fiber Type Distribution. Deep and 
superficial regions of the supraspinatus muscle showed distinct fiber types. The superficial region had 
no MyHC-I staining, smaller MyHC-IIa fibers, and greater proportion of MyHC-IIb fibers.  
Yellow: MyHC-I, Green: MyHC-IIa, Blue: MyHC-IIb, Red: Laminin 
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Table 3.2. Fiber Type Distribution, %. Superficial and deep regions of the 
supraspinatus muscle were analyzed separately for percent fiber type. The superficial 
region had no MyHC-I staining. (n=6-9 at 2 weeks, n=6-8 at 8 weeks) Mean ± StDev, * = 
ibuprofen had significant effect (p<0.05) compared to corresponding non-drug treated 
group 
 Superficial Deep 
Group 
MyHC- 
IIa 
MyHC- 
IIb 
MyHC- 
IIx 
MyHC- 
I 
MyHC- 
IIa 
MyHC- 
IIb 
MyHC- 
IIx 
CA2 9±3 66±6 25±7 13±2 29±5 26±7 32±3 
CA2IBU 8±5 *50±17 *41±19 11±2 28±7 27±9 34±8 
EX2 16±6 57±10 28±7 13±3 37±6 21±8 29±5 
EX2IBU *9±3 52±17 39±18 14±4 36±7 19±8 31±7 
CA8 11±5 60±8 28±4 16±3 30±3 18±5 36±3 
CA8IBU 9±2 60±7 31±6 14±5 32±5 15±5 39±5 
EX8 18±6 51±8 31±5 13±4 42±6 16±7 29±2 
EX8IBU 13±6 50±18 38±21 12±2 40±6 15±7 *32±4 
 
Table 3.3. Fiber Type Cross-Sectional Area, µm
2
. Superficial and deep regions of the 
supraspinatus muscle were analyzed separately for fiber type cross-sectional area. The 
superficial region had no MyHC-I staining. (n=5-9 at 2 weeks, n=6-7 at 8 weeks) Mean ± 
StDev, * = ibuprofen had significant effect (p<0.05) compared to corresponding non-drug 
treated group 
 Superficial Deep 
Group 
MyHC- 
IIa 
MyHC- 
IIb 
MyHC- 
I 
MyHC- 
IIa 
MyHC- 
IIb 
CA2 1455±198  3614±510 1755±228 2127±204 4048±365 
CA2IBU 1476±229 3440±418 1653±228 2018±367 3807±925 
EX2 1611±166 3848±547 1769±190 2220±196 4056±617 
EX2IBU 1499±172 *2985±342 2101±475 2459±619 3475±753 
CA8 1845±180 4225±485 2069±333 2783±481 4552±658 
CA8IBU *1585±191 4048±495 2105±442 2600±531 4441±512 
EX8 1890±304 4669±415 2083±357 2720±291 5088±349 
EX8IBU 1824±211 4333±751 2029±472 2613±606 4685±1275 
 
D. Discussion 
 In contrast to our hypothesis, results suggest that chronic intake of ibuprofen at 
pharmacologic doses does not detrimentally affect supraspinatus tendon mechanical 
adaptations to exercise. Tendon mechanical properties were not diminished and in some 
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instances increased with ibuprofen. This finding suggests that the arachidonic acid 
cascade may not play a major role in the adaptions of tendon to load in a non-injurious 
exercise model, in contrast to that seen with acute injury models.
e.g.,1,8,10,18
 On the other 
hand, total muscle fiber cross-sectional area decreased with ibuprofen at chronic time 
points, and some fiber type-specific changes were detected, indicating that chronic 
administration of ibuprofen impacts hypertrophy of sedentary and exercised 
supraspinatus muscles.  
 Previous in vitro studies on tenocytes have shown that ibuprofen reduces 
proliferation
33
 and migration,
32,33
 increases MMP expression, and has no effect on 
collagen types I or III.
31
 A tendon-bone healing co-culture model has shown COX 
inhibition leads to reduced cell viability, proliferation, and migration.
26
 Although these 
studies suggest important effects of NSAIDs on tendon, they were not designed to 
replicate in vivo conditions. Current literature on the in vivo effects of NSAIDs on tendon 
and muscle is unclear. Previous studies on tendon have reported the acute effects of 
ibuprofen combined with exercise to include decreases in collagen synthesis
6
 and blood 
flow
13
 or minimal effects.
21
 In our study we detected an acute decrease in tendon cross-
sectional area and increase in tendon modulus when ibuprofen was combined with a 
single bout of exercise, bringing these properties closer to previously measured baseline 
levels; however, since this study investigated only a single acute time point (24 hours 
after exercise), it is unknown whether these changes represent delayed or accelerated 
recovery.  
 Confirming a previous study,
3
 we detected apparent regional differences in 
muscle fiber type distribution within the supraspinatus, and future studies should 
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investigate the functional implications of these two distinct regions. Our finding of 
decreased muscle fiber cross-sectional area supports a previous study that showed 
ibuprofen reduced muscle hypertrophy in rats.
28
 Furthermore, while some studies have 
found no changes in myofibrillar and collagen protein synthesis in muscle with 
administration of NSAIDs,
16,20
 in subjects given ibuprofen in conjunction with high-
intensity eccentric resistance exercise, skeletal muscle fractional synthesis rates were 
attenuated, implying that the drug suppressed the beneficial muscle protein synthesis 
response to exercise.
30
 Other studies have shown that acute administration of NSAIDs led 
to fewer muscle satellite cells.
15,17
 Finally, prostaglandin F2α
 
(PGF2α) is thought to be 
regulator muscle protein synthesis, contributing to muscle hypertrophy.
29
 Prostaglandins 
are a downstream product of COX activity, so ibuprofen may be decreasing PGF2α 
production. Following a single bout of exercise combined with ibuprofen, reduced 
muscle protein synthesis, decreases in satellite cells, which are thought to mediate 
hypertrophy,
24
 or reduced PGF2α may have led to the decreased muscle fiber cross-
sectional area we measured chronically. Future studies should measure the acute effects 
of this exercise protocol on these parameters. Overall, the highly organized structure of 
the tendon collagen and the very few muscle fibers with centrally located nuclei in this 
study suggest that these tissues in this study were healthy and were not damaged by 
ibuprofen. 
 In general, muscle is more responsive to exercise than tendon, implying that 
different processes regulate the adaptations of these tissues to load. Supporting this, in a 
gene screening study we found distinct responses of supraspinatus muscle and tendon to 
both acute and chronic exercise.
23
 Therefore, it makes sense that treatments, like 
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ibuprofen, would have tissue-dependent and activity-dependent effects that must be 
considered when making clinical recommendations for treatment.  
 This study is not without limitations. First, muscle fiber type was only measured 
in the chronic groups, and MyHC-IIx was left unstained and unanalyzed. Some of the 
decreases in total fiber cross-sectional area could be due to changes in MyHC-IIx, which 
were not measured; however, the decreases in total muscle fiber cross-sectional area do 
include MyHC-IIx fibers and therefore represent the global changes to the muscle. 
Additionally, it is unknown whether the measured decreases in muscle fiber cross-
sectional area and altered fiber type distributions lead to functional differences of the 
whole muscle. The results of this study provide evidence for future investigations on the 
physiologic properties of the muscle including force production and fatigue. Additionally, 
this study investigates a single exercise protocol, and it is unknown how ibuprofen may 
affect supraspinatus tendon and muscle with a more intense exercise protocol; however, 
this protocol has previously been shown to induce beneficial adaptations to the rat 
shoulder without inducing chronic injury,
22,23
 indicating that it is a physiologically 
relevant model of non-injurious exercise. Finally, future studies should investigate the 
structural protein changes within the tissue that lead to the properties altered in this study 
as well as the baseline and exercise-induced temporal expression of COX enzymes and 
vascularity. 
 In conclusion, chronic administration of ibuprofen does not impair supraspinatus 
tendon mechanical properties in a rat model of exercise but does decrease supraspinatus 
muscle fiber cross-sectional area. These findings suggest the arachidonic acid cascade is 
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not a main regulator of tendon adaptations to exercise but may be important in muscle 
growth.  
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Chapter 4: Doxycycline Improves Sedentary, but not Exercised, 
Supraspinatus Tendon and Muscle in a Rat Model 
 
A. Introduction 
 Rotator cuff tendinopathy, which primarily affects the supraspinatus tendon, is a 
common clinical condition. Matrix metalloproteinases (MMPs) are enzymes that degrade 
extracellular matrix proteins such as collagens, the main structural component of tendon. 
MMPs have been implicated in the progression of tendon degeneration, which is 
supported by numerous studies that have found alterations in expression.
1,3,22
 While 
changes in MMP expression are characteristic of tendinopathy, non-injurious exercise 
also produces changes in tendon
e.g.,7,12
 and muscle
e.g.,19,20,24
 MMP expression, consistent 
with matrix turnover and beneficial adaptations. Potentially, one key distinguishing 
feature between maladaptations and beneficial adaptations to exercise is the role of 
MMPs.  
MMP inhibition has been proposed as a method to improve skeletal muscle and 
tendon healing.
6
 Doxycycline, in addition to being a commonly prescribed antibiotic 
medication, is a broad-spectrum MMP inhibitor that has been widely used clinically. 
Studies have investigated the effects of doxycycline on tendon healing, reporting 
contradictory results. Following acute detachment and repair of the rat supraspinatus 
tendon, doxycycline improved collagen organization and improved load to failure of the 
tendons at 2 but not 4 weeks.
5
 After acute Achilles tendon injury in a rat model, 
doxycycline inhibited MMP activity, leading to improved collagen organization and 
tendon mechanical properties in one study,
11
 but decreased tendon ultimate load in 
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another study.
13
 Doxycycline also reduced the severity of skeletal muscle reperfusion 
injury.
16
 These studies were designed to investigate doxycycline effects on acute injuries 
and not chronic tissue adaptations. It is unknown how doxycycline affects muscle and 
tendon adaptations to exercise or homeostasis in sedentary tissues.  
 The objective of this study was to investigate the effects of doxycycline as a 
broad-spectrum MMP inhibitor on sedentary and exercised supraspinatus tendon and 
muscle with our previously developed rat model of non-injurious exercise.
18
 Using this 
model we have demonstrated distinct acute and chronic effects of exercise to the muscle 
and tendon and found several altered genes associated with matrix turnover.
17
 We 
hypothesized that administration of doxycycline would abolish the beneficial adaptations 
found with exercise but have no effect on sedentary muscle and tendon properties.  
B. Methods 
1. Study Design and Treadmill Protocols 
 Following approval by the University’s Institutional Animal Care and Use 
Committee, 171 male, Sprague-Dawley rats (400-450g at start of study) were divided into 
cage activity (CA) or exercise (EX) groups. These groups were further divided into an 
acute time point or two chronic time points with half of these animals receiving 
doxycycline (DOX). The non-drug comparison groups are a subset of another study 
performed in the same time frame by the same personnel (as described in Chapter 2). 
Animals in the DOX groups were administered an oil suspension of doxycycline hyclate 
(Wedgewood Pharmacy, Swedesboro, NJ, USA) orally every 24 hours at a dose of 10 
mg/kg (standard veterinary clinical dose). This dose has previously been shown to induce 
significant changes in the healing Achilles tendon through MMP inhibition.
11
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To investigate the acute effects of doxycycline on muscle and tendon, animals in 
the acute EX group underwent 2 weeks of progressive, downhill treadmill training to 
acclimate to the treadmill, as previously described.
17
 Following 72 hours of rest, EX 
animals underwent a single treadmill exercise session at a constant speed of 10 
meters/minute for 1 hour on a flat treadmill. These animals were then euthanized by 
controlled flow-rate carbon dioxide 24 hours after completion of their single bout of 
exercise (EX24). Animals in the DOX groups began receiving doxycycline 24 hours prior 
to the start of their single bout of exercise and continued receiving doxycycline every 24 
hours until euthanasia (3 doses total, EX24DOX). A separate group of animals 
maintained normal cage activity for the 2 week duration and received 3 doses of 
doxycycline (every 24 hours) until euthanasia 1.5 hours after their last dose of 
doxycycline (CA24DOX). These animals were compared to a cage activity group that did 
not receive doxycycline (CA24, Figure 4.1).  
 To investigate the chronic effects of doxycycline on muscle and tendon 
adaptations to exercise, animals in the chronic EX groups underwent 2 weeks of flat 
treadmill acclimation and then walked on a flat treadmill at a constant speed of 10 
meters/minute, 1 hour per day, 5 days per week
18
 for 2 or 8 weeks (EX2, EX8). Control 
animals maintained normal cage activity for this duration (CA2, CA8, described in 
Chapter 2). Animals in the DOX groups received doxycycline every 24 hours, 7 days per 
week for the 2 or 8 week duration (EX2DOX, EX8DOX, CA2DOX, CA8DOX, Figure 
4.1).  
For both acute and chronic exercise groups, inclusion was set to >75% completion 
of the total treadmill protocol. Animals that completed <10% of the treadmill protocol 
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(they did not complete the 2 weeks of treadmill training and were removed before 
beginning the exercise protocol) were included in the CA groups.   
From every animal, each shoulder was designated to muscle/tendon histology or 
tendon mechanics. Tendon mechanical testing was not performed on the CA24 or 
Figure 4.1. Acute (A) and Chronic (B) Study Designs. A) An acute cage activity group 
maintained normal cage activity, received 3 doses of doxycycline, was euthanized 1.5 hours after 
their last dose of the drug (CA24DOX) and was compared to a group that did not receive 
doxycycline (CA24). Rats in acute exercise groups underwent 2 weeks of treadmill training 
followed by 72 hours of rest. These rats were euthanized 24 hours after completion of a single bout 
of exercise (EX24). These animals were compared to a group that received doxycycline beginning 
1 day before their exercise session and continuing until euthanasia (EX24DOX). B) For analysis of 
chronic effects, control cage activity groups maintained normal cage activity for an early time point 
(CA2, CA2DOX) or a later time point (CA8, CA8DOX). Rats in chronic exercise groups 
underwent 2 weeks of treadmill training followed by 2 or 8 weeks of the exercise protocol (EX2, 
EX2DOX, EX8, EX8DOX). DOX groups received doxycycline during this 2 or 8 week period. 
Assays were performed on supraspinatus: M- tendon mechanics, TH- tendon histology, MH- 
muscle histology 
 
A B 
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CA24DOX groups. At time of euthanasia, animals were weighed, shoulders allotted to 
histology were dissected, and the supraspinatus muscle was cut transversely through the 
mid-belly. This muscle piece was pinned to Styrofoam to maintain muscle architecture, 
covered in OCT, and immediately flash-frozen in liquid nitrogen-cooled isopentane. The 
specimens were stored at -80ºC until frozen sectioning. The remaining humeral head-
supraspinatus tendon-muscle half was immediately placed in formalin for fixing. For 
mechanics, the animals were stored at -20ºC, and the shoulders were dissected and 
prepared at the time of testing.  
2. Tendon Mechanical Testing 
For tendon mechanical testing, animals were thawed, and the left shoulder was 
dissected, keeping the supraspinatus tendon attached to its bony insertion on the humerus. 
Verhoeff’s stain lines for optical strain measurements were placed at the bony insertion 
site and 2, 4, and 8 mm proximally. Tendon cross-sectional area was measured with a 
custom laser device.
14
 Cyanoacrylate was used to fix the tendon between two pieces of 
sandpaper at the 8 mm stain line and gripped with a custom screw clamp. Humeri were 
potted in PMMA, and a custom fixture secured the potted humerus for testing with an 
Instron ElectroPuls E3000 affixed with a 250 N load cell and a LVDT for increased 
displacement resolution. Tendons were submerged in a 37°C PBS bath and underwent the 
following testing protocol: 1) preconditioning (10 triangle cycles from 1-1.5% strain at 
0.25 Hz then held at gauge length for 300s), 2) stress-relaxation to 4% strain held for 
300s, 3) frequency sweep (0.1, 1, 2, 10 Hz) of 10 sine cycles with amplitude of 0.125% 
strain, 4) return to gauge length and held for 60s, 5) stress-relaxation to 8% strain held for 
300s, 6) recovery to 4% strain held for 300s, 7) return to 8% strain and held for 300s, 8) 
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frequency sweep (0.1, 1, 2, 10 Hz) of 10 sine cycles with amplitude of 0.125% strain, 9) 
return to gauge length and held for 180s, 10) ramp to failure at 0.3%/s. Due to slip in the 
fixture that occurred near 4% strain, only the 8% data were analyzed (steps 5, 8, 10).  
Local 2D Lagrangian strain of the tendon relative to the bone during the ramp to 
failure was measured by tracking the stain lines with a custom MATLAB program. 
Stiffness was calculated as the slope of the linear region of the load-displacement curve, 
and elastic modulus was calculated as the slope of the linear region of the stress-strain 
curve. Percent relaxation was calculated as the percent change in the load after 300 
seconds of relaxation. The dynamic modulus (|E*|, ratio of the stress-to-strain amplitude) 
and tangent of the phase angle between the stress and strain (tan(δ), ratio of the loss-to-
storage modulus, a measure of viscoelasticity) were calculated using the middle 5 sine 
cycles at each frequency.  
3. Tendon Histology 
After fixing in 10% buffered formalin, bone-tendon-muscle units were decalcified 
in formic acid decalcifier (Immunocal, American MasterTech, Lodi, CA, USA) and then 
processed, embedded in paraffin, and sectioned at 7µm. Sections were stained with 
hematoxylin and eosin and the tendon midsubstance was imaged at 200x magnification 
and used for traditional (acute and chronic groups) and polarized light microscopy 
(chronic groups only). Cell density (cells/mm
2
) and cell shape (aspect ratio 0-1 with 1 
being a circle) were quantified using commercial software (Bioquant Osteo II, Nashville, 
TN, USA). Custom MATLAB software was used to analyze the polarized light images 
and calculate the circular standard deviation, a measure of the spread of collagen fiber 
alignment.
10
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4. Muscle Histology 
 Muscle specimens were cryosectioned at 10µm, transverse to the muscle fibers. 
For morphological analysis, sections were stained with an anti-laminin polyclonal 
antibody produced in rabbit (Sigma-Aldrich, Saint Louis, MO, USA), incubated with 
Alexa Fluor 488 goat anti-rabbit secondary antibody (Life Technologies, Grand Island, 
NY, USA), mounted and cover-slipped with ProLong Gold antifade reagent with DAPI 
(Life Technologies, Grand Island, NY, USA), and visualized with epifluorescence on an 
Eclipse 90i microscope. Six images were acquired at 100x magnification per specimen 
(resulting in analysis of ≥450 fibers per specimen). The number of centrally nucleated 
fibers (CNF) were counted and divided by the total number of fibers to determine 
percent. The total average fiber cross-sectional area was analyzed with a MATLAB 
application.
23
 For fiber type analysis, sections were simultaneously stained with anti-
myosin heavy chain-I (MyHC-I) BA-DF, MyHC-IIa SC-71, and MyHC-IIb BF-F3 
antibodies
21
 (Developmental Studies Hybridoma Bank, University of Iowa, Iowa City, 
IA, USA), and anti-laminin antibody (Sigma-Aldrich). MyHC-IIx fibers were left 
unstained and were not analyzed for cross-sectional area. Sections were incubated with 
secondary antibodies: Alexa Fluor 546 goat anti-mouse IgM (Life Technologies), 
DyLight 405 goat anti-mouse IgG 2b (Jackson Immuno, West Grove, PA, USA), Alexa 
Fluor 488 goat anti-mouse IgG 1 (Jackson), and Alexa Fluor 647 goat anti-rabbit IgG 
(Jackson). Stained sections were mounted and cover-slipped with ProLong Gold antifade 
reagent without DAPI (Life Technologies). As previously described, the rat supraspinatus 
muscle fiber type distribution differs in the superficial and deep layers of the muscle;
4
 
therefore, fiber types of these two regions were analyzed separately, and 3 images at 100x 
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magnification were captured for each region. These images were analyzed with a 
MATLAB application for muscle fiber type distribution and cross-sectional area.
23
    
5. Statistics 
 Statistical analysis was performed based on our hypotheses. A pre-study power 
analysis using data from a previous published study
11
 that administered the same dose of 
doxycycline and investigated rat Achilles tendon healing estimated a required sample size 
of 10 specimens per group to detect a doxycycline effect size of 1.2 on tendon stiffness. 
To determine the effects of doxycycline on muscle and tendon adaptations, t-tests were 
used to compare DOX-treated and non-drug treated groups separately for CA and EX at 
each time point. Comparisons between time points are inappropriate due to the significant 
animal growth that occurs. Since our hypotheses were specific to the effects of 
doxycycline, we did not make comparisons between exercise and cage activity groups. 
Significance was set to p≤0.05 and trends at p≤0.1. Figures are shown with mean and 
standard deviation. 
C. Results 
1. Tendon Mechanics 
Combined with an acute bout of exercise, administration of doxycycline 
decreased tendon cross-sectional area and increased tendon modulus and maximum stress 
(Figure 4.2), bringing properties to within 0.2-10% of previously measured baseline 
levels (baseline determined in Chapter 2). Doxycycline also increased dynamic modulus 
(Figure 4.3). The viscoelastic properties of percent relaxation (Figure 4.2D) and tan(δ) 
(Figure 4.4) were not altered by doxycycline combined with acute exercise.  
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In chronic groups, administration of doxycycline decreased tendon cross-sectional 
area (trends for CA2, CA8, EX8) and increased modulus (trend for EX2) for all groups 
(Figure 4.2) and increased dynamic modulus at all frequencies for the 2 week time point 
(exercise and cage activity) and 8 week cage activity time point (Figure 4.3). Dynamic 
modulus was not altered with administration of doxycycline in the 8 week exercise group. 
Doxycycline increased stiffness and maximum load (trend for CA8) in the chronic cage 
activity groups but decreased stiffness (trend for EX2) and maximum load (trend for 
EX8) in the chronic exercise groups (Figure 4.2). Similarly, at 2 weeks, doxycycline 
significantly increased maximum stress in the cage activity group but trended toward 
decreasing maximum stress in the exercise group (Figure 4.2). Viscoelastic properties 
A B C 
D E F 
Figure 4.2. Tendon Mechanics. Administration of doxycycline combined with a single bout of 
exercise returned tendon cross-sectional area, modulus, and maximum stress to baseline (gray dashed 
line) by 24 hours. Tendon cross-sectional area was reduced chronically and modulus and maximum 
stress were increased. Doxycycline had differential effects on percent relaxation, stiffness, and 
maximum load in chronic cage activity and exercise groups. Open bars- no drug, Solid bars- 
administered doxycycline (n=10-15 acute, n=12-17 at 2 weeks, n=10-14 at 8 weeks) 
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were also altered with administration of doxycycline: percent relaxation decreased with 2 
weeks of cage activity but increased with 2 weeks of exercise and 8 weeks of cage 
activity (Figure 4.2D). Doxycycline increased tan(δ) for all chronic groups at 0.1 Hz 
(trend for CA2) and all chronic groups except the 2 week cage activity group at 1 Hz 
(trend for CA8, Figure 4.4). At 2 and 10 Hz, doxycycline reduced tan(δ) with 2 weeks of 
cage activity but trended toward increasing tan(δ) with 2 and 8 weeks of exercise (Figure 
4.4).  
  
A B 
C D 
Figure 4.3. Dynamic Modulus. Administration of doxycycline combined with a 
single bout of exercise increased tendon dynamic modulus by 24 hours, approaching 
and exceeding baseline properties. Chronically, dynamic modulus increased at the 2 
week time point for both cage activity and exercise groups but only increased in the 
cage activity group for the 8 week time point. Open bars- no drug, Solid bars- 
administered doxycycline (n=11-13 acute, n=13-17 at 2 weeks, n=10-14 at 8 weeks) 
107 
 
2. Tendon Histology 
Acute administration of doxycycline had no effect on cell density or cell shape 
and only trended toward decreasing cell density when combined with a single bout of 
exercise (Figure 4.5). At the 8 week time point, doxycycline decreased cell density in 
cage activity and exercise groups. Doxycycline administration resulted in rounder cells in 
the cage activity groups at 2 and 8 weeks and the exercise group at 8 weeks (Figure 4.5). 
Tendon collagen circular standard deviation decreased, indicating increased organization, 
with 8 weeks of doxycycline in the cage activity group (Figure 4.6). Representative 
tendon histology images are shown in Figure 4.7. The mild changes in cell density and 
A B 
C D 
Figure 4.4. Tan(δ). Administration of doxycycline combined with a single bout of 
exercise had no effect on tan(δ). Chronically, tan(δ) increased with doxycycline at 0.1 
Hz for all groups and 1 Hz for all groups except 2 week cage activity. Differential 
effects of doxycycline on tan(δ) in cage activity and exercise groups occurred at 2 and 
10 Hz. Open bars- no drug, Solid bars- administered doxycycline (n=11-15 acute, 
n=12-17 at 2 weeks, n=11-14 at 8 weeks) 
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cell shape and highly organized collagen are in contrast to that seen with injury (Figure 
2.7, Chapter 2). 
 
 
 
 
 
 
 
 
 
 
Figure 4.6. Tendon Organization. After 8 weeks of cage activity, doxycycline increased collagen 
organization. Open bars- no drug, Solid bars- administered doxycycline (n=7-8 at 2 weeks, n=6-8 at 
8 weeks) 
A B 
Figure 4.5. Tendon Histology. Administration of doxycycline had minimal acute effects. Chronic 
administration led to fewer and rounder cells at 8 weeks and rounder cells in the cage activity group 
at 2 weeks. Open bars- no drug, Solid bars- administered doxycycline (n=7-8 acute, n=7-9 at 2 
weeks, n=6-8 at 8 weeks) 
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3. Muscle Histology 
For all groups, the average percent of centrally nucleated fibers was below 1%, 
and doxycycline had no effect (Table 4.1). Doxycycline decreased the average total 
muscle fiber cross-sectional area in all the exercise groups (trend for EX2) but did not 
affect the cage activity groups (Figure 4.8).   
Table 4.1. Centrally Nucleated Fibers, % 
 No drug Doxycycline 
Group 
% CNF 
(mean ± stdev) 
Sample size 
(n) 
% CNF 
(mean ± 
stdev) 
Sample size 
(n) 
CA24 0.31 ± 0.06 7 0.34 ± 0.30 8 
EX24 0.49 ± 0.40 7 0.36 ± 0.20 7 
CA2 0.32 ± 0.22 8 0.29 ± 0.25 7 
EX2 0.34 ± 0.08 7 0.39 ± 0.24 7 
CA8 0.40 ± 0.40 6 0.55 ± 0.23 6 
EX8 0.61 ± 0.25 7 0.59 ± 0.33 7 
 
CA8 CA8DOX 
EX8 EX8DOX 
Figure 4.7. Representative Tendon Histology Images. Doxycycline mildly 
decreased cellularity and increased the rounding of cells in 8 week cage activity 
and exercise groups. Doxycycline improved collagen organization in the 8 week 
cage activity group.  
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Similar to what has been shown previously,
4
 we found distinctions between the 
superficial and deep regions of the supraspinatus muscle (Figure 3.9, Chapter 3). Muscle 
fiber-specific changes were evident with administration of doxycycline. Specifically, in 
the superficial region of the muscle, doxycycline trended toward increasing the percent of 
MyHC-IIa positive fibers and decreasing the percent of MyHC-IIx positive fibers in the 2 
week cage activity group, decreasing the percent of MyHC-IIb positive fibers and 
increasing the percent of MyHC-IIx positive fibers in the 2 week exercise group, and 
increasing the percent of MyHC-IIx positive fibers in the 8 week cage activity group 
(Table 4.2). In the deep region of the muscle, doxycycline trended toward increasing the 
percent of MyHC-IIa positive fibers while decreasing MyHC-IIb and MyHC-IIx positive 
fibers in the 2 week cage activity group and decreasing the percent of MyHC-IIb positive 
fibers in the 2 week exercise group (Table 4.2). At 8 weeks, doxycycline trended toward 
increasing the percent of MyHC-IIa positive fibers while decreasing the percent of 
Figure 4.8. Average Muscle Fiber Cross-Sectional Area. 
Administration of doxycycline decreased average muscle fiber 
cross-sectional area in the exercise groups but not the cage 
activity groups. Open bars- no drug, Solid bars- administered 
doxycycline (n=7-8 acute, n=7-9 at 2 weeks, n=6-8 at 8 weeks) 
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MyHC-IIx positive fibers in the cage activity group and increasing the percent of MyHC-
IIx positive fibers in the exercise group (Table 4.2). 
Fiber-specific cross-sectional area was also altered with administration of 
doxycycline (Table 4.3). In the superficial region of the muscle, doxycycline decreased 
MyHC-IIa (trend) and MyHC-IIb fiber cross-sectional areas in the 2 week exercise 
group. MyHC-IIa fibers in the superficial region of the muscle trended toward decreased 
cross-sectional area with administration of doxycycline in the 8 week cage activity and 
exercise groups. In the deep region of the muscle, MyHC-I fiber cross-sectional area 
significantly increased and MyHC-IIb cross-sectional area significantly decreased in the 
2 week exercise group administered doxycycline. After 8 weeks of exercise, doxycycline 
significantly decreased MyHC-IIb fiber cross-sectional area and trended toward 
decreasing MyHC-IIa fiber cross-sectional area.  
Table 4.2. Fiber Type Distribution, %. Superficial and deep regions of the 
supraspinatus muscle were analyzed separately for percent fiber type. The superficial 
region had no MyHC-I staining. (n=5-9 at 2 weeks, n=6-8 at 8 weeks) Mean ± StDev, 
+
 = 
doxycycline trended toward having an effect (p<0.1) compared to non-drug treated group 
 Superficial Deep 
Group 
MyHC- 
IIa 
MyHC- 
IIb 
MyHC- 
IIx 
MyHC- 
I 
MyHC- 
IIa 
MyHC- 
IIb 
MyHC- 
IIx 
CA2 9±3 66±6 25±7 13±2 29±5 26±7 32±3 
CA2DOX 
+
11±3 67±3 
+
22±2 14±2 
+
35±9 
+
21±8 
+
29±5 
EX2 16±6 57±10 28±7 13±3 37±6 21±8 29±5 
EX2DOX 14±6 
+
49±12 
+
38±17 14±3 40±5 
+
16±3 31±5 
CA8 11±5 60±8 28±4 16±3 30±3 18±5 36±3 
CA8DOX 10±7 57±8 
+
33±7 15±5 
+
36±9 16±8 
+
33±4 
EX8 18±6 51±8 31±5 13±4 42±6 16±7 29±2 
EX8DOX 15±2 54±6 31±6 12±1 41±6 16±7 
+
31±3 
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Table 4.3. Fiber Type Cross-Sectional Area, µm
2
. Superficial and deep regions of the 
supraspinatus muscle were analyzed separately for fiber type cross-sectional area. The 
superficial region had no MyHC-I staining. MyHC-IIx fibers were not stained and not 
analyzed for cross-sectional area. (n=5-9 at 2 weeks, n=6-7 at 8 weeks) Mean ± StDev, * 
= doxycycline had significant effect (p<0.05) compared to corresponding non-drug 
treated group, 
+
 = doxycycline trended toward having an effect (p<0.1) compared to non-
drug treated group 
 Superficial Deep 
Group 
MyHC- 
IIa 
MyHC- 
IIb 
MyHC- 
I 
MyHC- 
IIa 
MyHC- 
IIb 
CA2 1455±198  3614±510 1755±228 2127±204 4048±365 
CA2DOX 1491±262 3682±334 1830±324 2190±321 3946±332 
EX2 1611±166 3848±547 1769±190 2220±196 4056±617 
EX2DOX 
+
1462±190 *3348±240 *1994±192 2281±355 *3140±518 
CA8 1845±180 4225±485 2069±333 2783±481 4552±658 
CA8DOX 
+
1636±289 4270±474 2105±442 2600±531 4441±512 
EX8 1890±304 4669±415 2083±357 2720±291 5088±349 
EX8DOX 
+
1745±101 4474±651 1929±276 
+
2533±150 *4619±416 
 
D. Discussion 
 In contrast to our hypothesis, administration of doxycycline significantly affected 
sedentary supraspinatus tendon properties. Surprisingly, in the cage activity groups, 
doxycycline resulted in beneficial increases in tendon mechanics and organization. These 
same increases were not always present in exercised tendons. In fact, doxycycline 
combined with chronic exercise led to decreases in stiffness and maximum load. Acutely, 
doxycycline combined with a single bout of exercise reduced tendon cross-sectional area 
and increased modulus and maximum stress, bringing these properties closer to 
previously measured baseline levels; however, since this study investigated only a single 
acute time point (24 hours after exercise), it is unknown whether these changes represent 
delayed or accelerated recovery. Dynamic modulus also increased acutely.  
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 These findings of beneficial adaptations of tendons from sedentary animals 
administered doxycycline suggest that MMP activity levels are higher in sedentary 
tendons than in tendons undergoing exercise. Indeed, an MMP activity assay revealed 
decreased generic MMP activity in supraspinatus tendons from rats after 8 weeks of 
chronic exercise compared to cage activity as well as decreased MMP activity 12, 24, and 
48 hours following a single bout of exercise (Chapter 2). These findings suggest that 
underused tendons express heightened catabolic processes, including matrix degradation 
facilitated by MMPs. A previous in vitro study found increased MMP-13 mRNA 
expression with stress deprived tendons, and administration of ilomastat (broad-spectrum 
MMP inhibitor) recovered the gene expression, returning the TIMP:MMP ratio to 
baseline.
9
 Similarly, the MMP inhibitors doxycycline and ilomastat administered to rat 
tail tendons that were subjected to one week of in vitro stress deprivation prevented the 
detrimental loss of mechanical properties.
2
 The results of the current study support the 
findings of these two previous studies, suggesting that disuse or underuse of tendons 
results in heightened MMP activity and consequently degenerative processes. 
Doxycycline inhibits the MMP activity to prevent these detrimental losses. Exercise can 
also benefit by decreasing MMP activity and thereby allowing for enhanced tendon 
mechanical properties compared to sedentary. 
 Muscle from animals undergoing exercise combined with doxycycline had 
decreased total fiber cross-sectional area; this change was not evident in cage activity 
groups. Confirming a previous study,
4
 we detected apparent regional differences in 
muscle fiber type distribution within the supraspinatus, and future studies should 
investigate the functional implications of these two distinct regions. The 2 week cage 
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activity group administered doxycycline demonstrated trends toward increased percent of 
MyHC-IIa positive fibers, which is an adaptation that can be found with beneficial 
exercise.
8,15
 Exercise combined with doxycycline for 2 weeks resulted in a significant 
increase in MyHC-I muscle fiber cross-sectional area in the deep region of the 
supraspinatus muscle and significant decreases in MyHC-IIb muscle fiber cross-sectional 
area in both superficial and deep regions, suggesting that the fatigue-resistant type I fibers 
may be playing a more important role than the fatigable type IIb fibers; however, by 8 
weeks of exercise combined with doxycycline, only a significant decrease in type IIb 
fiber cross-sectional area is found. Overall, changes in muscle fiber cross-sectional area 
were much more evident in the exercise than the cage activity groups.   
Several studies have shown alterations in MMP and TIMP expression with 
tendinopathy. It is believed that an imbalance in these enzymes leads to the advanced 
degeneration of the tendon. With beneficial adaptation to exercise, the synthesis-to-
degradation ratio is in favor of synthesis, whereas with maladaptation leading to 
tendinopathy, degradation overpowers synthesis. The results of this study support that 
even sedentary levels of use can result in a shift towards degradation, and administration 
of doxycycline can recover some of these lost properties. 
 This study is not without limitations. First, muscle fiber type was only measured 
in the chronic groups, and MyHC-IIx was left unstained and unanalyzed. Some of the 
decreases in total fiber cross-sectional area could be due to changes in MyHC-IIx, which 
were not measured; however, the decreases in total muscle fiber cross-sectional area do 
include MyHC-IIx fibers and therefore represent the global changes to the muscle. 
Additionally, muscle function was not measured in this study in an effort to reduce the 
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number of animals used, and it is unknown whether the changes in muscle fiber type 
proportion and cross-sectional area result in functional differences; however, the results 
in this study provide support for future investigations of muscle physiologic properties 
including force production and fatigue. Furthermore, to reduce the number of animals 
used in this study, tendon mechanical properties were not measured in the CA24-
CA24DOX sedentary groups, so it is unknown what influence the drug has on tendon 
mechanical properties acutely and how this may lead to the chronic adaptations that were 
measured; however, we did not detect any cell density or cell shape changes within the 
tendon due to acute administration of doxycycline. In this study, doxycycline was 
administered orally, as is normally done clinically. Although we did not confirm that 
doxycycline administration decreased local MMP activity, the dose we used (10mg/kg 
daily) has previously been shown to induce clinically relevant serum levels of the drug, 
decrease MMP activity in a rat Achilles transection after 4 weeks, and improve tendon 
healing,
11
 providing substantial support for this dose. Given our findings of activity-
dependent effects of doxycycline to the muscle, future studies should measure MMP 
activity in the supraspinatus muscle following acute and chronic exercise. Finally, this 
study investigated a single exercise protocol, and it is unknown how results would change 
with increased intensity of exercise; however, we have previously shown that this 
protocol produces significant adaptations to the rat shoulder without inducing 
supraspinatus tendon injury, indicating that it is a physiologically relevant model of non-
injurious exercise.
17,18
 
In this study, we detected several effects of doxycycline on sedentary tissues that 
mimicked the beneficial effects of exercise: enhanced tendon mechanical properties, 
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consistently healthy tendon histology with improved collagen organization, and trends 
toward increased proportion of MyHC-IIa muscle fibers without reducing the average 
muscle fiber cross-sectional area or increasing the number of centrally nucleated fibers. 
Future studies should further explore these exercise mimetic properties of doxycycline on 
sedentary tissues. In conclusion, results of this study suggest that administration of 
doxycycline at pharmaceutical doses induces beneficial supraspinatus tendon adaptations 
without negatively affecting the muscle in sedentary animals, supporting the use of 
doxycycline to combat degenerative processes associated with underuse; however, when 
combined with exercise, doxycycline does not produce the same beneficial adaptations in 
rat supraspinatus tendons and reduces muscle fiber cross-sectional area, suggesting that 
doxycycline is not advantageous when combined with activity. Future studies can explore 
the effects of doxycycline in overuse and stress-deprived conditions.  
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Chapter 5: Conclusions and Future Directions 
A. Introduction 
 In this dissertation, a rat model of supraspinatus exercise was used to explore the 
temporal tendon and muscle adaptations to load and the influences of ibuprofen and 
doxycycline. Acute mechanical and histological responses following a single bout of 
exercise and chronic mechanical, histological, and organizational adaptations in the 
tendon to exercise were defined (Chapter 2). This model was then used to investigate 
how ibuprofen, a commonly used nonsteroidal anti-inflammatory drug, affects 
supraspinatus tendon mechanical properties, tendon histological properties and 
organization, muscle fiber type, and muscle fiber cross-sectional area to elucidate the role 
of the arachidonic acid cascade in muscle and tendon responses to load (Chapter 3).  
Finally, this model was used to investigate how doxycycline, an inhibitor of matrix 
metalloproteinases, affects supraspinatus tendon mechanical properties, tendon 
histological properties and organization, muscle fiber type, and muscle fiber cross-
sectional area to elucidate the role of matrix degrading enzymes on muscle and tendon 
(Chapter 4). The main findings and conclusions from these chapters and proposed future 
directions are discussed in this final chapter. 
B. Rat Supraspinatus Tendon Responds Acutely and Chronically to Exercise 
Tendon can beneficially adapt to exercise, but it is unknown how acute responses 
following a single bout of exercise lead to chronic, beneficial adaptations. The objective 
of this study was to identify the acute responses and chronic adaptations of rat 
supraspinatus tendon in a physiologically relevant, non-injurious exercise model. We 
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hypothesized that chronic exercise would result in superior tendon mechanical properties, 
and acute exercise would result in increases in matrix metalloproteinase (MMP) activity.  
Consistent with our hypothesis, tendon mechanical properties increased after 2 
and 8 weeks of chronic exercise. In contrast, 24 hours after a single bout of exercise, 
tendon showed trends toward reduced mechanical properties. This mild decrease in 
tendon mechanical properties acutely may initiate the chronic, beneficial adaptations seen 
in this study. We detected more significant mechanical changes after 2 weeks of exercise 
than after 8 weeks, which suggests that this adaptive process begins soon after initiating a 
new exercise routine. This finding supports a previous gene screening study we 
performed that found more matrix turnover-related genes altered at an early time point 
than a later time point.
42
  
Exercise did not impact tendon cellularity or organization, suggesting that unlike 
tendinopathic conditions, the exercised tendon remained healthy. Cells became rounder 
with exercise, which could be due to altered cell type or metabolic activity, which was 
not measured in this study.  
 In contrast to our hypothesis, generic MMP activity decreased following a single 
bout of exercise and after 8 weeks of chronic exercise. This finding suggests that exercise 
induces a net anabolic instead of catabolic response, which may be one distinguishing 
factor between optimal tissue use and under or overuse. 
 In summary, this study used a previously validated rat model of supraspinatus 
exercise
43
 to investigate the temporal acute and chronic responses of tendon. Mild, acute 
decreases in MMP activity and tendon mechanical properties following a single bout of 
exercise led to enhanced tendon mechanical adaptations with repeated bouts of exercise. 
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These characterizations of non-injurious exercise will help future studies distinguish 
deleterious responses of tendon to load and investigate the biologic mediators of tendon 
adaptations or maladaptations to exercise, overuse, and disuse. 
C. Ibuprofen Differentially Affects Supraspinatus Muscle and Tendon Adaptations 
to Exercise in a Rat Model 
 Ibuprofen is one of the most used drugs by adults, particularly athletes, who 
commonly use ibuprofen prophylactically or as “treatment.” Ibuprofen is an inhibitor of 
cyclooxygenases-1 and -2 (COX-1, COX-2), which are components of the arachidonic 
acid inflammatory cascade. Previous studies suggest that early inflammation is important 
for successful tissue healing following acute injury, and ibuprofen can be detrimental to 
this healing; however, the effects of ibuprofen on tissue adaptations to exercise is 
equivocal with some studies finding detrimental effects and others finding no effect. The 
objective of this study was to determine the effects of ibuprofen on the adaptations of 
supraspinatus tendon and muscle in a rat model of exercise. We hypothesized that 
administration of ibuprofen would abolish the beneficial adaptations found with exercise 
but have no effect on sedentary muscle and tendon properties. 
 In contrast to our hypothesis, results suggest that chronic intake of ibuprofen at 
pharmacologic doses does not detrimentally impact supraspinatus tendon mechanical 
adaptations to exercise. Following chronic administration of ibuprofen, tendon 
mechanical properties were not impaired and in some instances increased. Administration 
of ibuprofen combined with a single bout of exercise brought tendon cross-sectional area 
and modulus closer to baseline properties, suggesting altered recovery. Whether this 
recovery is accelerated or delayed should be investigated with additional time points in 
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future studies. Tendon organization was not impacted by ibuprofen, suggesting that the 
tissue remained healthy. Similarly, the number of centrally nucleated muscle fibers 
remained less than 1%, suggesting the muscle fiber were not undergoing regenerative 
processes due to injury. 
 In contrast, chronic administration of ibuprofen decreased average muscle fiber 
cross-sectional area, and a few muscle fiber type-specific changes were detected as well. 
Taken together, these findings suggest that the arachidonic acid cascade is not a primary 
mechanism responsible for inducing tendon adaptations to non-injurious exercise; 
however, the arachidonic acid cascade appears to be important for muscle growth. This 
study adds to the growing body of literature on the effects of nonsteroidal anti-
inflammatory drugs on musculoskeletal tissues and suggests that athletes should consider 
the risks and benefits before taking ibuprofen. 
D. Doxycycline Improves Sedentary, but not Exercised, Supraspinatus Tendon and 
Muscle in a Rat Model 
 Matrix metalloproteinases (MMPs) are enzymes that degrade extracellular matrix 
proteins. MMP inhibition has been proposed as a method to improve skeletal muscle and 
tendon healing and some studies have shown improved healing following acute injury 
with administration of MMP inhibitors; however, the roles of MMPs and therefore the 
effects of MMP inhibition on muscle and tendon adaptations to exercise are unknown.  
The objective of this study was to investigate the effects of doxycycline as a broad-
spectrum MMP inhibitor on sedentary and exercised supraspinatus tendon and muscle in 
a rat model of non-injurious exercise. We hypothesized that doxycycline would abolish 
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the beneficial adaptations found with exercise but have no effect on sedentary muscle and 
tendon properties. 
 In contrast to our hypothesis, doxycycline significantly improved sedentary 
supraspinatus tendon mechanical properties and tendon collagen organization without 
adversely affecting the muscle; however, when administered to animals undergoing an 
exercise protocol, doxycycline did not produce these same beneficial effects. Combined 
with exercise, doxycycline increased tendon modulus but decreased tendon stiffness and 
maximum load. In addition, the average muscle fiber cross-sectional area was reduced in 
exercised, but not sedentary, animals administered doxycycline.  
 These results support previous studies that have shown increased MMP activity 
with stress-deprived tendons and that administration of MMP inhibitors can prevent the 
associated loss of tendon mechanical properties. The MMP activity assay in Chapter 2 
also revealed decreased MMP activity in exercised compared to sedentary tendons. These 
results suggest that in a sedentary state, tendon MMP activity is heightened, which leads 
to matrix degradation; administration of doxycycline as an MMP inhibitor can reduce the 
matrix degradation in sedentary tendons, leading to enhanced tendon mechanical 
properties. Furthermore, MMP activity may be important for muscle adaptations to 
exercise, as supported by the reduced muscle fiber cross-sectional area with 
administration of doxycycline. Taken together, MMP inhibition with doxycycline may be 
a useful treatment option for sedentary tissues but is not advantageous when combined 
with non-injurious activity. This study examines the roles of MMP inhibition in sedentary 
and exercised muscle and tendon, and future studies can explore the effects of 
doxycycline in overuse and stress-deprived conditions. 
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E. Final Conclusions 
In this dissertation, we characterized a rat model of supraspinatus exercise by 
examining both acute responses and chronic adaptations of tendon. We then used this 
model to explore the roles of cyclooxygenases-1 and-2 through inhibition with ibuprofen 
and matrix metalloproteinases through inhibition with doxycycline in sedentary and 
exercised rat supraspinatus muscle and tendon. We found that supraspinatus tendon 
beneficially adapts to non-injurious exercise by enhancing its mechanical properties and 
decreasing MMP activity. Administration of ibuprofen does not adversely affect this 
adaptation in tendon but does lead to reduced muscle fiber cross-sectional area 
chronically. Administration of doxycycline enhanced supraspinatus tendon mechanical 
properties in sedentary animals but not in exercised animals and led to decreases in 
muscle fiber cross-sectional area specific to exercised groups.  
 We conclude that the pathways responsible for muscle and tendon adaptations to 
exercise may differ depending on the tissue, and decisions regarding the use of drugs like 
ibuprofen and doxycycline should take into account differential, tissue-specific responses 
as well as activity-dependent effects.  
F. Future Directions 
Based on these findings, several possible future directions should be considered 
for this rat model of supraspinatus exercise.  
1. Additional Biologic Assays 
In this study, we measured MMP activity in tendon and investigated traditional 
histologic metrics including cellularity, cell shape, and collagen organization for tendon; 
however, a more comprehensive analysis of the biologic mechanisms responsible for the 
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changes detected in muscle and tendon as a response to exercise or as a response to drug 
administration should be performed. Specifically, given the changes measured as a result 
of ibuprofen and doxycycline, a natural next step is to explore the inflammatory 
processes in muscle and tendon. First, proteins associated with the arachidonic acid 
cascade should be measured. These include cyclooxygenases-1, and -2, prostaglandins 
(particularly PGE2 and PGF2α), thromboxane, lipoxygenase, and leukotrienes. It has 
previously been shown that tenocytes respond to strain by modulating production of these 
proteins,
32,52
 and this pathway has been implicated in the initiation of tendon degenerative 
processes;
13,14,21,46,55
 however, it is unknown what role this pathway plays in non-
injurious exercise. One study found improved tendon properties with prostaglandin 
injections
16
 and others have found physiologic (not pathologic) increases following 
exercise,
29,30
 suggesting that this pathway may be important for beneficial adaptations to 
load. Additionally, prostaglandins, exercise, and ibuprofen are known to alter blood flow, 
so vascularity, blood flow, and angiogenesis would be interesting mechanisms to 
investigate in future studies. Second, an in depth exploration of the specific MMPs and 
their inhibitors (TIMPs) altered with exercise should be measured. MMP-2, -3, -9, -13, 
and -14 have all been cited as potential key regulators of matrix turnover and are known 
to be altered with injury.
2,12,18,20,27,28,34,41,44
 Potentially, a key distinguishing feature 
between injurious maladaptations and non-injurious adaptations to load is in the 
expression of MMPs relative to TIMPs. MMP activity within the muscle as a result of 
acute and chronic exercise should also be measured. Third, in this dissertation, tendon 
collagen organization was unchanged with exercise, and it is unknown what contributes 
to the enhanced mechanical properties measured chronically. Measurement of collagen 
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content using o-hydroxyproline assay, collagen cross-linking, and collagen fibril size 
would help elucidate the structural adaptations that allow for the functional adaptations. 
Fourth, cell types within the tendon and muscle as a response to exercise should be 
explored. Early inflammation is characterized by infiltration of inflammatory cells, 
including mast cells, macrophages, and neutrophils. These cells initiate the repair 
response by releasing cytokines and chemokines to recruit additional inflammatory cells 
and stimulating fibroblast proliferation. Pro-inflammatory cytokines, which are known to 
be altered in injured states, can also induce COX-2
24
 and MMP expression.
35
 Whether an 
early inflammatory response initiates chronic tissue degeneration in overuse conditions is 
debated. Determining whether an acute inflammatory response occurs in muscle and 
tendon as a result of non-injurious exercise will begin to address physiologic versus 
pathologic processes. To determine protein expression of all of these targets, 
immunohistochemistry can be performed on muscle and tendon histological sections. 
Finally, to understand why the cells increased in roundness, electron microscopy could be 
used to investigate cellular contents, and metabolic activity assays could be used to 
determine cellular activity. Similarly, proliferation assays could be performed, 
particularly since ibuprofen has previously been shown to reduce cellular proliferation 
and migration in vitro.
49,50
 
2. Additional Muscle Assays 
In this study, we determined the percent of centrally nucleated muscle fibers and 
measured muscle fiber cross-sectional area and type; however, it is unknown whether the 
changes detected in these studies lead to changes in physiologic muscle function. First, 
the acute and chronic temporal response of muscle to exercise should be examined (e.g., 
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Aim 1 of this dissertation repeated with supraspinatus muscle). Assays include fiber 
morphological and type analysis, determination of the percent of fibers with centrally 
located nuclei, and measurement of biologic proteins described above across multiple 
time points to fully characterize the adaptive processes within the tissue. Second, 
physiologic muscle functional measurements should be added. Ex vivo measurements 
include fatigue index, contraction time, rate of force development, rate of relaxation, and 
twitch force, as previously described.
40
 In addition, measurement of oxidative 
phosphorylation metabolic proteins would further elucidate muscle adaptations to aerobic 
training.
43
 Finally, identification of satellite cells, which are believed to play important 
roles in muscle adaptations to exercise, can be performed through histological staining. 
Future studies should also explore the apparent differences between the 
superficial and deep regions of the supraspinatus muscle. The difference in fiber type 
distributions in these two regions has previously been identified
3
 and was also confirmed 
in the studies presented in this dissertation; however, it is unknown what functional role 
these regions play. Physiologic measurements of the muscle regions could be performed 
to determine whether these fiber type differences impact muscle contraction profiles and 
regional fatigability. Motor units could be analyzed. Importantly, compositional 
differences that lead to functional differences in the muscle may impact the loading 
profile experienced by the tendon, leading to altered regional (bursal and joint side) 
tendon properties. Previous studies have shown variations in human regional tendon 
mechanical
25,26
 and biological
36
 properties, but these regions have not been investigated 
in the rat. Inhomogeneous tendon properties could lead to delamination failures of the 
tendon. 
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3. Other Loading Conditions 
To investigate how exercise goes from good to bad, other loading conditions 
should be examined and compared to the results found in this study.  Specifically, future 
studies should explore the acute and chronic responses of muscle and tendon to an 
overuse protocol
45
 (increased loading) and immobilization (decreased loading) following 
a study design similar to Chapter 2 with the additional biologic assays described above. 
By identifying the acute responses and maladaptive tissue properties in these loading 
conditions and comparing them to non-injurious exercise, we can begin to understand 
how damage initiates and progresses.  Once this process has been characterized, then 
different treatments can be explored. Ibuprofen and doxycycline may be expected to have 
different effects on muscle and tendon from overuse and immobilized loading scenarios 
than in beneficial exercise. Ibuprofen is commonly taken by athletes and laborers with 
strenuous loading protocols, but it is unknown how the drug may impair or improve 
muscle and tendon adaptations in this more intense loading environment. As previously 
described, prior studies have found load-dependent increases in arachidonic acid cascade 
proteins, suggesting that a heightened response may be seen following overuse and 
indicating that ibuprofen may have a different effect than in non-injurious exercise. Study 
designs to test hypotheses that ibuprofen is beneficial to tendon and muscle following 
overuse and immobilization would be similar to Chapter 3. MMP inhibition has been 
proposed as a treatment for tendinopathy caused by overuse and stress-deprivation, which 
results in increased expression of MMPs as previously mentioned. Furthermore, the 
finding in this dissertation of beneficial effects of doxycycline in sedentary but not 
exercised animals leads to the hypothesis that doxycycline may be beneficial to reduce 
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tendon and muscle atrophy and degeneration in immobilized states. Study designs to test 
hypotheses that doxycycline is beneficial for muscle and tendon in overuse and 
immobilized loading scenarios would be similar to the study design of Chapter 4. Results 
would help guide clinical treatment protocols for muscle and tendon loading-induced 
injuries. 
4. Age 
In these studies, we used young-adult, skeletally mature rats; however, it is 
unknown how results would change if the rats were middle-aged or elderly. A recent 
study found that exercise mitigates the detrimental effects of aging on tendon stem 
cells.
54
 Associated with increased age is an increase in baseline inflammation levels.
38
 
Because overuse injuries affect both the young and middle-aged people, and rotator cuff 
tear incidence increases with age, it is important to consider these age groups as distinct 
populations in how they may respond to exercise and anti-inflammatory treatments. 
Muscle regeneration following injury is delayed in older individuals, and this may be 
attributed to an altered inflammatory response.
38
 Resistance training benefits older adults, 
but muscle adaptation to exercise is slower than in young adults.
40
 In aged rats 
undergoing repetitive reaching and grasping, a model of overuse activity in the upper 
extremity, flexor digitorum tendons had increased pro-inflammatory cytokines IL-1β and 
IL-6, which was not seen in young adult rats.
22
 Additionally, after 12 weeks of activity, 
the supraspinatus tendon had increased vascularity and cellularity (due to macrophages 
and fibroblasts in the peritendon) in aged animals but not young.
22
 These findings suggest 
an impaired inflammatory response following overuse injury in older compared to 
younger adults. Age may also affect response to NSAID treatment. Ibuprofen 
132 
 
administration to older adults undergoing chronic resistance training did not affect 
patellar tendon cross-sectional area, strain, or ultrasound readings but surprisingly 
increased muscle volume and strength.
8
 This finding contrasts the suggestion in other 
studies that NSAIDs may impair acute muscle and tendon adaptation to load. 
Additionally, ibuprofen in conjunction with chronic resistance training in older adults did 
not affect muscle protein content, water content, myosin heavy chain distribution, COX-
1, or COX-2,
8
 increased PGF2α receptor, and prevented the characteristic increase of IL-6 
and IL-10.
48
 A review is provided by Trappe and colleagues.
47
 While some studies 
suggest that ibuprofen administration may impede tissue regeneration following injury or 
adaptation to exercise, and this dissertation showed ibuprofen was not detrimental in 
tendon of young-adult rats undergoing exercise, anti-inflammatory drugs may enhance 
tissue adaptation in older adults due to the presumed deleterious increase in baseline 
inflammation. In addition, MMP expression has been shown to be enhanced in tendons 
from older animals and further enhanced with cyclic loading,
15
 suggesting that MMP 
inhibition with doxycycline would be beneficial.  To test these hypotheses that ibuprofen 
and doxycycline benefit muscle and tendon adaptations to exercise in older adult rats, 
older adult rats would be randomized into a drug treated or non-drug treated group and 
undergo exercise for 2 or 8 weeks to investigate chronic adaptations. Results would help 
clinicians form treatment plans specific to older and younger adult populations.  
5. Gender 
In this dissertation, we used male rats; however, prior studies have found higher 
incidence of shoulder complaints in women than men,
51
 women and men have 
significantly different tendon structural and mechanical properties,
37
 and adaptations to 
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exercise in the patellar tendons of women may be attenuated compared to men.
53
 These 
findings suggest that males and females have different responses to load which may lead 
to different injury risks. To test the hypothesis that gender influences adaptations to 
exercise (with females exhibiting fewer beneficial adaptations), female rats would 
undergo 2 and 8 weeks of exercise or cage activity and be compared to male rats.  A 
separate group of female, ovariectomized rats, which creates estrogen deficiency (e.g., 
postmenopausal women) would help to explore the specific role of the hormone estrogen 
in these adaptations. Results from this study would help explain the role of gender in 
adaptations or maladaptations to exercise. 
6. De-Training 
De-training is the process by which previously gained improvements to fitness are 
lost when an exercise routine is stopped.  These changes can be rapid, and if an exercise 
routine is started again too quickly (as in the transition from pre- to in-season training), 
then injuries can develop. A previous study has shown detrimental effects of de-training 
on rat patellar tendon,
17
 but no studies have investigated de-training in the supraspinatus 
tendon. More specifically, the biologic processes that govern the loss of beneficial 
adaptations are unknown. Given the beneficial findings in this dissertation of doxycycline 
in sedentary animals, doxycycline may also be advantageous to avoid tissue property 
losses due to de-training.  To test this hypothesis, rats would be divided into a 4 week 
exercise group and a 2 week exercise group followed by 2 weeks of cage activity as de-
training. Half of the detrained group would receive doxycycline during the 2 week de-
training period. Results would help elucidate the role of MMPs in de-training and inform 
the practices of clinicians and coaches. 
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7. Acute Responses to Exercise in Trained Animals 
In Chapter 2, we found more significant mechanical changes after 2 weeks of 
exercise than after 8 weeks, which was similar to a screening study we performed that 
found more matrix-related gene changes after 1 week than 8 weeks.
42
 Based on this 
finding, we speculated that as the tissue adapts to a new training routine, it requires 
increases in intensity in order to elicit the same mechanical and biological responses. This 
speculation suggests that acute responses to exercise in trained, fit tendon and muscle are 
reduced compared to the acute responses to exercise when a new exercise routine is just 
being established. To test this hypothesis, animals would be divided into a treadmill 
trained + acute bout of exercise group (as in Chapter 2) or a group that undergoes 
treadmill training + 8 weeks of exercise + acute bout of exercise. Tendon mechanical 
properties and tendon and muscle biological responses would be compared. Similarly, 
these groups could be compared to animals undergoing 8 weeks of overuse
45
 to test 
whether degenerate tendons respond differently to an acute bout of loading. A prior study 
suggests that inflammatory signaling is not increased in tendinopathic tendon 2 hours 
after a single bout of exercise, but these were not compared to uninjured, exercised 
tissues.
39
 Results from the proposed studies would help identify how acute exercise 
sessions lead to chronic adaptations or maladaptations. 
8. Recovery  
In the current study, we investigated the mechanical properties of supraspinatus 
tendon 24 hours after a single bout of exercise and found mild trends toward reduced 
properties; however, it is unknown how these properties change immediately following 
exercise and when they return to baseline levels. We speculated that these mild decreases 
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in mechanics help initiate the chronic tendon adaptations we detected and that one 
difference between beneficial and detrimental loading protocols is in how the tissue 
responds to and recovers from a single bout of exercise. For example, a more intense 
exercise session may require a longer time for properties to recover, suggesting greater 
amounts of rest are required to avoid injury, whereas increasing the resting time between 
bouts of this non-injurious exercise protocol may lead to reduced adaptations. To 
investigate this, more thorough acute responses and recovery profiles should be defined 
for the non-injurious exercise protocol (mechanical testing immediately after exercise and 
48 hours after exercise), and the overuse
45
 protocol (described in c. Other Loading 
Conditions). Then, to test the hypothesis that enhanced recovery time between sessions 
would diminish injury with the overuse protocol, animals would run on the treadmill 
every other day (or every 2 days, depending on the recovery profile) and would be 
compared to animals that ran the same number of sessions but ran every day. To test the 
hypothesis that enhanced recovery time would reduce beneficial adaptations with the 
non-injurious exercise protocol, animals would walk every other day (or every 2 days, 
depending on the recovery profile) and be compared to animals that walked the same 
number of sessions but every day.   
9. Acute Responses Lead to Chronic Adaptations 
In this dissertation, we proposed that the acute decreases in MMP activity and 
tendon mechanical properties lead to the beneficial chronic adaptations we measured; 
however, this is a research area that has significant potential for future growth. We found 
increased tendon cross-sectional area 24 hours after a single bout of exercise but not 
chronically, and we do not know what contributes to this acute increase. Presumably, 
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collagen content is not the main contributor since it would take longer than 24 hours for 
such a response, we would expect structural properties (stiffness, max load) to be 
increased, and we would expect the tendon cross-sectional area to be increased 
chronically. Instead, this increase in cross-sectional area may be due to increased water 
content, which may be regulated by aggrecan expression. Water content and aggrecan 
were not measured in the current dissertation but should be evaluated in future studies. 
Proteoglycans like aggrecan and versican and some glycoproteins like hyaluronan can be 
upregulated rapidly, within days.
11
 It has been proposed that a rapid response of the 
tendon to unaccustomed load may be to increase aggrecan production, which would 
enhance water content to increase the tendon cross-sectional area and minimize stress in 
the tendon as a protective mechanism until the tendon recovers.
11
 Whether this proposed 
mechanism occurs in this model of exercise is unknown and should be evaluated further. 
In addition, after more comprehensive evaluation of the acute responses of tendon and 
muscle to exercise (sections a and b above), these measured responses can be targeted 
(inhibited/overexpressed) to determine which are required for chronic adaptations to 
exercise. Then, these same responses can be altered in sedentary animals to determine 
whether manipulation can lead to chronic exercise-like benefits without activity.    
10. Temporal Drug Administration 
In the current studies, ibuprofen and doxycycline were administered daily for the 
entire duration (2 or 8 weeks); however, as previously described, the biologic processes 
governing the early and later adaptations to exercise may differ.
11
 Furthermore, a 
previous study has noted that early administration of ibuprofen following a rotator cuff 
repair impaired healing, and later administration had no effect.
10
 As already described, a 
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heighted matrix turnover response may exist at earlier time points,
42
 during which time 
ibuprofen and doxycycline may have greater effects than at later time points. To test the 
temporal effects of these drugs on supraspinatus tendon and muscle adaptations, which 
would help identify the stages of tissue adaptations to load, animals would undergo 4 
weeks of exercise. One group would receive ibuprofen or doxycycline during the first 2 
weeks (“early”), another group would receive ibuprofen or doxycycline during the second 
2 weeks (“late”), and a third group would not receive any drug. The results of these 
studies would help clinicians optimize treatment plans and delineate the temporal stages 
of tissue adaptations to exercise (i.e., early inflammatory period as the tissue responds to 
a new exercise routine vs. later proliferative period as the tissue becomes accustomed to 
the training). 
11. Prevention of Overuse Injuries 
In this dissertation, we have shown that a rat model of exercise induces beneficial 
mechanical adaptations to the supraspinatus tendon, but it is unknown whether these 
adaptations are enough to prevent future injury as the intensity of the exercise protocol 
increases. Many coaches would like to be able to appropriately train their athletes as they 
build strength and endurance while preventing overuse injury. To test whether this 
exercise protocol can reduce future injury, animals would undergo two weeks of exercise 
training to induce beneficial adaptations, followed by 4 weeks of overuse training,
45
 
which has previously been shown to induce injury. This group of animals would be 
compared to a group that only undergoes 4 weeks of overuse training. The hypothesis is 
that the exercise-trained group would have reduced tendon degeneration.    
138 
 
12. Fatty Atrophy 
In massive rotator cuff tears, one common negative feature is fatty atrophy of the 
muscle. This muscle degeneration can make rotator cuff repairs unfeasible. 
Accompanying this atrophy is significant fibrosis that is mediated by increases in 
MMPs.
31
 This fatty atrophy is believed to be irreversible. A rat model of rotator cuff fatty 
atrophy has been created and has demonstrated increased intramuscular fat in the rotator 
cuff muscle.
23
 Whether matrix metalloproteinase inhibitors may slow the fibrotic 
degeneration of the muscle and tendon in these scenarios is unknown. A future study 
could investigate the benefits of doxycycline administration in conjunction with rotator 
cuff tears in an effort to decrease the progression of fatty atrophy.  
13. Systemic Diseases 
In the current studies, healthy rats were used; however, a range of systemic 
diseases can impact rotator cuff muscle and tendon. For example, high cholesterol
1,4-6
 and 
diabetes
7,9
 may impact rotator cuff tendon properties and healing. In addition, MMP 
expression is increased in the wounds of diabetic patients, indicating that treatments 
aimed at reducing MMP activity may benefit.
33
 For both of these common conditions, 
exercise is often prescribed as treatment for the systemic disease, but it is unknown how 
local muscle and tendon are affected. Combining exercise with animal models of these 
diseases may help identify the systemic as well as local tissue benefits of exercise as 
treatment. 
14. Other Tendons and Muscles 
In the current studies, the supraspinatus tendon and muscle were explored; 
however, other muscles and tendons may also be impacted by exercise, ibuprofen, and 
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doxycycline. For example, the Achilles tendon and associated gastrocnemius and soleus 
muscles, which would also be loaded by walking on a treadmill, would be expected to 
show adaptations to exercise; however, whether these adaptations are the same as those 
found in the supraspinatus is unknown. It has previously been shown that the Achilles 
and supraspinatus tendons show distinct responses to an overuse treadmill protocol, 
wherein the Achilles tendon does not develop degeneration but the supraspinatus tendon 
does.
19
 In addition, the soleus muscle is primarily a slow extensor whereas the 
gastrocnemius is primarily a fast extensor, so the inherent fiber type differences in these 
two muscles and their subsequent responses to exercise and pharmacologic drugs would 
be of interest in future studies. Future studies could also explore the effects of exercise on 
the other rotator cuff tendons/muscles (infraspinatus, subscapularis), the biceps, the 
tibialis anterior, and the plantaris. Other tissues such as cartilage (e.g., glenoid articular 
cartilage) and bone (e.g., humerus, tibia, fibula, femur) may also be of interest. 
15. Genome Analysis for Predisposition 
Despite undergoing the same training protocols, some individuals develop injury 
while others do not. Experiments such as genome-wide association studies (GWAS) or 
single-nucleotide polymorphism (SNP) on patients and healthy people could be useful in 
identifying molecular variations among individuals that may lead to a predisposition for 
injury or altered responses to treatments, such as pharmacologic interventions. 
16. Final Conclusions 
In this chapter, we have proposed several future directions to characterize 
temporal muscle and tendon adaptations to exercise, define beneficial and detrimental 
changes, understand how acute sessions of exercise lead to chronic adaptations (or 
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maladaptations), and investigate potential drug treatments for altered loading states. 
Results from these studies will inform development of exercise training routines that 
minimize and prevent injury and treatment strategies for when injury does occur.  
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Appendices: Experimental Protocols 
Appendix 1: Rat Treadmill Protocols 
EXa: Acute Exercise on Flat Treadmill 
Animals undergo 2 weeks of overuse training on a -10° treadmill, followed by a single 
bout of exercise 
Protocol Week Day Duration 
Tach Reading  
(rpm) 
T1.1 1 Mon 0-10 min 37 
T1.2 1 Tues 0-15 min 40 
T1.3 1 Wed 0-20 min 43 
T1.4 1 Thurs 0-25 min 46 
T1.5 1 Fri 0-30 min 49 
T2.1 2 Mon 0-30 min 51 
T2.2 2 Tues 
0-5 min 
5-40 min 
Build up 
54 
T2.3 2 Wed 
0-5 min 
5-45 min 
Build up 
57 
T2.4 2 Thurs 
0-10 min 
10-50 min 
Build up 
60 
T2.5 2 Fri 
0-10 min 
10-60 min 
Build up 
63 
Exercise Single bout Mon 0-60 min 37 (flat!) 
 
EXc: Chronic Exercise on Flat Treadmill 
Animals undergo 2 weeks of training followed by their full protocol for up to 8 weeks 
Protocol Week Day Duration 
Tach Reading  
(rpm) 
T1.1 1 Mon 0-10 min 37 
T1.2 1 Tues 0-15 min 37 
T1.3 1 Wed 0-20 min 37 
T1.4 1 Thurs 0-25 min 37 
T1.5 1 Fri 0-30 min 37 
T2.1 2 Mon 0-40 min 37 
T2.2 2 Tues 0-45 min 37 
T2.3 2 Wed 0-50 min 37 
T2.4 2 Thurs 0-55 min 37 
T2.5 2 Fri 0-60 min 37 
EX1.1 up to 8 weeks Mon 0-60 min 37 
EX1.2 up to 8 weeks Tues 0-60 min 37 
EX1.3 up to 8 weeks Wed 0-60 min 37 
EX1.4 up to 8 weeks Thurs 0-60 min 37 
EX1.5 up to 8 weeks Fri 0-60 min 37 
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Appendix 2: Rat Syringe Training  
This protocol is meant to train rats to drink from a syringe for subsequent oral 
administration of drugs like ibuprofen or doxycycline.  We have found that the rats love 
children’s berry-flavored ibuprofen, but dislike doxycycline (despite being an oil 
suspension, tutti fruiti flavor) due to its bitter taste.  Most likely, doxycycline animals will 
need to be restrained and force-fed, but the ibuprofen animals will happily drink on their 
own.  Note that all drug animals should be syringe-trained. 
 
Day 1: Place a wooden popsicle stick that has a strip of honey on it in each cage.  Rats 
are free to sniff and eat the honey to avoid neophobia.  Once the rats have eaten the 
honey from the stick, create a mixture of honey and water (much more water than honey, 
not a very viscous solution) and draw it up into a needleless 1ml syringe.  Open the lid of 
the cage and allow the rats to sniff and lick the syringe.  Dispense a few drops of the 
honey solution onto the rats’ noses and paws as they sniff the syringe.  As they groom 
this off, they will discover that it tastes delicious.  Do not expect animals to freely drink 
from the syringe on their first day (though some might). 
 
Day 2: Assuming all animals cleaned their honey sticks yesterday, begin with the honey-
water syringe training.  Similarly, allow the animals to freely explore the syringe and 
squirt some fluid out as they come close so they can taste it.  If the rats did not clean their 
honey stick yesterday, again place a popsicle stick with a strip of honey into their cage. 
 
Day 3: Repeat honey-water syringe training. 
 
Day 4: Last day of honey-water syringe training.  By this day, nearly all animals should 
be comfortable drinking from the syringe. 
 
Note: For the first 2 or so doses of ibuprofen administration, rats probably will not drink 
from the syringe because it is a new taste; however, since they have been syringe trained, 
they know how to drink from the syringe, and they just need a couple doses to realize that 
they enjoy the taste of the ibuprofen and they will begin drinking on their own.  As 
already mentioned, doxycycline animals likely will need restraint.  Simply hold the 
animal and use your thumb and index finger to grasp their jaw as you gently squirt the 
fluid inside their cheek.  Do not try to get all 0.5 ml in their mouth at once; do about half 
of it at a time to allow them to swallow so they don’t spit it all out. 
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Appendix 3: Rat Supraspinatus Tendon and Muscle Dissection 
This protocol is adapted from the Multi-Tendon protocol, 1/20/2011. 
 
Equipment and Supplies Needed: 
#11 blades (1 per shoulder) 
Blade holder 
Hemostats 
Rat toothed pick ups 
 
Protocol: 
1) Clamp the paw with hemostats (handles facing anteriorly). Externally rotate limb 
by flipping hemostats over and tucking underneath rat’s abdomen. 
2) Using the flat portion of the blade, make an incision along the spine of the scapula 
and expose shoulder and arm. 
3) Starting at the cephalic vein, incise up along the posterior border of the scapular 
spine (down to bone) and peel away the trapezius anteriorly.  
4) Laterally cut away the bursa, cut the AC joint, and peel away clavicle. 
5) Grab the acromion with the pick ups, lift off of the body and cut away connective 
tissue, then twist pick ups to break away acromion. 
6) Carefully incise along the edges of the supraspinatus while peeling the muscle 
away from the scapula.  Make vertical “lines” with your blade tip along the 
scapula to fully isolate the supraspinatus muscle. 
7) Follow the medial border of the scapula to divide the supraspinatus from the 
subscapularis muscle and expose the joint.    
8) Follow the humeral head with the blade to cut the other rotator cuff 
tendons/biceps and free the humeral head from the glenoid. 
9) Cut away excess muscle from the humeral head and expose down to the elbow 
joint.  Dislocate the elbow joint to remove the humerus from the body. 
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Appendix 4: Rat Supraspinatus Muscle and Tendon Tissue Harvest for MMP 
Activity  
 
Dissection Prep (day before) 
1. For all samples that will be used for protein assays/MMP activity assay: 
While wearing gloves (to prevent contamination), label Eppendorf tubes (lid and 
side of tube) with date, rat ID number, and tissue type (see key below).  Each 
rat should have the following 3 labeled tubes: 
 1 right supra tendon (R-SUP-T) 
 1 right supra muscle (R-SUP-M) 
 1 right excess supra muscle (R-SUP-EM) 
Place labeled tubes in Eppendorf tube holder with lids closed. 
2. Label biohazard bags (1 per animal) with animal ID number and date of 
sacrifice.  Also label an index card with this information and a place to write the 
animal weight.  Place index card in pocket of biohazard bags.  
3. Gather all equipment and materials: 
 Blue “diapers” 
 Black pad (1 per dissector) 
 Specimen cup for ethanol (1 per dissector) 
 Specimen cup for PBS 
 Liquid nitrogen container 
 PBS squirt bottle 
 Gauze 
 Rat-toothed pick-ups (1 per dissector) 
 Blade holder (1 per dissector) 
 #11 blades (at least 2 per rat) 
 Curved hemostats (1 per dissector) 
 Bone cruncher (optional) 
 List of rats to be sacrificed and corresponding assays 
 Paper towel 
 Scale with bowl for animal 
 Labeled biohazard bags (1 per animal) 
 Labeled Eppendorf tubes (3 per animal) 
 Lab notebook 
 Pen and permanent marker 
 
Dissection Prep (day of) 
1. Fill cup(s) with 70% ethanol. 
2. Fill cup with PBS. 
3. Get liquid nitrogen. 
4. Cover dissection table with blue “diapers.” 
5. Line CO2 chamber with paper towel. 
6. Spray and wipe all equipment and surfaces with ethanol.  
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Dissection 
1. Sacrifice animal (1 at a time if 1 dissector or up to 1 cage with 2 animals at a time 
for 2 independent dissectors).  Confirm death with extended duration in CO2 
chamber, cessation of breath, and lack of heart beat.  
2. Weigh animal.  Record weight in lab notebook and appropriate index card 
(located in pocket of biohazard bag).  
3. Working quickly, dissect the right shoulder to isolate the humerus, supraspinatus 
tendon, and supraspinatus muscle (Appendix 2). 
Note: When not using tools, store in ethanol.  Swirl in PBS before using again. 
4. Rinse in PBS by swishing specimen in PBS to remove excess blood and loose 
hair. 
 
For steps 5-7, diligence and patience are key to ensure tissue is as isolated as possible! 
5. Place sample on black pad (bursal side down for stability).  Use curved forceps to 
grasp muscle and use blade to cut a muscle chunk from the curved side, avoiding 
cutting the tendon.   Be sure to take both deep and superficial regions of the 
muscle.  Place in properly labeled Eppendorf tube, and immediately submerge in 
liquid nitrogen.  
6. Once muscle sample is taken, use back of blade to scrape remaining muscle from 
tendon. Place this remaining muscle in properly labeled Eppendorf tube, and 
immediately submerge in liquid nitrogen.  This is a tube of “extra” muscle to be 
used just in case. 
7. Once tendon is free of muscle, use blade to transect tendon at bony insertion.  Cut 
away any remaining non-tendon tissue.  Immediately place tendon in properly 
labeled Eppendorf tube and submerge in liquid nitrogen. 
8. Change blade and rinse all tools in ethanol and then PBS.  Wipe black pad with 
ethanol. 
9. Once shoulders are dissected, soak gauze in PBS and place over shoulder of rat to 
reduce freezer burn.  Place rat in properly labeled biohazard bag. 
10. Repeat steps 1-10 on next animal. Between animals, make sure all tools and 
surfaces have been rinsed and wiped dry with ethanol and are free of tissue.  
Always use a new blade.  Change paper towel lining CO2 chamber.   
11. Store dissected rats in -20°C freezer.  Be sure to label biohazard bag with any 
missing body parts (e.g., “No Shoulders”) using a permanent marker. 
12. Store tissue samples in -80°C freezer until ready for homogenization. 
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Appendix 5: Rat Supraspinatus Muscle and Tendon Tissue Harvest for Histology 
This protocol is intended to be used on a single shoulder.  Tendon will be preserved for 
longitudinal paraffin histology, and muscle will be preserved for transverse muscle 
histology (cryo).  The muscle embedding/sectioning protocol was developed upon 
watching Dr. Beth Barton freeze, embed, and cryosection a rat supraspinatus tendon.   
 
Materials Needed: 
 Razor blade  –or– blade holder and #11 blades 
 Histology cassettes with foam or folded KimWipes 
 KimWipes 
 Formalin in specimen cup 
 Small insect pins (e.g., item # 26002-20 from Fine Science Tools) 
 Insulated container to hold liquid nitrogen 
 Small aluminum foil tin to hold isopentane 
 Isopentane (2-methylbutane) 
 Base of Styrofoam cup or Styrofoam plate 
 OCT 
 Permanent marker + pencil 
 Aluminum foil 
 Long forceps (to submerge in liquid nitrogen) 
 
Prep 
1. Label 1 histology cassette per specimen with the sample ID, initials (SIR), and 
date on at least 2 sides.  Be sure to use pencil! 
2. Fill a specimen cup with formalin.  Label specimen cup (using permanent marker) 
with the date, specimen numbers, formalin, and name. 
3. Cut Styrofoam to fit muscle, and label (using permanent marker) the underside 
with the specimen ID and date. Label top with P for proximal (medial) and D for 
distal (lateral, tendon side). 
4. Fill insulated container with liquid nitrogen. 
5. Fill aluminum foil tin with isopentane deep enough to submerge muscle 
specimens.  Float aluminum boat filled with isopentane in liquid nitrogen. 
6. Fully dissect humeral head- tendon- muscle unit from one shoulder of recently 
euthanized rat (Appendix 2).   
 
Muscle 
1. Rinse bone-tendon-muscle unit in PBS to remove pieces of hair or excess blood. 
2. Using a razor blade or scalpel, cut transversely through the midbelly of the 
supraspinatus muscle/tendon.  
3. Blot piece of muscle using a KimWipe to remove excess PBS. 
4. Put small amount of OCT on labeled Styrofoam (be sure label is on the underside 
and will not be covered by specimen/OCT).  Use just enough OCT to provide a 
surface for the tissue to stick. 
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5. Place the deep layer of the muscle (side where you can see tendon more clearly) 
down on the OCT-coated Styrofoam. 
6. Pin the muscle (proximal and distal in a triangle shape) to keep the muscle taut 
but not stretched (i.e., “resting length” of the muscle). 
7. Lift the muscle up slightly on the posts (helps prevent sticking). 
8. Cover the muscle in OCT using the least amount of OCT possible (more OCT 
means the tissue will take longer to freeze, increasing the odds of freezing 
artifact). 
9. Submerge muscle/Styrofoam in isopentane for ~15 seconds, until it turns opaque 
white and is frozen.   
10. Wrap unit in labeled aluminum foil and float in liquid nitrogen or dry ice while 
working on other samples. Do NOT allow unit to thaw.  
11. Store at -80°C until ready to section. 
 
Tendon 
1. Sandwich the bone-tendon-muscle unit (now missing some muscle) between a 
piece of folded KimWipe that fits within a histology cassette. 
2. Place unit in properly labeled histology cassette. 
3. Place cassette with specimen directly in formalin.  Specimen should stay in 
formalin for 1 week before being switched into Immunocal for decalcification.   
4. Decalcification should occur for 1 week on a shaker.  Change immunocal on 
second day.  After 1 week, the humeral head should be soft enough to cut with a 
scalpel or 20G needle without feeling “crunchy.”  Continue immunocal until no 
longer crunchy.   
5. At this point, specimens should be cut in half (using scalpel) through the width of 
the tendon/bone (coronal plane) and transferred into labeled “A” and “B” 
cassettes.   
6. Transfer to 70% ethanol until processing.   
7. Processing is performed at the VA using the 3mm tissue protocol. 
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Appendix 6: Supraspinatus Muscle Cryosectioning 
This protocol is intended to be used on rat supraspinatus muscle samples embedded in 
OCT upon harvest, flash frozen, and stored at -80°C.  The muscle embedding/sectioning 
protocol was developed upon watching Dr. Beth Barton freeze, embed, and cryosection a 
rat supraspinatus tendon.   
 
Materials Needed: 
 Razor blade –or– blade holder and #11 blades 
 OCT 
 Pencil 
 Slides (LabStorage Systems MS-P30001/CS) 
 Slide box- narrow for 50 slides (Genesee Scientific 29-105B) 
 Microtome blades 
 
Embedding 
1. Remove specimen from -80C freezer and place in cooled (-20°C) cryostat for 30 
minutes to allow specimen to equilibrate. 
2. Gently pull out pins from tissue (represented by “x” in the figure below), and 
remove specimen from Styrofoam. 
3. Using razor/blade, cut a ~5mm piece of muscle (dashed line in figure) from the 
distal end of the specimen (labeled “D” on the Styrofoam, the side that has 2 pins 
instead of 1).  For these specimens, the “distal” end has been cut in the mid-belly.  
If the sample is large enough, also cut off the most distal edge, which has pin 
holes.  Note: The deep region of the muscle is down on the Styrofoam, and the 
superficial portion is up.  Careful: Cutting too quickly or forcefully or attempting 
to cut before allowing the specimen to equilibrate to the cryostat temperature may 
result in a shattered specimen! 
 
 
 
 
 
 
 
 
4. Place a coating of OCT on the small cryostat button, and immediately place the 
cut muscle sample on top.  The most recently cut edge of the muscle (more 
proximal) should be down on the OCT so that sectioning will begin at the most 
distal edge (mid-belly) and work towards the proximal (non-tendinous) end of the 
muscle.  Note: Do not completely cover the specimen with OCT or you will end 
up with a much larger section than necessary; however, do make sure that the 
sample is stable and will not fall off the button due to excessive torque (e.g., if it’s 
too large of a section or doesn’t have enough OCT surrounding the bottom edge). 
 
x 
x 
P D 
x 
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Sectioning 
1. Secure the button in the cryostat so specimen is horizontal.  
Blade angle: 10° 
Temperature: -20°C  
Sections: 10μm 
2. Deface specimen until whole muscle cross-section is obtained. 
3. Begin sectioning at 10μm, collecting every good section. 
 
Tips: 
 Do not attempt to create a ribbon like paraffin sectioning; sections do not always stick 
together and may slide under each other. 
 On a good day, the clear plastic protector can be flipped down during sectioning to 
allow for a single smooth frozen section to be obtained—on most days, this doesn’t 
work, and a paintbrush technique must be used.  If using this plastic piece, make sure 
the piece is slid all the way to the left, stabilized by the two pins. 
 If using the paintbrush technique, gently and slowly use the paintbrush to unroll the 
section while cutting.  Keep the section connected to the block or the section will roll 
up completely as you try to collect it on the slide.  Try flipping the section up to grab 
it on the slide. 
 Do not complete your stroke to bring the button back up until after collecting a 
section on your slide.  As the button raises back up, it could hit/ruin your freshly cut 
section. 
 To grab a section, simply touch it to the slide.  Sections will not adhere if the slide is 
too cold; warm up the slide by leaving at room temperature or gently rubbing the 
back of the slide with your finger. 
 If things aren’t going well, try a new blade or try again another day—don’t waste the 
specimens! 
 
4. Label each slide using pencil with the specimen ID, date, and slide number 
(beginning at 1 for the most distal slide, increasing in number as going proximal). 
5. Collect 4 sections per slide.  
6. During collection, store slides in cryostat.  For long-term storage, keep slides at -
80°C.   
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Appendix 7: Supraspinatus Tendon Paraffin Sectioning 
 
Embedding: 
1. Place processed samples in cassettes in paraffin wax tray.  Allow to 
equilibrate for 20-30 minutes. 
2. Fill a mold with a small layer of paraffin and place on the cold block.  When 
this wax begins to solidify, place the sample (flat, cut side down) on the wax 
and press to flatten it.  Make sure samples are not angled. 
3. Place cassette lid on top of the mold and fill with paraffin. 
4. Place on freezing stage until hard. 
 
Sectioning: 
1. Fill bowl with ice and add a small amount of water. 
2. Soak samples in ice bath for at least 20 minutes prior to sectioning. 
3. Turn water bath on to reach 40-50ºC. 
4. Set the microtome blade angle to 15º. 
5. Mount the block on the microtome so that it sections evenly across the surface 
and so that the sample is being cut horizontally. 
6. Deface the block just until tendon is reached. 
7. Place defaced block back in ice bath and continue onto other specimens. 
8. When ready to section, place sample in Mollifex tissue softener for 5 minutes. 
9. Section at 7µm and collect every good section.  
10. Cut ribbon into sections of 2 and place in water bath to remove wrinkles. 
Collect on slide labeled in pencil with specimen ID, date, and slide number.  
11. Collect as many slides per specimen as possible.  
12. Bake slides 1 hour at 60ºC to ensure sections adhere. 
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Appendix 8: Tendon Histology H&E Staining 
 
De-waxing 
3 minutes                          Xylene  
3 minutes                          Xylene  
3 minutes                          Xylene  
 
Dehydration 
2 minutes                       100% Ethanol 
2 minutes                       100% Ethanol 
2 minutes                       100% Ethanol 
2 minutes                       95% Ethanol 
2 minutes                       95% Ethanol 
2 minutes                       70% Ethanol 
2 minutes                       DH2O 
 
Stain 
10 minutes                      Hematoxylin (clean off iodized surface) 
 
Rinse 
Until water is clear          DH2O 
3 Dips                             Clarifier 
2 minutes                        DH2O 
3 Dips                             Bluing 
2 minutes                        DH2O 
2 minutes                        95% Ethanol 
 
Stain 
10 seconds                     Eosin 
 
Rehydration 
2 minutes                       95% Ethanol 
2 minutes                       95% Ethanol     
2 minutes                       100% Ethanol 
2 minutes                       100% Ethanol 
2 minutes                       100% Ethanol 
 
Final cleaning 
3 minutes                          Xylene  
3 minutes                          Xylene  
3 minutes                          Xylene 
Coverslip  
Dry flat overnight in hood 
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Appendix 9: Tendon H&E and Polarized Light Imaging 
 
This protocol is divided into three sections: 
1. Color Images @ 2.5, 5, 10, 20X  
2. Polarized light images (uncomp & comp @ 20X) 
3. Analyzing these images using PolarWare program written in Matlab 
________________________________________________________________________ 
 
1. Taking color images 
The setup on the microscope from top to bottom should be: eyepiece, rotating analyzer, 
objective, slide, stage, condenser, compensator (only for compensated images as 
described below), rotating polarizer 
a. Turn on the microscope and the camera (plug firewire cable into either input on side 
of camera). 
b. On the computer connected to the microscope, load QCapture Pro software.  Click on 
the camera icon to bring up the capture menu.  Click Preview to view the image  
c. Select setting Lucas BF and make sure Acq resolution at 1280 x 960 FF, Pvw 
resolution 640 x 980 FF and Capture depth 24 bit color 
d. Before putting slide on, auto white balance  reset area to full frame 
 calculate 
e. Put slide on and click calculate auto exposure 
f. Using the 2.5X objective, find the region of interest and focus the 
specimen.  Orient the specimen at ~45°.  (Knobs on stage move the 
stage and knob on side focuses). Continue to increase to 5X, 10X and 
20X until you have the region you want at 20X (aim for maximum 
focus number which is shown at the bottom of the preview image) 
g. Zoom back out to 2.5X and take image at 2.5X, 5X, 10X, and 20X 
(auto expose at each magnification and remember to maximize the 
focus). Create a folder with the specimen number and within that create a folder 
called “Color.” Label the files:  
32-XXX_Slide#_locationonslide_magnification (e.g., 32-081_22_2_2X)  
h. After taking the 20X image, stay in the same location to do polarized light at 20X. 
 
2. Taking polarized light images 
a. Take the noncompensated images first. With the 20X objective in place, load the 
PolLightUncomp (8 bit mono) profile. Without the analyzer and polarizer, click 
Auto White Balance and select a region of the slide that does not contain the 
specimen. Slide the analyzer and polarizer in place and click Auto Exposure (do not 
auto expose between images, only once at the beginning of noncomp and comp 
images). 
b. Insert  the analyzer all the way in (located top left) and the polarizer (under the stage) 
and make sure the compensator is not in the polarizer for the first set of images 
c. Set the analyzer to 180 degrees and the polarizer to 270 degrees. This position 
will be considered 45 degrees when saving the images.  Rotate through the various 
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angles of the polarizer/analyzer to ensure that the images do not saturate.  If 
saturation occurs, simply turn down the light. 
d. Rotate both the analyzer and polarizer in a clockwise direction by the same 
increment (10). For both noncompensated and compensated images, pictures need to 
be taken across a 90 range in 10 increments. 
e. Press Snap and save each picture as a .tiff file. For each specimen, go to the folder 
created in step g of section 1 above with the specimen number.  Within this, create 
separate folders for compensated (“comp”) and noncompensated (“uncomp”) images.  
Save pictures using a 3 digit filename format.  For example, a picture taken at 45 
should be saved as 045. Repeat until a span of 90 (image named 135) has been 
reached. 
f. Insert the compensator in its slot above the polarizer with the nail pointing down. 
The compensator must be oriented 45 counterclockwise from analyzer and polarizer 
(i.e., compensator nail should be pointing at 225 degrees –always aligned with the 
blue dot – on the polarizer). 
g. Load the PolLightComp (24 bit) profile and click Auto Exposure 
h. Repeat steps d-f; however, this time rotate the compensator in a clockwise 
direction with the analyzer and polarizer (make sure that compensator is always 
oriented 45 from the analyzer and polarizer while you are rotating, pointing to the 
dot).  Instead of going from light to dark (or vice-versa) as you rotate analyzer 
compensator and polarizer, the images should go from blue to red (or vice versa). 
i. Turn off camera by unplugging firewire cable and turn off microscope lamp. 
 
3.  Using PolarWare 
a. Run Matlab. 
b. Set the correct path (U:\software cooker-freezer\polarware\rc).  Where U is the 
soslowskylab max drive. 
c. Type in “polarware_gui;”. 
d. Press button “NON-compensated”. 
e. Navigate to the correct directories where the noncompensated and compensated 
images are saved and click on a noncompensated image. 
f. Change parameters: 
Bundle spacing determines the pixel distance between adjacent bundles (left, 
right, top, bottom) 
 Bundle spacing = 50 
Bundle size determines the size of each bundle.  This value must be odd. 
 Bundle width = 7 
g. Input the specimen name in the Output File Prefix box (e.g., 32-008_mid). 
h. Press button “NON-Bundle” and save the INTD file in a new folder labeled 
“QPLM.” 
i. Press button “NON-Fit” and save the NNF file. 
j. Press button “COM-Bundle” and save the INTD file. 
k. Press button “COM-Fit” and save the CNF file. 
l. Press button “Shift noncomp” and save the SNF file. 
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m. Press button “Apply Mask”. Change automask parameters to desired values: 
Phi-CI Threshold = 15 
Phi-Sensitivity Threshold = 1.0 
(Note, these values were determined to be appropriate for Sarah’s thesis after 
analysis of all the 2/8 wk EX/CA specimens). 
n. Go through each bundle and ensure that the quiver plot seems appropriate for the 
region.  Any bundle located in a gap in the tissue, on muscle, or on a cell should be 
masked to avoid including in analysis. To manually remove bundles, click “Point 
Mask” in the Mask GUI.  Click on any bundles that should be removed and press 
enter on the keyboard when done. 
o. Press button “Save Mask” and save the MSK file  
p. Press button “OUTPUT RESULTS” and copy the data to an Excel file. 
q. Copy the following 3 output figures to a PowerPoint:  
 Figure 19: Fiber Direction Histogram 
 Figure 10: Noncomp Node File Threshold Figure 
 Figure 2: Bundle Figure 
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Appendix 10: BioQuant Software for Tendon Histology Cellularity and Cell Shape 
Open Existing Data Set  
1. File>> Open Data Set>> select your data volume(SIR_thesis_Chronis_mid)>> select 
a data set(anyone works (ie. 32-090_Mid_21_1_20X)>> press “Open” 
a. This is just to make sure you are working with a template that has the 
correct arrays to measure 
Note: Data Directory should be on C:\BQDATA\ in order for the name of your data 
volume to appear in the scroll menu. If you click “Browse” and search within the 
BQDATA folder there will only be numbered folders, e.g. “DATA170”. 
 
Create New Data Volume 
1. Open existing data set, which has 
functions you desire (e.g. 
SIR_thesis_chronic_mid) 
 
*To keep functions that calculate 
total area, cell count, cell shape, and 
cell area, base new data set off of 
old one 
2. File>> New Data Set>> Create 
New Data Volume  
*To create new Data Volume, 
which has aforementioned 
prewritten function 
3. Keep Data Directory as C:\BQDATA\  
4. Finish wizard  
*Note which Data Volume you created 
(e.g. “DATA170”). This will be used 
to save data as a .txt file. 
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Analyze an image 
1. Image>> Type: Image File>> Open Single>> select image to analyze 
Select the image you want (20x color) and it should pop up on the big screen  
2. Before doing anything else, create a new data set: 
File>> Quick Data Set>> rename the new data 
set>> Current Data Set>> Create 
3. Choose correct camera 
magnification/calibration:  
a) Underneath where you opened your 
image click: 
Calibration>> File>> Load…>> e.g. Leica.cal 
4. Now see this box:  
a. Make sure to select the correct 
magnification (X20-L if you have 
used the polarizing scope)  
b. This is a key step, make sure the 
correct magnification is selected 
throughout your entire analysis  
5. Next define ROI (Region of Interest) you are 
interested in analyzing 
Usually full screen, but if not: 
Irregular>> click “Spacebar to End”>> 
Define>> select ROI with mouse 
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Push spacebar and RIGHT CLICK to end. (There will be a green outline) 
Now this area will be the only area analyzed 
6. Select Array: 
a) Double click on A2 Cell Area (Notice all values are (0)) 
b) This will make the area you defined in step 5 turn pink 
c) In the both on the right make sure the Type: General is selected and click 
preview and the measure. A number will appear in the Raw Data: Current 
Array window and that is your total area  
d) Now double click in the Available array 
box A1 Cell Area (make sure 
magnification is set to X20-L after you 
double click 
e) This will allow you to measure the 
specific cells you are interested in with 
your ROI 
f) Now continue on with step 7  
7. Adjust Threshold 
Press “Select”>> click on cells>> same color regions will turn pink 
Once satisfied, right click. 
 
 
 
 
 
 
 
 
 
 
 
 
This tool is useful but sometimes it does not select all the cells or it selects areas that 
aren’t cells. After using this tool you can use the paintbrush and eraser in the 
threshold section to clean up the picture and make sure you have only selected the 
cells you want to measure. (More details about this in step 10-13). You can adjust the 
size of the eraser and paintbrush by using the scroller on the mouse. In order to get 
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out of using either tool you must right click. Once you have the cells you want 
selected move to step 8. 
 
8. Press “Preview” 
Yellow outline will form around each cell.  
Note: Each yellow-bordered region is what Bioquant will recognize as a cell, not the 
pink. If you like what you see click measure and your data will appear in the raw data 
window 
 
 
 
 
 
 
 
 
 
 
 
9. Useful Tool:  
a. Press “Show” 
i. Pink fill will disappear. Qualitatively measures accuracy of pink on 
cells.  
b. Press “Show” again to make pink fill reappear. 
10. Fine-tune selection: Draw Threshold 
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Use mouse to color in cells>> use mouse scroller to adjust marker size>> right click to 
end 
Note: Right clicking allows your cursor to exit the picture window, and it also creates 
yellow borders around each cell. Note that Bioquant only registers these yellow-bordered 
regions as cells, not the pink. 
 
11. Fine-tune selection: Erase Threshold (the eraser sign below Draw Threshold) 
Use mouse to color over unwanted regions>> use mouse scroller to adjust eraser 
size>> right click to end 
Note: Watch out for small, yellow regions that Bioquant picks up without your 
knowledge. Erase these.  
Note: look at text file for cells with area~0. These “cells” are actually this yellow noise. 
 
12. To more quickly switch between the eraser tool and the paintbrush tool, press either 
of the two arrows located by your thumb. You must already have selected either the 
paintbrush or eraser for this shortcut to work.  
Doing so will unselect the “pesky” yellow borders, thereby allowing you to better see 
the cells and ultimately increase accuracy of cell shape selection and differentiation 
between cells. The yellow borders will reappear via a right-click. 
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13. To increase accuracy of cell shape drawings: 
a. Decrease cursor speed by pressing the negative shortcut on the mouse. 
b. Using the smallest marker size of the paintbrush, draw an enclosed border for 
each cell instead of filling the entire cell in.  
14. When satisfied>> click “Preview”>> click “Measure” 
15. When done File>> Save Data 
 
Export Data as a .txt File 
1. File>> Data Manager 
2. Uncheck: Desktop>> My Computer>>OS (C:)>> BQDATA>> Click 
“DATA###(Your Data Set)” 
a. Data 254 for Sarah’s Thesis 
3. Click on the icon of a folder with binoculars on top on the toolbar 
4. The folder with all your previous data sets will appear, select whichever data set you 
want to save to a .txt file and right click on it and select save to file 
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Appendix 11: Laminin-DAPI Immunofluorescence Staining on Muscle Cryosections 
This protocol, modified from one originally used by Ed Pistilli in the Khurana lab, is 
intended for muscle cryosections that have been stored in the -80C freezer.  Total 
protocol is ~3.5 hours. I normally do 20 slides at once. 
 
Reagents Needed:  
Vehicle solution: 10% normal goat serum (NGS), 1% Triton X-100 in PBS (made fresh) 
 For 14 ml: 12.46 ml PBS + 140 μl Triton X-100 + 1.2 ml NGS  
Cut pipette tip for Triton X-100 (viscous); add this to the PBS first, then vortex, 
then add NGS 
PBS (for immunoassays) 
Anti-Laminin (Sigma L9393) produced in rabbit  
Secondary Antibody Alexa Fluor 488 Goat Anti-Rabbit IgG  
(Life Technologies A-11008)  
Spin at 10,000 rcf for 1 min at room temperature prior to use to avoid non-specific 
binding 
ProLong Gold Antifade reagent with DAPI (Invitrogen P36935, Cell Center) 
Clear nail polish 
 
Equipment and Supplies Needed: 
Cover slips 
PAP pen 
Pipettors and tips 
15 ml tubes 
KimWipes 
Black slide box for IHC/IF 
Vacuum set-up  
 
Protocol:  
1. Thaw slides at room temperature and let them air dry (~10 minutes). 
2. Wash slides with PBS (quick washes). 
3. Circle each section with a PAP pen. 
4. Block with vehicle solution for 30 minutes at room temperature.  From this point on, 
store slides in humidity chamber (wet KimWipes and place them in the black 
immunoassay slide box).   
5. Use vacuum system to remove excess vehicle solution from sections.  Incubate with 
anti-laminin 1:1000 in vehicle solution for 1 hour at room temperature.   
(For 4ml: 4 ml vehicle + 4 µl anti-laminin) 
6. Wash 3 times 5 minutes each with PBS. 
7. Incubate with secondary antibody 1:500 in vehicle solution for 45 minutes in the 
dark at room temperature.  From this point on, the sections are photosensitive; avoid 
direct light when possible. 
(For 2.5 ml: 2.5 ml vehicle + 5μl secondary antibody) 
8. Wash 3 times 5 minutes each in PBS.   
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9. Mount coverslip on slides with ProLong Gold Antifade with DAPI.  Avoid air 
bubbles. 
10. Allow slides to cure for 24 hours at room temperature in the dark on a flat, dry 
surface. 
11. Seal edges of coverslip with clear nail polish.  Store at room temperature in dark slide 
box. 
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Appendix 12: Muscle Fiber Type Staining on Cryosections 
This protocol, modified from one originally used by Emanuele Loro in the Khurana lab, 
is intended for muscle cryosections that have been stored in the -80C freezer. I normally 
do 20 slides at once.   
 
Reagents Needed:  
Blocking Solution: 4% BSA in PBS (for 5.5 ml, add 220 mg BSA to 5.5 ml PBS) 
1% BSA solution: Add 1.5 ml 4% BSA to 4.5 ml PBS 
PBS (for immunoassays) 
Primary antibody solution: See chart below. 
 For ~3ml: 3 ml 1% BSA + 30µl each MyHC antibody +3µl anti-laminin 
Secondary antibody solution: See chart below. 
For ~3ml: 3ml 1% BSA + 30 µl IgG2b + 7.5 µl IgG1 + 6 µl IgM + 6 µl anti-
rabbit IgG 
ProLong Gold Antifade reagent without DAPI 
Clear nail polish 
 
Antigen Primary ab 
Clone 
Primary 
ab Isotype 
Primary 
ab dilution 
Secondary 
ab 
Secondary 
ab dilution 
MyHC-I BA-D5 
supernatant 
IgG2b 1:100 Goat Anti 
mouse IgG2b 
DyLight 405 
(Jackson 
Immuno) 
1:100 
MyHC-2A SC-71 
supernatant 
IgG1 1:100 Goat Anti 
mouse IgG1 
Alexa 488 
(Jackson 
Immuno) 
1:400 
MyHC-2B BF-F3 
purified 
IgM 1:100 Goat Anti 
mouse IgM 
Alexa 546 
(Jackson 
Immuno) 
1:500 
* Type 2x fibers will not be stained, therefore will appear as black 
MyHC antibodies are from the Developmental Studies Hybridoma Bank at the 
University of Iowa 
 
Equipment and Supplies Needed: 
Cover slips 
PAP pen 
Pipettors and tips 
15 ml tubes 
KimWipes 
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Black slide box for IHC/IF 
Vacuum set-up  
 
Protocol:  
1. Thaw slides at room temperature and let them air dry (~10 minutes). 
2. Circle each section with a PAP pen. 
3. Wash twice with PBS. 
4. Block with 4% BSA in PBS for 1 hour at room temperature.  From this point on, 
store slides in humidity chamber (wet KimWipes and place them in the black 
immunoassay slide box).   
5. Use vacuum system to remove excess vehicle solution from sections.   
6. Wash 2 times 2 minutes each with PBS. 
7. Incubate with primary antibody solution for 1 hour at 37ºC.   
8. Wash 3 times 5 minutes each with PBS. 
9. Incubate with secondary antibody solution for 30 minutes in the dark at 37ºC.  From 
this point on, the sections are photosensitive; avoid direct light when possible. 
(For 2.5 ml: 2.5 ml vehicle + 5μl secondary antibody) 
10. Wash 3 times 5 minutes each with PBS.   
11. Mount coverslip on slides with ProLong Gold Antifade without DAPI.  Avoid air 
bubbles. 
12. Allow slides to cure for 24 hours at room temperature in the dark on a flat, dry 
surface. 
13. Seal edges of coverslip with clear nail polish.  Store at room temperature in dark slide 
box. 
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Appendix 13: Muscle Histology Imaging 
Using the Eclipse 90i 
 
Laminin-DAPI Imaging 
1. With the Eclipse set to the green filter and using a 4x objective, scan the 4 
sections per slide and choose the section that has the least freezing, sectioning, 
and staining artifact. 
2. Switch to 10x objective and scan over the chosen specimen to identify 6 regions 
to image.  These regions should be spread throughout the specimen.  Avoid 
freezing artifact when possible. 
3. Begin taking images.  For each region, focus, auto-expose, and capture for the 
green filter AND the DAPI filter.  Save each of these images as TIFs with the 
following file names: 
32-xxx_slide number_section number_laminin_image number 1-6 
32-xxx_slide number_section number_DAPI_image number 1-6 
4. Merge these two channels and save the merged file as a JPG (color) with the 
following file name: 
32-xxx_slide number_section number_merged_image number 1-6 
5. Repeat to take images of 6 regions. 
 
Fiber Type Imaging 
1. With the Eclipse set to the greem filter and using  a4x objective, scan the 4 
sections per slide and choose the section that has the least freezing, sectioning, 
and staining artifact. 
2. Switch to 10x objective and the DAPI filter.  This will expose the MyHC-I fibers 
as blue.  For the supraspinatus muscle, this region is small and located on the edge 
of the fiber.   
3. Identify 3 regions within the MyHC-I section of the muscle and image.  We will 
call this section of the muscle “region 2.”   
4. For each of the “region 2” images, capture the following as TIFs: 
MyHC-I with DAPI filter: 32-xxx_slide number_section number_myhc1_image 
number 1-3 
MyHC-2a with green filter: 32-xxx_slide number_section 
number_myhc2a_image number 1-3 
MyHC-2b with TRITC filter: 32-xxx_slide number_section 
number_myhc2b_image number 1-3 
Laminin with Cy5 filter: 32-xxx_slide number_section number_laminin_image 
number 1-3 
5. For each of the “region 2” images, merge to create the following JPGs (color): 
MyHC-I (blue) + Laminin (red): 32-xxx_slide number_section number_myhc1-
laminin_image number 1-3 
MyHC-2a (green) + MyHC-2b (blue) + Laminin (red): 32-xxx_slide 
number_section number_myhc2a-myhc2b-laminin_image number 1-3  
6. Repeat to capture 3 regions within “Region 2.”  By the end, you should have 6 
jpgs for this region. 
175 
 
7. Now, move on to Region 1, which is larger and does not contain MyHC-1 
expressing fibers.  Repeat the above steps but don’t worry about capturing any 
images with the DAPI filter since there are no MyHC-1 fibers!  Again, capture 3 
regions within Region 1.  By the end you should have only 3 jpgs for this region 
(since you don’t need a myhc1-laminin merged image; you only need myhc2a-
myhc2b-laminin merged images) 
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Appendix 14: Muscle Histology Analysis Using SMASH MATLAB Application 
These directions are directly modified from SMASH_Instructions, a Word document that 
is contained in the SMASH download options online: 
http://figshare.com/articles/SMASH_semi_automatic_muscle_analysis_using_segmentati
on_of_histology_a_MATLAB_application/1247634 
SMASH is a MATLAB application written by Lucas Smith for segmentation and analysis 
of fluorescently stained transverse muscle histology sections. 
Smith LR, Barton ER. SMASH- semi-automatic muscle analysis using segmentation of 
histology: a MATLAB application. Skelet Muscle 2014 Nov;27:4-21. 
 
1. Follow provided SMASH_Instructions to install the SMASH app on Matlab 2014 
and locate the excel file to alter the default parameters  
2. Input the following defaults and ensure the default output folders exist to prevent 
an error during data output 
a. For fiber type analysis, fiber outline channel = 1 
b. For Laminin-DAPI analysis, fiber outline channel = 2 
Default Values 
 Pixel Size (um/pixel) 0.645 
Fiber outline channel (red = 1, green =2, blue 
=3) 1 
Nuclei channel (red = 1, green =2, blue =3) 3 
Fiber type channel (red = 1, green =2, blue 
=3) 2 
Object channel (red = 1, green =2, blue =3) 2 
Segmentation smoothing factor 6 
Nuclear smoothing factor 10 
Object smoothing factor 10 
Minimum fiber area (um2) 750 
Maximum fiber area (um2) 10000 
Maximum eccentricity 0.98 
Minimum convesity 0.7 
Nuclear distance from boarder (um) 15 
Minimum nuclear size (um2) 5 
Fiber properties output folder Enter pathway for output folder 
Fiber type output folder Enter pathway for output folder 
Central nuclei output folder Enter pathway for output folder 
Objects output folder Enter pathway for output folder 
 
I. Running Muscle Histology Analysis and selecting File 
1. Select the “SMASH_App” App from the App Menu. 
2. Locate and press the “Select File” button. 
3. Navigate to and select the jpeg image file you would like to analyze 
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a. Always select the original image file, not the mask file created by the 
program. 
b. The selected file name will appear on the screen 
4. In the Select Function window select the analysis function to perform and press 
“Select Parameters.” 
a. Initial Segmentation must be run before any other functions. 
b. It is also recommended that fiber filter is run prior to other analysis 
functions. 
 
II. Initial Segmentation 
5. Manually modify the parameters for initial segmentation from the defaults if 
necessary and press the “Run Function” button 
a. If a mask for the file is already created you will be asked to overwrite the 
previous mask to continue. 
6. Examine the image that is produced containing white lines over the fiber borders 
and if it is satisfactory press the “Manual Edit” button, otherwise change the 
Segmentation Filter value and press “Run Function” again. 
a. General segmentation values range from 4 to 8 (lower number is a more 
segmented image) 
b. The Zoom and drag button at the top toolbar allow the user to scan the 
image in detail. 
7. Manually fix any undersegmentation using the Edit Segmentation menu tools 
a. Draw Line 
i. Once pressed, any previously drawn line is saved. 
ii. Pan and zoom to the conjoined fiber. 
iii. Freehand draw a line to create a boarder to fully separate the fiber. 
iv. Ensure that no tools are selected so that the freehand draw is 
active. 
v. Repeat until all fibers are properly segmented. 
b. Undo: Press if the most recent fiber drawn was not drawn correctly. 
c. Done: Press when all fibers have been segmented. 
i. A new mask file will be saved. 
 
III. Fiber Filter 
1. Manually modify the parameters for filtering fibers from the defaults if necessary 
and press “Run Function” 
2. Inspect image that appears to determine if it is satisfactory. 
a. If filter parameters should be changed edit them in the window and re-
press “Run Function.” 
b. If the filtering was satisfactory press “Manual Filter.” 
3. Navigate to any objects that are not fibers using pan and zoom and press any key 
a. Locate and open the original image for comparison 
4. Click on all visible objects that are not fibers. 
a. A cross hair will be placed on the image where clicked. 
b. To remove most recent selection press “backspace” or “delete.” 
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c. To end selecting double-click on final selection, ctrl/alt click on final 
selection, or press “Enter.” 
5. The image will show the fibers removed and allow you to make a selection to 
confirm fiber removal  
a. Yes: to delete selected fibers and continue to select fibers at step 3). 
b. No: keep all fibers selected, but continue to select fibers at step 3). 
c. Done: to delete selected fibers, save the modified mask file and proceed to 
further analysis. 
Note: If Yes is pressed after the last fiber to be filtered place a new cross 
hair over a non-fiber area to bring up the menu. 
 
IV. Fiber properties 
6. Manually modify the parameters for fiber properties from the defaults if necessary 
and press “Run Function” 
7. Examine the histograms and choose if you would like to output the data to Excel 
by pressing “Yes” or “No.” 
 
For Fiber Type Analysis: 
V. Fiber Typing 
8. Manually modify the parameters for fiber typing from the defaults and press “Run 
Function” 
a. Fiber Type Color:  
i. Region 1: Green = type 2a; Blue = type2b 
ii. Region 2: Blue = type 1; Green = type 2a; Blue = type 2b 
9. Examine the image with pan and zoom to determine if calls for fiber type are 
appropriate. 
10. If you would like to change the automatic threshold for fiber types enter the new 
threshold value and press “Adjust”, otherwise press “Accept.” 
a. Locate and open the original image for comparison 
b. The histogram of average intensity is helpful in determining appropriate 
thresholds. 
11. Choose if you would like to output the data to Excel by pressing “Yes” or “No.” 
a. Note: If analyzing more than one fiber type on an image, rename the excel 
file 
12. To analyze another fiber type on the same image, repeat steps 8-11 and change 
the fiber type color. 
 
For Laminin-DAPI Analysis: 
VI. Centrally Nucleated Fibers 
13. Manually modify the parameters for CNFs  from the defaults and press “Run 
Function” 
14. Examine the image with pan and zoom to determine if calls for CNFs are 
appropriate. 
a. Locate and open the original image for comparison. 
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15. If you would like to change the automatic threshold for nuclei enter the new 
threshold value and press “Adjust”, otherwise press “Accept.”  
a. Pointing over the nuclear image in the top left to display pixel intensity 
info can be helpful for determining an appropriate threshold value 
16. Choose if you would like to output the data to Excel by pressing “Yes” or “No.” 
**Note: if samples have freezing/staining/sectioning artifact, it will be more reliable to 
manually count the number of centrally nucleated fibers instead of using this program.   
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Appendix 15: Tendon Mechanical Testing Prep 
This protocol is for the preparation of rat supraspinatus tendon for mechanical testing. 
 
Equipment and Supplies Needed: 
KimWipes 
 
Protocol:  
1. Dissect supraspinatus muscle-tendon-bone unit (refer to Supraspinatus 
Dissection Protocol). 
2. Let specimen sit in PBS for 5 minutes. 
3. Blot specimen on KimWipe to remove excess PBS. 
4. Gismo supraspinatus muscle starting at the distal (tendon) edge, making passes 
every 2 mm. 
5. Fine dissect supraspinatus tendon (refer to Supraspinatus Tendon Fine 
Dissection Protocol). 
6. Add stain lines (refer to Supraspinatus Tendon Stain Lines Protocol). 
7. Gismo tendon (refer to Supraspinatus Tendon Gismo Protocol). 
8. Pot tendon (refer to Supraspinatus Tendon Potting Protocol). 
9. Sandpaper tendon (refer to Supraspinatus Tendon Potting Protocol). 
10. Load tendon in ElectroPuls Instron and test (refer to Supraspinatus Tendon 
Mechanical Testing Protocol). 
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Appendix 16: Supraspinatus Tendon Fine Dissection for Mechanical Testing 
This protocol is meant for fine dissecting the rat supraspinatus tendon prior to application 
of stain lines/Gismo for mechanical testing. 
 
Equipment and Supplies Needed: 
#11 blades 
Blade holder 
Hemostats 
Jeweler’s forceps 
Micro-scissors 
Black pad 
Wax 
 
Protocol: 
1. Use back of blade to scrape muscle away from tendon. 
2. Use jeweler’s forceps and micro-scissors to remove all “goo” from tendon 
insertion site and mid-substance.  “Goo” is pinkish or yellowish, not the bright 
white color of the tendon.  It also moves differently from the tendon. 
Remove any tissue that is not well-formed enough to bear load; leave tissue that 
bears load.  
 Manually grip end of tendon and apply minimal amount of load.   
Non-load bearing (remove): Tissue that move but doesn’t stretch or deform 
under load 
 Load bearing (keep): Tissue that stretches under load and therefore bears load 
3. Keep tendon fully hydrated! 
4. Make sure to fine dissect all sides of the tendon, focusing particularly on the 
insertion site.  Change the grip of the hemostats to fine dissect the joint and bursal 
sides. 
5. At the very end, use the micro-scissors to cut directly into the bone between the 
infra-supra insertions to ensure that they are fully separated and remove any 
excess rotator cuff tendons that may be in the way for Gismo. 
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Appendix 17: Supraspinatus Tendon Stain Lines for Mechanical Testing 
This protocol is for an 8 mm gauge length rat supraspinatus tendon for mechanical 
testing. 
 
Equipment and Supplies Needed: 
KimWipes 
6-0 silk suture 
Verhoeff’s stain 
Weigh boats 
Ruler (mm) 
Pink dental wax 
 
Verhoeff’s Stain 
A- 5% hematoxylin solution (0.4g Hematoxylin + 20 ml 95% EtOH) 
B- 10% aqueous ferric chloride (2g Ferric chloride + 20 ml dH2O) 
C- Weigert’s iodine solution (2g potassium iodide + 1g iodine + 100 ml dH2O) 
Dissolve all solids and add in order B to A, then C to A in the following ratio of A:B:C = 
2:1:1 
Solutions A, B, and C can be made up ahead of time and stored separately.  Solution C 
should be stored in a dark bottle.  Place small amount (~0.5 to 1 ml) of stain in angled 
weigh boat or in an Eppendorf tube. 
 
Protocol:  
1. Set up pink dental wax to be the height of the humeral head so that the tendon can 
lie flat.  Place ruler under top layer of wax so that it does not get stain all over it 
but so that the numbers can still be seen. 
2. Blot tendon with KimWipe to remove excess PBS so stain does not spread.   
3. Lie tendon flat with bursal side up, joint side down on wax. 
4. Dip suture in stain (wait until small stain bubbles appear on suture).   
5. Place first (0mm) stain line at point of insertion, as shown in picture.  The 
insertion site is slightly angled; follow this angle.  The goal is to place the stain 
line directly on the insertion site so that it does not move under tension. 
6. Place the remaining stain lines measuring from the highest point of the insertion 
stain line.  Stain lines are indicated by black rectangles in the figure below and are 
spaced from the 0 stain line by the number of millimeters indicated.   
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0 
 
4 
 
2 
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Appendix 18: Supraspinatus Tendon Cross-Sectional Area Measurement 
This protocol is to determine the supraspinatus tendon cross-sectional area for 
mechanical testing (8 mm gauge length). 
 
 
Protocol:  
1. Blot tendon with KimWipe to remove excess PBS. 
2. Place tendon bursal side down and ensure tendon is lying flat with no space 
between tendon and base; if necessary, angle humerus using pink dental wax.   
3. Do not save: Zero Gismo at first (insertion) stain line.  Move Gismo to just after 
humeral head so that a complete pass could be made without interruption and 
record distance (A).  This distance will vary between specimens.  Stop the 
program but do NOT re-zero.     
4. Save: Start the program in capture (save) mode.  Immediately zero the thickness 
but NOT x or y.  Make first pass across width of tendon at non-zeroed distance 
“A” (where you left off before saving).  The remaining passes are indicated by the 
distance (in millimeters) from the start (where Gismo was zeroed).  Be sure to 
note if Gismo does not correspond with stain lines.  If distance A is so large that it 
goes beyond the 2
nd
 stain line, adapt the Gismo protocol by only doing those 
passes that are appropriate.  For example, if A = 2.54 mm, make passes at 2.54 
mm, 3 mm, 4 mm, 6 mm, and 8 mm.        
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Appendix 19: Supraspinatus Tendon Potting/Sandpaper for Mechanical Testing 
 
Equipment and Supplies Needed: 
Small pots (cut to 1” length): Harvel Clear ¼” SCH 40 P NSF-61  
PMMA 
1x PBS 
3 mL syringe 
Sandpaper (P400) cut into 1.2 x 1.5 cm rectangles 
Small curved forceps 
Loctite glue 
 
Potting Protocol:  
1. Ensure pot fits inside testing fixture. 
2. Tape bottom of pot, and label pots with specimen ID on side of pot and on bottom 
of tape. 
3. Fill pot with PMMA.  
4. Insert humerus into PMMA so that the humeral head rests above the lip of the pot.  
Be sure to keep the humerus out of the pot far enough so that the tendon insertion 
site is clearly visible when viewed how the camera would see them during 
loading.  Be sure not to get PMMA on tendon. 
5. Wrap tendons into a “turban” and set them on the top of the humeral head.    
6. Let PMMA cure.  Keep an eye on the tendons to ensure that they do not dry out.   
7. Once PMMA begins to cure, mix up another batch of PMMA and fill syringe.   
8. Coat humeral head with second pot (to keep growth plate from fracturing during 
loading).  Avoid getting PMMA on tendon.  Be sure PMMA does not interfere 
with the tendon loading direction.     
9. Wrap tendons into a “turban” and set them on the top of the humeral head.    
10. Once PMMA begins to harden, remove tape and put pots into specimen cup filled 
with 1x PBS.  This can be stored in the fridge overnight. 
 
Sandpaper Protocol 
1. Dab tendon on KimWipe to remove moisture from sandpaper region- tendon will 
slip from sandpaper during testing if not dried first! 
2. Cover one piece of sandpaper with glue.   
3. Place tendon on sandpaper with sandpaper towards tendon.  Be sure bottom of 
sandpaper aligns with top stain line and that the tendon is set in the direction it 
will be loaded.  Spread tendon to lie flat on glue.   
4. Add glue to second piece of sandpaper.  Place second piece of sandpaper on top 
of tendon. 
5. Pinch tendon/sandpaper sandwich for ~30 seconds to let glue cure.  
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Appendix 20: Supraspinatus Tendon Mechanical Testing 
This protocol is for the preparation of rat supraspinatus tendon for mechanical testing on 
the ElectroPuls Instron. 
 
Equipment and Supplies Needed: 
Fixture for supaspinatus tendon testing on the ElectroPuls 
Grips 
Camera/image capture program 
BioPuls bath 
 
Protocol:  
1. Use 250 N load cell (smallest available for ElectroPuls). 
2. Set up fixture in BioPuls bath so that the tendon will point towards the window of 
the bath for image capture. 
3. Heat bath to 37°C. 
4. Plug in the LVDT for fine displacement control. 
5. Restore LVDT calibration. 
6. Ensure Instron is tuned to a specimen with a stiffness of 16 N/mm. 
7. Load specimen into fixture. 
8. Zero load when the tendon is slack. 
9. Manually pre-load tendon to 0.165 N, and zero the digital displacement and 
“strain 1” (LVDT). 
10. Set limits. 
11. Open WaveMatrix, and load the Rat Supra_SIR Thesis protocol. 
12. Simultaneously begin Instron protocol, zero time on the image capture program, 
and set a timer for 34 min. 
13. When timer buzzes, remove LVDT from Instron.  Begin image capture at 175s 
into the last step (25) of the protocol, capturing 2 frames per second. 
14. Stop image capture program and end/finish Instron protocol when the specimen 
begins to fail. 
15. Manually raise the Instron to better visual how specimen failed (e.g., at grip, mid-
tendon, insertion, shear, etc.).  Record this failure method. 
16. Remove specimen from tank. 
17. Acquire calibration image by taking image of a ruler (millimeter side). 
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WaveMatrix Testing Protocol 
Rat Supra_SIR Thesis (8 mm gauge) 
 
STEP 1| Ramp to 1% strain @ 0.1%/s (0.008 mm/s) 
STEP 2| Preconditioning 1-1.5% strain, 0.25 Hz, 10 triangle cycles 
STEP 3| Return to gauge length @0.1%/s (0.008 mm/s) 
STEP 4| Hold 300s 
STEP 5| Ramp to 4% strain (0.32 mm) @ prescribed 50%/s (4 mm/s) 
STEP 6| Hold 300s 
STEP 7| 10 sine cycles, 0.1 Hz, amp = 0.01 mm (0.125%) 
STEP 8| 10 sine cycles, 1 Hz, amp = 0.011 mm  
STEP 9| 10 sine cycles, 2 Hz, amp = 0.013 mm 
STEP 10| 10 sine cycles, 10 Hz, amp = 0.015 mm  
STEP 11| Return to gauge length @ 0.1%/s (0.008 mm/s) 
STEP 12| Hold 60s 
STEP 13| Ramp to 8% strain (0.64 mm) @ prescribed 50%/s (4 mm/s) 
STEP 14| Hold 300s 
STEP 15| Recovery to 4% strain (0.32 mm) @ prescribed 50%/s (4 mm/s) 
STEP 16| Hold 300s 
STEP 17| Return to 8% strain (0.64 mm) @ 0.1%/s (0.008 mm/s) 
STEP 18| Hold 300s 
STEP 19| 10 sine cycles, 0.1 Hz, amp = 0.01 mm (0.125%) 
STEP 20| 10 sine cycles, 1 Hz, amp = 0.011 mm  
STEP 21| 10 sine cycles, 2 Hz, amp = 0.013 mm 
STEP 22| 10 sine cycles, 10 Hz, amp = 0.015 mm  
STEP 23| Return to gauge length @ 0.1%/s (0.008 mm/s) 
STEP 24| Hold 180s  Remove LVDT, capture images at 175s into this step 
STEP 25| Ramp to failure @ 0.3%/s (0.024 mm/s) 
 
Bolded steps indicate LVDT control.  All other steps are digital position control. 
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Appendix 21: Supraspinatus Tendon and Muscle Cross-Sectional Area 
Measurement 
 
 Gismo Protocol 
1. Setup 
2. Muscle analysis 
3. Tendon Analysis 
 
 
1. Setup 
a) Open MATLAB R2012a 
b) In the current folder box at the top change the directory to: 
\\medfiles\ort\McKay_Lab_Folders\shared\Software_released\Gismo_area\release
d 
c) Type “gismo_area;” and click enter and a GUI will pop up on the side with Load, 
Mark Gismo, Local Area etc… 
2. Muscle analysis 
a) Click Load and select the .txt Gismo file you want to analyze. 
b) Click Mark Gismo and use the cursor to select the sides of each peak going from 
left to right. When all the peaks are marked click enter. Create a folder with the 
name of the tendon and save all files there. 
c) An area vs. length bar graph will pop up. Eyeball the peak in the middle region (a 
range of 4mm). On the GUI toolbar type your estimated middle region (ex. 4 – 8) 
and click Local Area. Another graph will pop up showing if your area included 
the whole peak. Try and include as much of the peak as possible and be even on 
both sides. You can adjust your region by changing the numbers and clicking 
Local Area. An example of this is shown below. Once you have a good region go 
to the Matlab main console and copy the Local Area information to the excel file. 
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3. Tendon Analysis 
a) Repeat steps a) and b) from muscle analysis. 
b) Look at four regions: insertion (0-2mm), midsubstance (2-4mm), whole tendon 
(0-4mm) and then the region from 4-8mm (sandpaper). In order to get the data for 
each region plug in the region to the local area boxes and click Local Area. You 
do not need to enter 0 for the insertion or whole tendon regions; instead, use the 
initial starting point that gismo automatically inserts in the local area box (i.e., the 
distance “A” value recorded during your Gismo measurements). Once you 
calculate the Local Area from each region go to the Matlab main console and 
copy the Local Area information to the excel file. 
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Appendix 22: Frequency Sweep Analysis for Tendon Mechanical Testing 
 
Frequency sweep analysis 
4. Setup 
5. csv2txt_ePuls 
6. LoadAndFitSine_v3 
7. GetLength 
 
 
1. Setup 
d) Open MATLAB R2012a 
e) In the current folder box at the top change the directory to:  
\\max\software cooker-freezer\SLRP\Cooker\v1.0.1_Matlab M files combined 
 
2. csv2txt_ePuls 
a) Type “csv2txt_ePuls;” 
b) Select the Instron Test1.steps.tracking.csv file 
c) The program will create a new file in the same location with the same name but 
with .txt after 
d) To streamline the process, you can type csv2txt_ePuls; csv2txt_ePuls; 
csv2txt_ePuls; for as many specimens as you have to retain the same folder 
information. 
 
3. LoadAndFitSine_v3 
a) Type “LoadAndFitSine_v3;” and click enter and a window will pop up to open a 
file. Open the file created in step 2. 
b) A screen will pop up asking for Input Parameters. For the Vector of block 
numbers enter “[7 8 9 10 19 20 21 22]” and for the Vector of frequencies enter 
“[0.1 1 2 10 0.1 1 2 10]”. 
c) Another screen will pop up to enter the Cycle # start and end. Enter 4 for the start 
and 9 for the end. 
d) Twenty four graphs will pop up that contain the graphs of the frequency sweep in 
order from 4% to 8%. Look at each graph and make a note about the graph. Notes 
can include if the graph in noisy, has a plateau or weird line shape. Two examples 
graphs are shown below. The one on top is a 10 Hz frequency at 8% strain. This 
graph is good, no funny line shapes, or noise. The second graph is of a 2 Hz 
frequency at 4% strain. This graph is noisy and also you can see a plateau at the 
minimum points of the green line. These are the type of notes you should take in 
the excel file.  
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e) After recording the notes from the graphs, copy over the data in the Matlab 
console to the excel file.  
4. GetLength 
a) Type “GetLength;”  
b) Type “y” to select a new calibration image (each new specimen should have its 
own calibration image) 
c) Select the calibration image (ruler image) for that specimen.  Maximize the 
image. 
d) Click to the left of one tick mark on the ruler and then to the left of another tick 
mark on the ruler to span a region of ~10-15 mm (easy to do multiples of 5 mm). 
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Enter this span in mm and click OK. 
 
e)  Select the first image saved for the specimen.  This image should be when the 
specimen is in an unloaded state prior to the ramp to failure.  Maximize the 
image. 
f) Use the cross-hairs to click to select the bottom of the tendon (in the middle of 
the insertion stain line) and then click to select the top of the tendon at the 
sandpaper. 
 
g) In the MATLAB command window, copy and paste the “mmpermix” value into 
the Excel spreadsheet in the “calib” tab.  In Excel, take the inverse of this value 
(1/mmpermpix) to determine the calibration in pixels/mm. 
h) In the MATLAB command window, copy and paste the “L0_mm” value into the 
Excel spreadsheet in the “GetLength” column of the Fresh Data tab.  
 
5. Calculations 
a) Stress at each frequency is calculated as Force/Area.  The force is taken from the 
Instron output, and the area is tendon cross-sectional area (2-4 mm). 
b) Strain at each frequency is calculated as ΔLength/Length.  The ΔL is taken from 
the displacement amplitude of the sine waves, and the length is measured from the 
pre-loaded tendon image using the GetLength Matlab function. 
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c) Dynamic modulus at each frequency is calculated as Stress/Strain.  Stress and 
strain are calculated as described above. 
d) Tangent δ at each frequency is calculated as tan(δ).  The tangent of the phase 
angle is equal to the ratio of the loss modulus to the storage modulus.   
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Appendix 23: Optical Strain Analysis from Tendon Mechanical Testing Images 
 
Optikos Protocol 
8. Setup 
9. Optikos command 
10. Apply_disp 
11. Trk2element 
12. El2d_stiffness 
13. Calib_image 
 
 
1. Setup 
a) Open MATLAB R2012a 
b) In the current folder box at the top change the directory to: 
\\medfiles\ort\McKay_Lab_Folders\shared\Software_released\optikos\released  
c) On the computer go to where your data files are stored. Open the file called 
“Test1.steps.tracking_csv.txt” in excel. Edit the document so that only four 
columns exist in this order: Time-Disp-Load-Block (copy column C over column 
G and then delete columns B,C & D). Save this file as 
“Test1.steps.tracking_optikos_csv.txt” 
 
2. Optikos command 
a) Type “optikos;” into the command line and click enter and a GUI will pop up on 
the side with Load at the top.  
b) Load the images for your specimen. If you load one the rest will automatically 
load. 
c) Change the display from Not Enhanced to Contrast + Filtered 
d) Click Instron Restrict and load the file you created earlier called 
“Test1.steps.tracking_optikos_csv.txt”. Once you load this a bubble will pop up 
called Image capture correction where you can adjust the time your testing began. 
Usually it is 0.0 and click enter and record this in the excel file. 
e) A screen will pop up asking you to choose the maximum displacement as well as 
a graph. Click ok and use the cursor 
to choose the point where the slope 
is maximum, before tendon failure. 
After you select the point a warning 
dialog will pop up and tell you how 
many images there are to analyze. 
Write this in the excel document, 
click ok and then record how many 
images the program is going to 
analyze (e.g., every 4
th
 image). 
f) Next click Choose ROIs (regions of 
interest). There are four regions of 
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interest, PMMA, Stain line 1, 2 and 3 (S1, S2 and S3). The PMMA is located on 
the bone area, and when you select regions of interest for PMMA you want to 
select an area that is unique for both points. For stain line 1, 2 and 3 select the 
regions from left to right and make sure to get the full length of the stain line in 
the box. An example is shown above of PMMA and stain line 2. 
g) After you mark the regions of interest click Track ROIs and it will take about a 
minute or so to track the regions on all the images. 
h) After the tracking is done a graph will appear showing how far your regions 
moved. To ensure your tracking worked use the scroll feature located right above 
the Instron Restrict button to view your boxes across all the images. 
i) After checking that the tracking worked click Text Output and save the file as 
“32-XXX_PMMA-LR.roip” and change PMMA to S1, S2, or S3 depending 
what stain line was tracked. 
j) Lastly, copy the line from the MATLAB command window to excel 
 
3. Apply_disp 
a) This step allows us to apply the displacement of the PMMA to the first stain line 
so that we can determine the tendon strain relative to bone.  These markers should 
not move a lot. A file is created, which is used in the following steps.  
b) Type “apply_disp;” into the command line and a window will appear to choose a 
file. Choose the file you created in step 2i) for the PMMA. Click open and then 
another window will ask you to select another file and select the file from step 2i) 
for S1. 
c) A graph will appear and another window asking you to save the output file. Label 
this output file: “32-XXX_S1SYN-LR_trk.txt”. 
 
4. Trk2element 
a) This step is going to compare the movement of S2 to S1SYN, S3 to S1SYN and 
S3 to S2. 
d) Type “trk2element;” into the command line and a window will appear to choose 
a file. Choose the file you created in step 3c) called “32-XXX_S1SYN-
LR_trk.txt”. Click open and then another window will ask you to select another 
file and select the file from step 2 called “32-XXX-S2-LR.roip”.  
b) A graph will pop up showing how the two stain lines are moving relative to one 
another. After a few seconds a box will appear asking if you want to save. Click 
save and save as “32-XXX_S1SYN-S2_trk.txt”.  
c) A few other graphs will appear after you save. Copy these graphs to the 
Optikos_Figures excel spreadsheet  
d) In the MATLAB console copy the mean angle and the three lines that have data 
and start with 32-XXX_S…..txt to the respective excel pages. 
e) Repeat steps b-d comparing the file 32-XXX_S1SYN-LR_trk.txt to 32-XXX-S3-
LR.roip for S3 to S1 and 32-XXX-S2-LR.roip to 32-XXX-S3-LR.roip for S3 to 
S2. 
 
5. El2d_stiffness 
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a) Type “el2d_stiffness;” into the command line and a window will appear to 
choose a file. Choose the …eld2D.txt file you created in step 4. Click open and 
then another window will ask you to select another file and select the file from 
step 1c called “Test1.steps.tracking_optikos_csv.txt”. 
b) Once you load this a bubble will pop up called Image capture correction where 
you can adjust the time your testing began. Usually it is 0.0 so click OK. It will 
then ask you the primary loading direction. Since we stretched in the Y direction 
click Y. 
c) A graph will appear with Load against Optical Strain and a box with the image 
number will appear. Each image is represented on the graph with the blue 
diamond and black circle around it. The black line represents the best fit to these 
images. In order to achieve the best fit, delete the images associated with the toe 
region and try and get the line as fit as possible to the point. An example is shown 
above.  Specifically, choose the steepest region that best represents the curve.  
Avoid any points that stack on top of each other.  You can add/remove images by 
using the Ctrl and Shift keys on your keyboard. 
d) Click close on the image selector when your graph looks good and save the graph 
as the default name. Copy the graphs to the Optikos_Figures excel spreadsheet 
and copy the line in the MATLAB command window to excel. 
 
6. Calib_image 
Note: this step is not necessary if using 
GetLength command for frequency sweep 
analysis 
a) Navigate to the folder on the 
computer with the images for your 
specimen. Open up the images 
labeled calib~… and preview them to 
make sure they look normal. 
b) In the MATLAB console enter the 
command “calib_image;”. Select one 
of the normal images you previewed 
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in step a. 
c) A cursor will appear and select a region on the ruler (easy to do scales of 5 mm). 
When clicking the cursor select to the left of the line and drag the cursor to the 
left of another line to mark the range. An example image is shown to the right 
with the line shown in yellow. 
d) After you draw the line double click and a box will appear that says enter 
calibration object length. Enter the length that your line spans and click enter.  
e) In the MATLAB console copy the third number shown (L_cal (pix/mm)) into 
the excel file 
 
7. Calculations 
a) Stiffness (optical) is calculated by converting the Optikos output Kopt in 
N/pix to N/mm by multiplying by the conversion factor in pix/mm calculated 
using GetLength or calib_image Matlab functions.  Typically, however, we 
report grip stiffness (Kgrip) instead. 
b) Modulus (optical) is calculated by multiplying the Optikos output Kstrn in 
N/% by 100% and dividing by the tendon cross-sectional area (2-4mm). 
 
 
  
197 
 
Appendix 24: Supraspinatus Tendon MMP Activity Using Anaspec SensoLyte 520 
Generic MMP Assay Kit 
 
I. Tissue Homogenization 
A. Mince tendon samples 
1. Remove samples from -80ºC and immediately transfer to liquid 
nitrogen. 
2. Remove single sample from liquid nitrogen and place on black pad. 
3. Use blade to mice tissue into small pieces. 
4. Place samples back in tube and immediately place in liquid nitrogen. 
5. Wipe down mat/forceps with ethanol between each sample. 
6. Continue with remaining samples.   
7. Store samples at -80ºC until ready to homogenize. 
B. Tendon Homogenization 
1. Remove minced samples from -80ºC and immediately transfer to 
liquid nitrogen. 
2. Remove sample from liquid nitrogen and sandwich between folded 
aluminum foil. 
3. Use large pestle to smash sample.  Repeatedly return to liquid 
nitrogen and smash until sample is in powder form. 
4. Once pulverized, return sample to tube. 
5. Add 150µl assay buff (provided in kit) with 0.1% Triton X-100. 
6. Use micro-pestle to further homogenize sample. 
7. Store samples on ice while working on remaining samples.  
8. Centrifuge: 4ºC, 10000 rcf, 15 minutes 
9.Transfer supernatant to new labeled tube 
10. Take 28µl aliquot (transfer to new labeled tube) for BCA. 
11. Store all samples at -80ºC. 
II. Protein Quantification (BCA Assay) 
A. Refer to BCA kit directions! 
B. Make working reagent 50:1 from kit 
C. Create standards: 
Label µg/ml Buffer (µl) BSA 
H Blank (0) All none 
G 125 60 60F 
F 250 60 60D 
E 375 30 90D 
D 500 105 105B 
C 750 30 90B 
B 1000 130 130A 
A 2000 none All (full concentration) 
 
D. To each 28 µl aliquot of homogenized tendon samples add 28 µl assay buffer 
to get 1:1 dilution. 
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E. Add 25 µl of each dilute sample and standard in duplicate to plate. 
F. Add 200 µl working reagent to each well.  Pipette up and down to mix.  
G. Incubate 30 minutes at 37ºC . 
H. Read on plate reader 
I. For analysis: 
1. Average each duplicate 
2. Subtract average blank reading from each sample/standard averages 
3. Create standard curve and plot best fit line with equation 
4. Use equation to determine protein quantity from each sample 
III. MMP Activity (SensoLyte 520 Generic MMP Assay Kit) 
A. Refer to MMP activity kit directions! 
B. Calculate the amount of sample and buffer to add for each sample to ensure 
equal quantity of protein is placed in each well.  For acute tendon I used 36µg 
and chronic I used 39µg.  Total volume of sample + assay buffer should be 
49µl so that adding 1µl dilute component C (see below) will create 50µl total 
volume.   
C. For 1 plate: 
1.Dilute 5µl Component C in 100 µl assay buffer 
2.Dilute 45 µl substrate in 4455 µl assay buffer 
D. Create standards using purified human MMP-13 (also include blank): 
Label Quantity (ng) MMP-13 (µl) Assay Buffer (µl) 
I 0.1 110H 110 
H 0.2 165G 165 
G 0.4 200D 200 
F 0.5 110C 110 
E 0.6 315D 105 
D 0.8 294A 441 
C 1.0 165A 165 
B 1.5 165A 55 
A 2.0 4.1 MMP-13  995.9 
E. Plate all samples/blanks/standards in duplicate. Make sure to use 96-well 
plates, black polystyrene, non-binding surface (CLS3991 from Sigma) 
F. Activation: incubate 2 hours, 37ºC with dilute component C 
G. Activity: incubate 45 minutes room temperature with MMP substrate 
(50µl/well) covered with foil to block light 
H. Stop solution: 50µl/well 
I. Immediately read on plate reader 
J. For analysis: 
1. Average each duplicate 
2. Subtract average blank reading form all other sample/standard 
average 
3.Create standard curve and plot best fit line with equation for the 
human MMP-13 readings 
4. Use equation to determine “normalized” MMP activity of each sample 
